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Section 1 Implications of Transseptal Punctures 
The focus of this section of my thesis is assessing the biomechanical properties of the 
interatrial septum as it relates to transseptal punctures and navigation of catheters for 
ablation procedures. During a transseptal puncture procedure, incorrect device 
positioning may lead to serious complications, such as perforation of the aorta and/or 
cardiac tamponade. It is important to also consider that as a catheter crosses the septum 
there is a strain imposed on the tissue, and as such procedures continue, catheters are 
extensively manipulated to reach the desired anatomies, such as the mitral isthmus or 
pulmonary vein ostia: ultimately this may tear or shear the septal tissues. Noteworthy, 
during typical radiofrequency ablative procedures, with singular catheter tip electrodes, 
this issue is exacerbated due to the number of lesions necessary to electrically isolate the 
aberrant electrical signals. Furthermore, ablations targeting the right pulmonary vein 
antrum require an acute angle inflicting a substantial moment on the fossa ovalis, often 
eliciting septal damage. Even during catheter manipulation for more accessible 
anatomical structures, the fossa ovalis may undergoes extreme stresses and as a result 
iatrogenic atrial septal defects are induced. Importantly, these procedurally induced 
defects thus create a sufficient opening between the right and left heart, which can allow 
for the mixing of oxygenated and deoxygenated blood amongst other negative effects. 
With the direct visualization of this phenomenon using the Visible Heart® 
methodologies, one is able to directly observe their creations during radiofrequency 
and/or cryothermal ablation therapeutic procedures. 
 
In order to better understand the responses of the septum to the transseptal puncture 
procedures and/or manipulation associated with subsequent catheter navigation, we 
aimed to identify the force limits that may be imposed on the septum so not to induce 
significant iatrogenic atrial septal defects. There exists tremendous growth in the field of 
ablative therapies for treating atrial fibrillation, with new technologies being readily 
developed. Given the common range of catheter sizes, 5-12 Fr, employed today for 
clinical radiofrequency and cryothermal ablation treatments, in work described within my 
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thesis these bounds were expanded so that future iterations of such devices would not be 
excluded. The following studies were designed and performed to comprehensively 
characterize the relative behaviors of the fossa ovalis during and following the transseptal 
punctures so that device designers and clinician may better understand the impacts of 
each crossing. 
  3 
Tissue Properties of the Fossa Ovalis as They Relate to Transseptal 
Punctures: Translational Approach 
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Preface 
In order to gain access to perform cardiac ablation procedures for treating arrhythmias, 
transseptal punctures are routinely performed. With the continued growth and interest in 
such transcatheter procedures, more complex and difficult disease states can and are on 
the horizon for being treated.  Along with these treatment strategies, it should be noted 
that the required catheter sizes have increased, thus adding additional strain to the fossa 
ovalis. It was recently reported that iatrogenic atrial septal defects persistence rates were 
50% following transcatheter mitral valve repair using a 16 Fr catheter, and individuals 
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with iatrogenic atrial septal defects had increased mortality rates by a staggering 6 fold 
[1]. This highlights the need for a more comprehensive understanding of the clinical 
limits that may be imposed on the septum during cardiac procedures that utilize a 
transseptal puncture. In this study we specifically characterized the relative puncture 
forces and lateral tearing forces of the fossa ovalis induced by a range of catheter sizes. 
The data herein identified the relative consequences of performing a transseptal puncture 
and the bounds that the septum may endure prior to inducing injury. 
 
I was responsible for assisting with the protocol development with the aid of Steve 
Howard and Cole (Bryce) Holmgren: specifically Cole and I harvested, prepared, and 
performed the lateral tear force experiments. In addition, I was also responsible for the 
data and statistical analyses along with contributing to the manuscript for the lateral tear 
portions. Steve Howard led the portion of the project composing puncture forces and 
Mark Benscoter, Chris Rolfes, and I all aided in performing these experiments. 
Furthermore, I presented the preliminary results of this study at the European Cardiac 
Arrhythmia Society (ECAS) in Munich, Germany in March 2014. 
Summary 
Objectives: This study focused on how catheter size affects transseptal puncture, what 
transseptal indication means, and whether the swine model is predictive for humans. 
Background: Transseptal puncture is a common procedure that gains access to the left 
atrium, allowing percutaneous mitral valve repair, left atrial appendage closure, and left-
sided ablations. The basic approach has not changed in many years, however the 
frequency of transseptal punctures and the size of devices are increasing with emerging 
treatments. This study focused on how catheter size affects transseptal puncture, what 
transseptal indication means, and if the swine model is predictive for humans. 
Methods and Results: A broad range of devices (4F-18F) were advanced through atrial 
septa of swine hearts; some devices were inserted in both swine and human hearts using 
10F catheters. Greater forces were required to puncture through the septa of human hearts 
compared to those of swine. Larger catheters used in swine hearts required greater force 
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to advance them through the septa, causing greater dilation of tissue and sometimes 
tearing the floor of the fossa ovalis; analyses indicated an exponential increase in size of 
the iatrogenic atrial septal defect. Specific tissue property testing of the septum primum 
showed that this tissue sheared at a lower exerted force in a superior to inferior direction. 
Conclusions: Results may provide physicians with important knowledge about what to 
expect when treating a possible iatrogenic atrial septal defect or help them understand the 
consequences of transseptal punctures. Comparative data between swine and human atrial 
septal tissue properties provide critical insights between the species and offer clinicians 
and device designers important information relative to differences in tissue behaviors.  
Introduction 
Transseptal punctures (TSP) have been performed since the 1960s for a variety of clinical 
procedures [2]. The avascular fossa ovalis (FO) in the atrial septum provides an optimal 
location, as this tissue is thin and facilitates tenting to obtain access to the left side of the 
heart. It should be noted that other routes (e.g., through the arterial vasculature or 
transmyocardially) may elicit associated complications or be more difficult relative to a 
transseptal approach [3]. To perform a TSP, access to the right atrium is obtained through 
the venous system, then transseptal sheaths are advanced through the vasculature and into 
the right atrium. The placement of the sheath onto the FO is identified by watching for a 
characteristic “jump” of the dilator tip following retraction and dragging of the 
transseptal equipment inferiorly. After the FO has been located, the tenting can be 
generally visualized through fluoroscopy and, more commonly, echocardiography [4,5]. 
A physician will tend to look for the most optimal portion of the septum to puncture 
based on the type of left atrial procedure that needs to be conducted. Additionally in some 
patients, more than one puncture may be conducted to simultaneously advance different 
types of catheters into the left atrium. Nevertheless, the optimal placement of the 
puncture location is very important, as it will commonly affect the ultimate success or 
ease of a given clinical procedure [6].  
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The complication rates associated with transseptal punctures are cited to be as low as 
0.74% of procedures intraoperatively [7]. Yet, the post-operative outcomes are 
considered separately and incidences of remnant interatrial shunts have been reported. 
For example, McGinty et al. presented a review indicating prevalence of iatrogenic atrial 
septal defects (IASDs) to be as high as 87% post procedure and, at an 18-month follow-
up, incidences were reported as high as 15% [8]. Although the authors suggest that most 
of these created holes were resolved over time and the IASDs were not associated with 
clinical issues such as embolism, cyanosis, or right heart failure, they could still present 
issues especially if one assesses potential new procedures involving TSPs with larger 
sheaths [8].  
 
As mentioned above, there are a number of procedures that require a TSP including left-
sided cardiac ablations, percutaneous mitral valve repairs, mitral balloon valvulotomies, 
left atrial appendage closures, and certain ventricular assist device placements [3,9–18]. 
These procedures along with some newer and future procedures, including left ventricular 
endocardial pacing and percutaneous mitral and aortic valve implantation, could 
potentially bring about a greater prevalence of TSPs and thus higher incidences of 
potential complications [19–21]. As cardiology procedures have progressed, the range of 
sizes for transseptal devices has increased. To date, the smallest transseptal devices 
typically are 4F and range up to the largest reported of 22F [8,20]. This latter size range 
has prompted discussions regarding what the FO is capable of tolerating, a topic 
addressed in previous publications [8,12,14,22]. Yet, we consider here that a detailed 
study investigating the specific tissue properties of the FO and the impact of the various 
sized catheters on IASD formation is necessary to help understand clinical limits.  
 
In addition to the puncture that is created in the FO, manipulation of catheters and tools 
across the septum may result in the tissues being stretched and/or torn, resulting in larger 
IASDs. A previous study relative to this topic was performed by Saitoh et al. with a 
mitral valve clip procedure under echocardiography [10]. The subsequent holes created 
and identified were elongated and elliptical (not circular), suggesting that the simple 
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puncture forces were not the only strains being placed on the septum, but rather some 
radial/shear forces applied by the catheter could potentially cause tears in an axial 
direction. Our present study was designed to provide additional insights relative to the 
tissue properties of the FO in relation to TSPs. Yet, by additionally utilizing both ex vivo 
swine and human hearts for a subset of our experiments, multiple variables could be 
studied and a relation to human cardiac anatomy can be specifically assessed [23–25].  
Methods 
Obtaining tissue and preparation 
Swine hearts (n=48) were obtained fresh and were transported on ice and then dissected 
within 8 hours post excision. The right and left atria were opened to expose the interatrial 
septum while keeping intact the tissue surrounding and supporting the FO. The isolated 
cardiac tissues were warmed to 37°C using a circulating water bath. Images of the FO 
were taken pre- and post- puncture. 
 
Human hearts were received as a donation for research to the University of Minnesota 
from organ donors whose hearts were deemed not viable for transplantation (via 
Lifesource, St. Paul, MN, USA). Table 1 provides brief medical histories of the donors 
including these cardiac conditions: one with atrial fibrillation, one with hypertension, and 
one with an unspecified “heart problem.” Exclusion criteria for testing included lack of 
an intact atrial septum and other congenital abnormalities that would disallow the suction 
device to be implemented. These hearts were warmed with 37°C saline. 
Table 1. Baseline characteristics of human hearts (n=7). 
 
Demographic Measurement 
Male (%) 57.1 
Age (years) 58.4±5.7 
Weight (kg) 86.0±30 
 
Catheter and fossa holder method  
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A suction device on a positionable arm provided circumferential adhesion surrounding 
the FO to hold the interatrial septum in a secure manor (Figure 1). The devices used in 
these experiments were composed of a dilator and sheath, and had internal diameters of 4, 
8, 10, 12, 16 and 18 French, according to manufactures’ specifications. 
 
Figure 1. Radial adhering suction device for stabilization of the atrial septum for tissue puncturing. 
(A) Force testing machine with transseptal device attached and puncturing the atrial septum. (B) 
Close-up view of the atrial septum and stabilization device employed for puncturing.  
 
 
Catheters were trimmed to a length of 15cm, and the dilator and sheath were bonded 
together with ultraviolet cure adhesive (Loctite, Henkel, Düsseldorf, Germany) at the cut 
end of the catheter. A Brockenbrough® (BRK, Medtronic, Inc., Fridley, MN, USA) 
transseptal needle, was cut 18cm from the tip and straightened to protrude from the 
dilator tip, as it would in clinical practice. The end of a Brockenbrough needle was 
separated from the main shaft and adhered into the tips of each of the dilators of those 
catheters with a stiff metal rod through the dilator to provide mechanical support for the 
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needle tip (Figure 2). The catheters were either clamped or inserted into a connector 
attached to a load cell for obtaining puncture forces.  
 
Figure 2. Schematic of transseptal devices used for testing. The dilator was seated into the sheath and 
attached at the proximal end via adhesive. The center lumen was kept clear for a needle to be placed 
through it and protrude from the distal tip.  
 
Tenting and puncture testing 
A circumferential suction device was attached to the atrial septa of either swine or human 
hearts (Figure 1) to allow for continuous and repeatable fixation of the FO, as noted 
above. The device was locked into place with the FO in the center of the suction ring, and 
the FO was placed perpendicular to the trajectory of the transseptal catheter.  
 
The forces required to puncture and tent the FO at various locations were obtained by 
using mechanical force tester (Instron, Norwood, MA, USA; Chatillon TCD225, Largo, 
FL, USA). The relative locations of tenting and punctures were defined in relation to the 
superior, inferior, anterior, and posterior orientations (Figure 3). The shortened catheters 
were affixed to the load cell so that their trajectory was normal to the floor of the FO. 
Following stabilization of the FO with the suction device, the catheters (without the 
needle protruding from the dilator) depressed the FO to a depth of 8mm for swine hearts 
and 12mm for human hearts at a rate of 254mm/min and then retracted to the starting 
position. The difference in the protocol between human and swine experiments was 
related to the identified differences in the tissue compliance between the swine and 
human tissues based on pilot studies of the tissue (data not shown). Then the catheters 
were driven through the FO with a transseptal needle protruding from the dilator at a rate 
of 254mm/min at various locations on the FO. 
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Figure 3. Location of the fossa ovalis (FO) in relation to other anatomy within the right atrium (RA): 
the inferior vena cava (IVC), and the coronary sinus ostium (CS Os). The numbers indicate various 
puncture locations: (1) center, (2) inferior, (3) posterior, (4) superior, and (5) anterior. 
 
 
Initial analyses of the force versus distance relationships indicated that the largest forces 
required for transseptal puncture were when the tips of the needles, tips of the dilators, 
dilations of the septum, and tips of the sheaths were going through the septum (Figure 4). 
The forces and distances were recorded by the system for each of these events for the 
various puncture locations. Following the punctures, the remnant holes were measured. 
 
  11 
 
Figure 4. Characteristic force verses distance graph during fossa ovalis puncturing. Note the 
distinctive peaks during each transition of the dilator and sheath; upon reaching a new layer, the 
force increases due to the need for fossa ovalis expansions. 
 
Fossa shear force analyses 
Additional swine hearts were obtained ranging from 400-650g in size (n=70). The atrial 
septum including approximately 5mm of tissue surrounding the floor of the FO was 
excised from each heart. Samples were randomized to size and direction groups, and the 
inferior or posterior portion of the musculature surrounding the FO floor was cut off 
(Figure 5 A). The FO was punctured with a transseptal Brockenbrough® needle and then 
a 4F, 12F, or 18F sheath was advanced through the septum. In all cases, the sheath and 
dilator were maintained in a perpendicular position relative to the floor of the FO via a 
custom fixture (Figure 5 B). While the side of the FO opposite the cut side was anchored, 
the sheath was pulled away from the base at a rate of 100mm/min causing it to rip 
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through the FO, employing a mechanical force tester. These atrial septa were ripped 
towards the cut section of the septum in either a superior or posterior direction. The 
average sheath ripping forces were defined as the average forces while the septum 
primum was ripping. To illustrate, Figure 5 C shows that the 10-19mm extension portion 
for this sample was defined as the average ripping force, while the peak sheath ripping 
force was the highest force recorded. Fossa ovalis dimensions, average ripping force, and 
peak sheath ripping force were also recorded. 
 
Figure 5. Schematic representation of the fossa ripping test setup. The muscular tissue adjacent to 
the septum primum (posterior rim of the fossa ovalis for posterior pulls and superior rim for inferior 
pulls) was cut off to allow the sheath to fully disengage from the atrial septum without consequence 
from the muscular portion of the atrium surrounding the floor of the fossa ovalis (A). The fossa 
ovalis was ripped by a catheter which was inserted through the floor of the fossa ovalis in the 
mechanical force tester (B). An example of the resultant force versus extension plot is shown in (C). 
 
 
 Statistical analyses 
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All data are represented as the mean±SE unless otherwise noted. Student’s T-tests were 
used for one-to-one comparison and ANOVA was employed for multi-group 
comparisons. Significance was determined with a p-value<0.05. 
Results 
Tenting studies 
The initial tenting experiments showed that the average forces required to tent and extend 
the septum primum by 8mm were greater for the human hearts compared to swine 
(199±30gf vs. 135±5gf respectively, p<0.001). By breaking down the data to assess the 
relative effects of location on the tenting forces, only one statistically significant 
difference was identified in the inferior portion of the FO, where the human tenting was 
significantly higher (145g±65g, n=40, vs. 292g±213g, n=8; p<0.01). The remainder of 
the species comparisons for each location were not significantly different (Figure 6). Yet, 
if one combines all tenting data per species, the swine hearts were shown to require 
significantly less force to tent the fossa regardless of the location (swine 138±5g n=180 
vs. human 199±30g, n=23, p<0.001). 
 
Figure 6. Forces required to tent the fossa ovalis by 8mm. Experiments were performed on excised 
human (n=8) and swine (n=40) hearts. (*=p<0.01, **=p<0.001) 
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Puncture forces: human vs. swine comparisons 
Human heart specimens were punctured only with the 10F catheter for comparison to the 
swine hearts. These punctures produced characteristic force versus distance plots, where 
the forces for the needle, tips of the dilator, and the sheaths to pass across the septum 
were easily observable as transient peak forces (Figure 4). The other force recorded of 
interest was the maximum force seen during the dilation phase of the septum (i.e., when 
the tapered portion of the dilator passed through the FO).  
 
When comparing the 10F catheter data between swine and human samples, the results 
showed a higher force required for each portion of the catheter (Figure 7). The greatest 
difference between species was observed for the data between the peak forces of the tip 
of the dilator, requiring 240% greater forces for the human hearts. It should be noted that 
significant differences were found when comparing the average forces required to pass 
the various potions of the catheter through the septum for the tip of the dilator, dilation, 
and the sheath (p<0.01 for each; Figure 7). 
 
Figure 7. Average peak forces required to pass various portions of 10F sheath through the septum 
primum in isolated septa of human and swine hearts. Significant differences were found 
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between these two species when comparing the tip of the dilator, dilation, and sheath forces 
(*=p<0.01, **=p<0.001) 
 
Puncture forces: sheath size comparisons 
The variability in the needle punctures alone resulted in an average puncture force of 
201±75gf (±SD) with the 176 punctures that were performed with the Brockenbrough® 
needle. To account for these variations in tissue performance, the subsequent portions of 
the sheath were normalized to the needle puncture forces. This was done to help 
determine the relative relationship between sheath sizes and resultant forces required to 
traverse the atrial septum. Subsequently, it was found that there was a direct correlation 
between catheter size and the forces required to pass through the septum. ANOVAs were 
performed for each of the sheath sections and we found significant differences within 
each group with p-values<0.001 (Figure 8). The other notable trend observed was that the 
dilation forces were significantly less for each of the sheath sizes compared to both the 
passing of the tips of the dilator and/or the shaft of each sheath (p<0.02 in all instances).  
 
Figure 8. Relative forces required to traverse the atrial septum with various portions of a transseptal 
sheath of difference sizes. (Ŧ=p<0.001 based on ANOVA) 
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Following the punctures, images were taken of the resultant holes formed in the atrial 
septa. The minimum and maximum lengths were determined and plotted in relation to the 
outer diameter of the sheath. There was a positive correlation between the resultant hole 
sizes and the sheath sizes, as would be predicted. These data identified an exponential 
increase in resultant hole sizes (Figure 9).  
 
Figure 9. Minimum and maximum diameters of induced iatrogenic atrial septal defects, following 
transseptal punctures employing various sized catheters. 
 
Septal ripping forces 
A summary of septum ripping by utilizing different sheath sizes is presented in  
Table 2. The chosen direction of induced FO ripping had a significant impact on the 
resultant average tearing force and peak tearing force (p<0.05). Superior-to-inferior 
induced rips required an average tearing force of 301±26gf, while those elicited in the 
anterior-to-posterior direction required 363±41gf ( 
Table 3). Also, larger forces were required to rip the septa with larger sized sheaths 
(Figure 10). The averages of the mean sheath tearing forces were 258±20, 362±25, and 
555±56gf for the 4F, 12F, and 18F sheaths respectively; there were significant 
differences between the sheath sizes and sheath tearing forces between the 18F and 4/12F 
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groups (p<0.001). Heart weight, animal weight, FO thickness, and width (superior-to-
inferior) did not statistically differ between any of the groups (p>0.05). 
 
Table 2. Summary of fossa ovalis dimensions and sheath tearing forces listed by sheath size. 
 
4 F 
(n=15) 
12 F 
(n=20) 
18 F 
(n=15) p-value 
Fossa ovalis thickness 
(mm) 1.1±0.1 1.2±0.1 1.1±0.1 0.727 
Superior/inferior width 
(mm) 16.5±1.1 14.3±0.7 15.7±1.2 0.241 
Anterior/posterior width 
(mm) 10.7±0.9 7.7±0.6 9.2±0.7 0.005 
Average tearing force (gf) 258±20 301±26 555±56 p<0.001 
Peak tearing force (gf) 344±26 417±37 704±72 p<0.001 
Heart weight (g) 487±10 464±13 451±10 0.563 
*Values are reported as mean±SE 
 
Table 3. Directional differences in septal tearing forces using a 12F sheath. 
 
Superior-to-
Inferior 
(n=20) 
Anterior-to-
Posterior 
(n=20) p-value 
Fossa ovalis thickness (mm) 1.2±0.1 1.1±0.1 0.717 
Superior/inferior width (mm) 14.3±0.7 14.8±1.1 0.569 
Anterior/posterior width (mm) 7.7±0.6 7.9±0.7 0.480 
Average tearing force (gf) 301±26 424±41 0.012 
Peak tearing force (gf) 417±37 551±60 0.033 
Heart weight (g) 464±13 452±18 0.844 
*Values are reported as mean±SE 
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Figure 10. Catheter size versus average tearing force. Tearing forces of the fossa ovalis increased 
with the usage of a larger diameter sheath, but did not significantly differ between the 4F and 12F 
sheaths (p>0.05). Error bars depict mean±SE. *p-value<0.001 
Discussion 
There are a number of different procedures requiring TSP including left-sided cardiac 
ablations, percutaneous mitral valve repairs, mitral balloon valvulotomies, left atrial 
appendage closures, and certain ventricular assist device placements [3,9–18]. In many 
cases, the tissue of the FO is punctured and manipulated with large size devices. This 
study described a series of translational experiments that were performed to better 
understand the biomedical impacts of procedures that require the transseptal delivery of 
catheter systems through the atrial septum.  
 
The results of this study showed that a swine model is helpful to determine the forces 
required for eliciting tenting and punctures, and that the forces measured were less than 
those seen in humans (121±11gf  vs. 146±26gf, p<0.001). Further, it is important to note 
that in both human and swine hearts, with the exception of potentially trying to tent the 
muscular septum, the relative septal location at which one chose to puncture was not 
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material to the amount of force that may be required to produce tenting. The devices used 
in this study showed that, on average, the needle tented the septum 9.3±.3mm in humans 
and 9.8±.14mm in swine hearts (p=0.2), prior to ultimately perforating the septum. These 
outcomes demonstrate the ability of the swine model to serve as a proxy for humans.  
 
In addition, the risk of cardiac tamponade continues to be a concern when conducting the 
TSP. Using the outcomes from this study, in an a heart ranging from approximately 
30mm to 50mm in diameter [26–28], the needle will strain the FO approximately 25% of 
the distance into the left atrium before perforating and thus protruding into the left 
atrium. One should also keep in mind that this does not take into consideration that there 
is a slightly lateral but also superior trajectory on the needle when deployed through most 
TSP devices. These factors could potentially explain clinical incidents of left atrial 
perforation and resultant tamponade [13].  
 
Within the puncture data, the relative variability was notably similar between the swine 
and human tissue groups; the standard deviation was 33% of the mean for human 
punctures and 37% for swine. Further, these values correlated to 75gf for the swine hearts 
and 90gf for human specimens, when assessing the Brockenbrough® needle puncture 
forces alone. Importantly, since the same needle was used, this variation was most likely 
due to the differences in cardiac anatomy or slight changes in tissue thickness. 
Furthermore, larger catheters resulted in greater forces required to cross the septum; 
similarly, it was observed visually that as catheter size increased so did the remnant holes 
that were created. These remnant holes may contribute to the ability for post-procedure 
healing. It has been reported that most IASDs close in patients over time, but in some 
individuals this can take up to year
7
. 
 
An observation was made that subsequent stretching of these tissues required lower 
forces in swine, especially in the case of the dilator tips and dilation shafts. However, this 
is not necessarily the case for human tissue. Notably, the dilator tips deployed in the 
human septum required more than twice the force relative to swine tissue. This can be 
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interpreted to indicate that there are clear distinctive differences between the atrial 
anatomies of these two species, which could potentially relate to the tissue structure or 
composition. Yet, it should be noted that another potential source of variability in our 
data could be associated with varied disease states and cardiac morphologies that were 
present within the donated human hearts.  
 
While medical device developers are striving to use the smallest types of delivery 
systems possible, catheter sizes in the realm of overall TSPs are getting larger due to their 
more complicated nature, e.g., with percutaneous mitral repair systems like the Abbott 
Mitra Clip being placed through a 22F catheter. Similarly, there is a major industry push 
to develop transcatheter mitral valve replacement systems that will be delivered via TSP; 
for comparison, the current transcatheter aortic valve systems utilize delivery catheter 
sizes ranging from 18F to 24F
 
[29]. Needless to say, new mitral valve delivery catheters 
would probably be similar in size (if not larger) due to the difference in mitral and aortic 
valve circumferential areas. Thus when these technologies are deployed in humans, the 
clinician should have a good understanding of how the septum will react to the TSP 
[10,30]. In clinical use, navigating transseptal catheters within the left atrium typically 
requires sheath manipulation and risks FO tearing. Although procedures are trending 
toward larger sheath use, the incidence of FO tearing may be lower due to the larger 
sheer forces in larger sized catheters (Figure 10). Further studies will need to specifically 
investigate FO tearing in order to fully characterize septal damages sustained by various 
clinical procedures. 
 
Study limitations 
The availability of human hearts for such studies is rare as one would expect, thus the 
majority of described experiments were performed with swine hearts. The use of swine 
hearts provided a method to test multiple catheter types, and we were able to relate these 
results to a subset of comparative human tissue trials.  
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The true mimicking of physiological conditions imposes other issues related to force 
application on the catheter to puncture the atrial septum while accurately recording the 
displacement and the load. Using a consistent and repeatable suction device to hold the 
septum allows for a more controlled study with respect to load and displacement. Along 
with the consistency, the rate at which the tissue was pulled or punctured was kept 
consistent as a way to reduce the variables in the experimental setup.  
Conclusion 
These translational in vitro studies of fresh heart specimens, both human and swine, 
provide a unique perspective on the challenges of conducting a transseptal procedure and 
present compelling data for further discussion on the device size constraints as more 
devices are constructed. In these uniquely designed experiments, we specifically 
observed that swine can serve as a reasonable model to mimic the human condition. In 
addition, advancements that are tested in the swine model can serve as a more rigorous 
application due to the more delicate nature of the swine anatomy.  
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Preface 
As previously mentioned, transseptal punctures usage has been increasing in recent years 
with the advent of technological advancement and/or numerous novel minimally invasive 
cardiac procedures. In this study, our aim was to distinguish if performing the transseptal 
puncture with an array of needle types could reduce the relative required forces needed to 
cross the septum and/or to minimize damage to the fossa ovalis during catheter 
manipulation. Specifically, we developed a transseptal puncture system to compare 
against the two currently employed clinical systems that are routinely utilized. Using 
methodologies I helped previously developed within our laboratory [31], Mark 
Benscoter, Megan Schmidt, Lars Mattison, and I together harvested, prepared, and 
performed the herein described puncture and lateral tear force experiments. I was the lead 
investigator for the septal tearing component of the project and completed the data and 
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statistical analyses as well as contributed to the manuscript for those sections. Mark and 
Megan shared these same responsibilities for the punctures portion of this experimental 
paradigm.  I also presented preliminary results of this study at the Transcatheter 
Cardiovascular Therapeutics (TCT) conference in Washington, DC in September of 
2014. 
Summary 
Objectives: Quantitatively compare catheter delivery systems of different sizes, with and 
without RF needles, for performing atrial transseptal crossing. Investigate puncture force 
required to cross the septum and potential anatomic damage of the fossa ovalis (FO). 
Background: Left atrial access is required for transcatheter therapeutic approaches, such 
as mitral valve repair/replacement, left atrial appendage closure/ligation, and left heart 
endocardial ablation. Advancements in device designs have changed how catheter 
delivery systems perform transseptal punctures, including variations in sheath size and 
use of RF energy instead of mechanical force for device delivery. Questions exist 
regarding the ability of the FO and associated structures to withstand the biomechanical 
impact of transseptal puncture force.  
Methods: We analyzed the puncture and tear force of FOs from 167 swine hearts after 
transseptal punctures using: conventional curved transseptal needles (TN), RF transseptal 
needles (RFTN), or 5-Fr RF electrodes tipped with small segment of a TN (ETN). Four 
delivery systems were assessed (12-, 16-, 18-, 23-Fr).  
Results: Mean puncture force for the dilator and sheath was significantly different for the 
3 methods for 12-, 18-, and 23-Fr sizes (P<0.05). Comparing needles, normalized mean 
puncture force of the TN (100±54.6 grams) was significantly different from ETN 
(64.9±32.9 grams)(P=0.01). Comparing delivery systems, normalized mean puncture 
force of the 12-Fr system (100±36.7 grams) was significantly different from the 23-Fr 
system (157.6±66.2 grams)(P=0.005). The FO withstood greater peak tearing forces with 
a 23-Fr ETN, compared with all other sizes (P=0.01).  
Conclusions: These results are invaluable for clinicians and engineers designing new 
transseptal medical devices to prevent anatomic damage.  
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Keywords: Atrial fibrillation; atrial fibrillation ablation; transseptal catheterization; 
transseptal puncture; left atrial access 
 
Abbreviations 
ETN=radiofrequency electrode with the tip of a transseptal needle 
FO=fossa ovalis 
RF=radiofrequency 
RFTN=radiofrequency transseptal needle 
TN=transseptal needle  
 
Introduction 
Ongoing development of new devices for cardiac therapies continues to rely on 
performing transseptal punctures to access the left atrium, a technique originally 
developed by Ross et al. and Cope et al. in 1959 [32,33]. But the increasing size of 
devices and their subsequent manipulation because of increasing procedural complexity 
are, more and more, challenging the limits of the fossa ovalis (FO), particularly its ability 
to stretch without tearing (Figure 11). 
 
Figure 11. (A) Swine heart’s torn fossa ovalis with a sheath through the opening made by a 
transseptal puncture, as viewed from the left atrium. (B) Human fossa ovalis puncture, as viewed 
from the left atrium. 
 
To successfully treat cardiac diseases, it is essential to have access to the anatomy in a 
way that is least likely to incur injury. Crossing the septum through the FO has a major 
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impact on device delivery into the left heart and on the ability to reach key anatomic 
locations, such as the mitral isthmus, the mitral valve, and the pulmonary veins. The use 
of cryogenic balloon ablation therapies and transcatheter mitral valve repair and 
replacement devices requires 12- to 24-Fr delivery systems. Ideally, systems for 
accomplishing transseptal punctures would allow the tissue to dilate and be manipulated 
without tearing.  
 
Recent advancements in device designs have prompted changes in how catheter delivery 
systems perform transseptal punctures, including variations in sheath size (12-, 16-, 18-, 
and 23-Fr) and the use of radiofrequency (RF) energy rather than mechanical force. RF-
based needles, intended to reduce the risk of cardiac tamponade, use RF energy delivered 
through the tip of the transseptal needle, typically at 10 watts for a period of 1 to 10 
seconds [34–38].  
 
In our study, the primary objective was to quantitatively compare catheter delivery 
systems using different sheath sizes (12-, 16-, 18-, and 23-Fr), with or without RF, for 
performing atrial transseptal crossing. Specifically, our focus was on the puncture force 
required to cross the septum and its impact on anatomic damage (tearing) of the FO. We 
reviewed the puncture force and dilation strain of traditional and RF-based transseptal 
puncture systems, analyzed the impact of large-diameter delivery systems, and assessed a 
RF device using 4 different delivery system sizes.  
Methods 
Study population  
Fresh swine hearts (n=167) were obtained from Glencoe Family Farms (Glencoe, MN, 
USA), the University of Minnesota’s Large Animal Veterinary Department (St. Paul, 
MN, USA), and the Visible Heart
® 
Laboratory (Minneapolis, MN, USA). Hearts were 
dissected within 24 hours after they were excised. We first visualized the FO through the 
inferior vena cava, and then opened the right and left atria to expose the interatrial 
septum. Next, we removed the septal tissue, taking care to keep intact all tissue 
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surrounding and supporting the FO. Each specimen included at least 5 mm of adjoining 
atrial septal tissue.  
 
Puncture devices  
To perform transseptal punctures of the FO, 3 devices were utilized: (1) conventional 
curved transseptal needle (TN) (Brockenbrough
®
 Medical, Medtronic, Inc., Minneapolis, 
MN, USA) with a dilator and sheath; (2) NRG
® 
RF transseptal needle (RFTN) (Baylis 
Medical Company, Montreal, QC, Canada) with a dilator and sheath; and (3) 5-Fr RF 
electrode with the tip of a TN (ETN) along with a dilator and sheath (Figure 12). We used 
the 5-Fr ETN to understand whether an initial puncture with a larger RF tool would have 
an effect on the subsequent force for the dilator and sheath, particularly in the 18- and 23-
Fr sheath sizes. 
 
Figure 12.  (A) Three transseptal puncture devices used in this study including (top to bottom): 5-Fr 
RF electrode with the tip of a transseptal needle (ETN), radiofrequency transseptal needle (RFTN), 
and a conventional curved transseptal needle (TN) (scale bar=1 cm). (B) Components of the three 
devices (purple=sheath, green=dilator).  
 
Each delivery system was comprised 3 parts: sheath, dilator, and needle. For dilator 
dimensions, we defined the distal diameter as the diameter of the opening at the tip of the 
dilator, taper length as the distance from the tip of the dilator to the end of the tapered 
section of the dilator on the shaft of the dilator, and shaft diameter as the diameter of the 
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shaft of the dilator at the end of the tapered section (Table 4). For sheath dimensions, the 
outer diameter was measured (Table 5).  
 
Table 4. Dilator dimensions for each delivery system 
 
12-Fr 
TN & 
RFTN 
12-Fr 
ETN 
16-Fr 
TN & 
RFTN 
16-Fr 
ETN 
18-Fr 
TN & 
RFTN 
18-Fr 
ETN 
23-Fr 
TN & 
RFTN 
23-Fr 
ETN 
Distal diameter 
(mm) 
1.63 2.43 1.57 1.97 1.5 1.95 2.21 2.42 
Taper length 
(mm) 
14.02 10.14 65.04 49.5 56.12 59.58 64.15 68.77 
Shaft diameter 
(mm) 
3.56 3.5 5.36 5.32 5.82 5.8 7.57 7.59 
ETN=5-Fr RF electrode with the tip of a transseptal needle; RFTN=radiofrequency 
transseptal needle; TN=transseptal needle 
 
Table 5. Sheath dimensions for each delivery system 
 
Sheath size 
12-Fr 16-Fr 18-Fr 23-Fr 
Outer diameter (mm) 4.84 5.86 6.83 8.60 
 
Force testing  
For all force measurements, both the puncture device and the septal tearing method used 
the same load cell for force measurements. To measure the puncture and tearing force of 
the FO, we used the Chatillon TSD110 Digital Force Tester™ (Chatillon, Largo, FL, 
USA). We mounted the specimens as described by Howard et al. [31]. After tissue 
mounting, we activated the tester with data logging to complete either FO puncturing or 
septal tearing. To determine maximum puncture force, maximum tearing force, and mean 
tearing force, we used MATLAB (MathWorks, Natick, MA, USA) assessing the stress-
strain curve.  
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FO puncturing 
To confirm the puncture location, we directly visualized the FO (Figure 13B). The 
selected needle or electrode was inserted into the dilator until it extended approximately 2 
cm past the tip of the dilator, then it was placed in close proximity against the FO, 
perpendicular to the center of the FO. The needle or electrode was extended past the tip 
of the dilator and placed against the FO. Then, the septum was mounted in preparation 
for puncture (Figure 13A). The system was advanced at a rate of 254 mm/min upon the 
FO until the needle, dilator, and sheath fully crossed the FO. The remaining pieces of the 
delivery system were advanced across the FO, with all 3 devices, once the septum was 
punctured. 
 
Figure 13. (A) Setup for transseptal punctures, with the device positioned to be inserted through the 
fossa ovalis (FO) mounted on a plate; all 3 components—sheath (S), dilator (D), and needle (N)—
were oriented perpendicular to the specimen. (B) Septal tissue prepared for puncture (red oval shows 
the FO). 
 
The approach was similar with the RFTN. The RFTN was connected to the RF generator 
(Baylis Medical Company), and RF energy was delivered using 10 watts while the entire 
system was advancing toward the fossa at a rate of 254 mm/min. The rate of movement 
was set to match the same rate as the conventional curved TN, in an attempt to mimic 
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current clinical practice. Energy delivery was initiated before contact with the tissue and 
terminated after puncture.  
 
With the ETN, a 5-Fr electrode using RF energy was delivered using 30 watts with the 
Medtronic Atakr
®
 (Medtronic, Inc.) generator. The ETN was connected to the RF 
generator and advanced at a rate of 127 mm/min until puncture was achieved. Note that, 
with the ETN, the rate was reduced by half, in order to allow time for the RF energy to 
affect the tissue. The photo and diagram in Figure 13 were each derived using a Chatillon 
TSD110 Digital Force Tester™ (which moved the system and recorded forces). The 
tissue specimen was bonded to the holding apparatus using Loctite adhesive (Henkel 
Corporation, Westlake, OH, USA).  
 
Contained within the dilator of the ETN was a 5-Fr electrode with a TN tip at the distal 
end, which enabled contact with the tissue. The outer diameter of the dilator and the inner 
diameter of the sheath were similar to prevent a gap at the interface of each. In addition, 
the dilator had a tapered tip to allow for easy advancement across the septum, reducing 
the risks of tearing the FO. The dilator tip of the ETN was placed against the tissue to 
induce a mild degree of tenting. The device was advanced, while energy was delivered to 
the tip, to perform the puncture. The internal lumen of the dilator remained unobstructed, 
to allow for the needle and electrode to pass through the lumen and extend beyond the tip 
of the dilator. The amount of needle extension beyond the tip of the dilator was 
predetermined, given a restriction in the internal diameter of the dilator at the tip. The 5-
Fr electrode was placed on the tip of a flexible Pebax
®
 shaft (Arkema, Colombes, France) 
and then inserted through the inner lumen of the dilator. The catheters were attached 
using a custom fixture to a load cell for obtaining continuous puncture forces.  
 
Septal tearing  
For septal tearing experiments, we used 86 swine hearts (weight: 175 to 625 grams). For 
each specimen, we excised the FO and surrounding tissue, then punctured each FO with 1 
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of 3 devices (TN, RFTN, or ETN). Next, we advanced the dilator and sheath (12-, 16-, 
18-, or 23-Fr) through the specimen.  
 
Once the puncture was performed, we mounted the specimen on the fixture such that no 
force was being placed against the specimen, as described by Howard et al. [31]. The 
delivery system was maintained in a perpendicular position relative to the FO via a 
custom fixture. To remove any excess septal tissue, we made a cut superior to the FO, 
thereby ensuring that only FO tissue would tear during each test while leaving the 
surrounding septal tissue unaffected. For each test, we used a TSD110 Digital Force 
Tester™ to pull the sheath away from the base, tearing through the tissue at a rate of 100 
mm/min. The atrial septa were ripped in an inferior to superior direction. Once the sheath 
was no longer in contact with tissue, the test was terminated. We defined sheath tearing 
force as the mean force while the septum primum was tearing, and adapted our FO 
tearing method from Howard et al. [31]. For this study, we recorded all FO dimensions, 
as well as mean and peak sheath tearing force. 
 
Statistical analysis 
Each experiment included randomized specimens of the variables, along with t tests and 
P values (set at <0.05), to determine statistically significant differences between means. 
To examine the influence of change in variation, we normalized the puncture force data, 
using a needle type and sheath size as a reference point. To examine the relationship 
between the anatomy and puncture devices, we used analysis of variance (ANOVA) with 
a resulting R
2
value. For all analyses, we used Minitab version 12 (Minitab Inc., State 
College, PA, USA).  
 
Results 
In our comparison of the needle subgroups, we found that sheath size affected the force to 
cross the septum and FO resistance to tearing. In addition, the use of RF energy changed 
the force necessary to cross the FO. To the best of our knowledge, this study is the first to 
show how a larger puncture device can acutely affect performance of transseptal 
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punctures, sometimes doing so as well as, or even better than, more traditional methods 
(Figure 14).  
 
Figure 14. (A) Force data (in grams) for all tearing and puncturing by needle type: transseptal needle 
(TN), radiofrequency TN (RFTN), or 5-Fr RF electrode with the tip of a TN (ETN). (B) Force data 
(in grams) for all tearing and puncturing by sheath size: 12-, 16-, 18-, or 23-Fr. 
 
To analyze the results, we first divided all data points into subgroups by needle type (TN, 
RFTN, and ETN). For those 3 subgroups, we calculated the mean and standard deviation 
(SD) for the dilator (TN, 299.5±135.3; RFTN, 332.1±107.6; and ETN, 221.1±74.7 
grams), sheath size (TN, 337.8±126.9; RFTN, 353.9±90.2; and ETN, 272.9±100.4 
grams), and tearing force (TN, 272±128; RFTN, 239±128; and ETN, 272±151 grams) 
independent of sheath size (Figure 14A). Next, we divided all data points into subgroups 
by sheath size (12-, 16-, 18-, and 23-Fr). For these 4 subgroups, we calculated the mean 
and SD for the dilator (12-Fr, 240.4±71.3; 16-Fr, 298.8±131.3; 18-Fr, 202.7±102.01; and 
23-Fr, 379.8±118.9 grams), sheath size (12-Fr, 413.7±101.4; 16-Fr, 260.2±125.5; 18-Fr, 
185.4±64.3; and 23-Fr, 426.9±132.1 grams), and tearing force (12-Fr, 236±9; 16-Fr, 
242±128; 18-Fr, 227±114; and 23-Fr, 365±173 grams) independent of needle type 
(Figure 14B). 
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FO puncturing  
Our study produced a total of 81 FO punctures from 81 specimens. We first analyzed 
puncture force across all sheath sizes by the 3 components (needle, dilator, sheath) of the 
delivery system (Figure 15A). Then we calculated the mean and SD of each of the 3 
devices across all sheath sizes (TN, 300.7±163.1; RFTN, 207.6±139.4; and ETN, 
181.8±93.5)(Figure 15B). The puncture force for the 2 RF-based methods (RFTN, ETN) 
was significantly less than for the TN (RFTN vs. TN, P=0.03; ETN vs. TN, P = 0.004). 
Finally, we examined the puncture force of each paired dilator/sheath combination. In our 
analysis of all 81 specimens, we found no relationship between the dilator and sheath 
puncture force (R
2
=0.29)(Figure 15C).  
 
Figure 15. (A) Mean puncture force and standard deviation (in grams) for the needle, dilator, and 
sheath by sheath size (for all specimens). (B) Mean puncture force and standard deviation (in grams) 
by needle type: transseptal needle (TN), radiofrequency TN (RFTN), or 5-Fr RF electrode with the 
tip of a TN (ETN) (for all specimens). (C) Relationship between dilator and sheath puncture forces 
with an overall R
2
 of 0.29.  
 
Next, we grouped all data points by sheath size (12-, 16-, 18-, and 23-Fr) and then placed 
them in subgroups by needle type (TN, RFTN, and ETN)(Figure 16). To determine any 
significant differences in the amount of force to cross the FO, we compared each of our 
delivery systems against the 12-Fr system, which is used extensively in transseptal 
applications. Using the TN, we found significant differences between the 12- and 18-Fr 
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sheaths (P=0.001) and between the 12- and 23-Fr dilators (P=0.003). Using the RFTN, 
all of the sheath forces were significantly different from the 12-Fr (16-Fr, P=0.003; 18-
Fr, P=0.001; and 23-Fr, P=0.004). Using the ETN, we found significant differences 
between the 12- and 18-Fr sheaths (P=0.001) and between the 12- and 23-Fr dilators 
(P=0.05).  
 
Figure 16. Mean puncture force and standard deviation (in grams) by needle type and sheath size. * 
P≤0.05 
 
Given the specimen variation associated with inherent FO tissue properties, we 
performed an additional analysis; data were normalized to account for this variation. 
First, we normalized the puncture methods, using TN as the reference. By doing so, the 
mean force to cross the FO was not significantly different from the TN when using the 
RFTN (P=0.11), but the mean force was significantly different when using the ETN 
(P=0.01)(Figure 17A). 
 
Second, we normalized sheath sizes. Using the 12-Fr as the reference point, we found 
that the force to cross the FO when using a 23-Fr sheath was significantly different 
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(P=0.005). However, we found no significant differences when using either the 16-Fr 
(P=0.09) or the 18-Fr sheath (P=0.30)(Figure 17B). 
 
Figure 17. (A) Puncture force (in grams), with data normalized against the transseptal needle (TN) 
and 12-Fr size, by needle type: TN, radiofrequency TN (RFTN), or 5-Fr RF electrode with the tip of a 
TN (ETN). (B) Transseptal crossing force (in grams) by sheath size: 12-, 16-, 18-, or 23-Fr.  
 
Septal tearing  
The baseline septal tearing characteristics by needle type (Table 6) and sheath size (Table 
7) are summarized. The anatomic measurements of the FO, by sheath size and needle 
type, are presented in Table 8. The baseline FO characteristics by needle type (Table 9) 
and by sheath size (Table 10) are also provided in tabular form. We found a statistically 
significant difference between the tearing force of the 23-Fr sheath as compared with the 
12-, 16-, or 18-Fr sheaths (Figure 15). However, needle type had no statistically 
significant impact on tearing initiation distances or on mean or peak tearing forces 
(P>0.05).  
 
Table 6. Baseline tearing characteristics by needle type 
 
TN RFTN ETN  
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(n=26) (n=28) (n=32) P 
Tearing initiation distance (mm) 7.5±3.2 6.8±3.1 5.8±2.7 0.068 
Mean tearing force (gf) 272±128 239±128 272±151 0.55 
Peak tearing force (gf) 360±173 306±161 372±208 0.33 
ETN=5-Fr RF electrode with the tip of a transseptal needle; RFTN=radiofrequency 
transseptal needle; TN=transseptal needle 
 
Table 7. Baseline tearing characteristics by sheath size 
 
12-Fr 
(n=23) 
16-Fr 
(n=23) 
18-Fr 
(n=21) 
23-Fr 
(n=19) 
 
P 
Tearing initiation distance (mm) 6.7±2.7 6.0±2.4 7.0±3.7 6.4±3.1 0.72 
Mean tearing force (gf) 236±99 242±128 227±114 365±173 0.002 
Peak tearing force (gf) 308±138 312±157 296±139 515±233 <0.001 
 
Table 8. Anatomic measurements of the fossa ovalis  
 TN RFTN ETN P 
12-Fr 
SI length (mm) 
AP length (mm) 
Thickness (mm) 
 
13.5±2.8 
7.2±2.6 
0.39±0.3 
 
11.6±3.7 
7.8±2.4 
0.5±0.1 
 
15.7±4.1 
7.07±2.05 
0.32±0.1 
 
0.56 
0.89 
0.14 
16-Fr 
SI length (mm) 
AP length (mm) 
Thickness (mm) 
 
12.9±3.5 
8.6±4.9 
0.5±0.1 
 
15.3±2.9 
7.1±5.3 
0.6±0.3 
 
13.7±4.6 
7.7±2.2 
0.5±0.1 
 
0.47 
0.89 
0.75 
18-Fr 
SI length (mm) 
AP length (mm) 
Thickness (mm) 
 
15.3±3.3 
8.3±3.4 
0.4±0.1 
 
14.5±4.4 
7.9±2.6 
0.6±0.3 
 
13.9±2.1 
8.3±2 
0.3±0.1 
 
0.87 
0.94 
0.11 
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23-Fr 
SI length (mm) 
AP length (mm) 
Thickness (mm) 
 
12.4±4.5 
6.9±3.3 
0.4±0.1 
 
13.5±1.3 
8.2±1.8 
0.4±0.1 
 
17.0±7.1 
10.1±5.6 
0.29±0.26 
 
0.45 
0.42 
0.25 
AP=anterior/posterior length; ETN=5-Fr RF electrode with the tip of a transseptal needle; 
RFTN=radiofrequency transseptal needle; SI=superior/inferior length; TN=transseptal 
needle.  
 
Table 9. Baseline fossa ovalis characteristics by needle type 
 
TN 
(n=26) 
RFTN 
(n=28) 
ETN 
(n=32) 
 
P 
SI length (mm) 11.8±2.3 14.4±4.5 13.2±2.5 0.01 
AP length (mm) 5.8±2.2 8.6±4.5 7.8±2.0 <0.001 
Thickness (mm) 0.8±0.5 0.9±0.7 0.9±0.3 0.58 
Heart weight (grams) 387±81 415±110 376±74 0.22 
AP=anterior/posterior length; ETN=5-Fr RF electrode with the tip of a transseptal needle; 
RFTN=radiofrequency transseptal needle; SI=superior/inferior length; TN=transseptal 
needle. 
 
Table 10. Baseline fossa ovalis characteristics by sheath size 
 
12-Fr 
(n=23) 
16-Fr 
(n=23) 
18-Fr 
(n=21) 
23-Fr 
(n=19) 
 
P 
SI length (mm) 13.3±3.2 12.6±2.7 12.7±3.6 14.2±3.6 0.37 
AP length (mm) 7.7±3.6 7.3±3.0 7.3±2.2 7.8±3.0 0.92 
Thickness (mm) 0.8±0.4 1.0±0.6 0.9±0.5 0.8±0.5 0.49 
Heart weight 
(grams) 
379±109 408±80 391±89 389±79 0.75 
AP=anterior/posterior length; SI=superior/inferior length.  
 
Anatomy for puncture  
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The variation in anatomy among our specimens affected both the FO puncturing process 
and the septal tearing forces.  
 
FO puncturing  
Overall, we found only a narrow variation in the FO thickness of our specimens 
(0.46±0.07 mm). We found no statistically significant relationship between FO thickness 
and the type of device used (R
2
 for TN, 0.001; ETN, 0.005; and RFTN, 0.11). In addition, 
we analyzed the relationships between sheath size (12-, 16-, 18-, or 23-Fr) and FO 
anatomic measurement by needle type, but found no statistically significant differences 
(Table 5).  
 
Septal tearing 
We collected anatomic measurements for all of the specimens used for tearing, to 
determine any relationship between anatomy and tearing resistance, but found none. We 
found a statistically significant difference when each method of puncture was compared 
against the superior/inferior length (P=0.01) the anterior/posterior length 
(P<0.001)(Table 6). No other statistically significant differences were found. Although 
samples were randomized, there was a significant difference between anterior/poster and 
superior/inferior width for the needle groups (P<0.05)  
Discussion 
Our 4 main findings were as follows: (1) In the case of 16- and 23-Fr sheath systems, the 
force required to cross the FO is higher than for a 12-Fr system; (2) when comparing the 
3 types of devices, the ETN significantly differed from the TN, but the RFTN did not; (3) 
with the 23-Fr sheath size, the FO’s tearing resistance was significantly higher than the 
other sizes; and (4) between the 12-, 16-, and 18-Fr sheath sizes, the FO’s resistance to 
tearing did not significantly differ.  
 
FO puncturing 
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When comparing the TN with the RFTN, the TN resulted in lower transseptal crossing 
forces of the dilator and sheath with the smaller 12- and 16-Fr systems, and the RFTN 
resulted in lower transseptal crossing forces with the 18- and 23-Fr systems. The use of 
the larger ETN resulted in lower mean transseptal crossing forces with the 12-, 16-, and 
18-Fr systems. It is possible that the RF lesion created by the ETN enabled the dilator and 
sheath to cross with greater ease, an occurrence also observed with the RFTN.  
 
The dimensions of the dilators and sheaths might contribute to differences in force by 
delivery system size. The variation in forces by delivery system size and by needle type 
may be due to the unique design of each dilator. Additional work is necessary to optimize 
dilator tip design. Our data (normalized against the 12-Fr system) showed no significant 
differences in mean puncture forces with the 16- and 18-Fr systems. The lack of 
differences in normalized mean puncture force may be due to design elements such as tip 
contour or tolerance differences between each component of the delivery system.  
 
Furthermore, when comparing all needle types by sheath size, FO thickness had no 
significant impact. However, the difference in FO thickness with the ETN subgroup was 
significantly smaller than with the other 2 devices (P<0.05). Our additional analysis 
comparing FO thickness and puncture force (grams) revealed, with all 3 needle types, the 
lack of a strong correlation between FO thickness and puncture force. Thus, the variable 
of FO thickness could be a confounding factor. In future studies, a broader selection of 
same-size devices is warranted, in order to explore the variation from device to device 
within a particular size.  
 
It is important to note that during transseptal punctures with the 5-Fr electrode needle 
(i.e., with the ETN), in some specimens, we observed steam pops when using a power 
setting of 30 watts. The use of RF energy might cause the tissue temperature to increase, 
resulting in dielectric breakdown and vaporization of the fluid, damage to the adjacent 
tissue, and release of the contents as a steam pop. In our observations, the amount of 
power applied exceeded the amount required to cause rupture, and resulted in fluid 
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vaporization near the tip of the catheter. With the optimization of applied power and 
temperature settings, it may be possible to control the energy delivery and eliminate this 
phenomenon; the literature suggests that tuning ablation parameters can minimize steam 
pop occurrences [39].  
 
These results indicate that additional studies of a larger RF-based device might yield 
improvements in reducing the amount of force required to perform transseptal punctures. 
The lack of a significant difference between the normalized mean puncture force of the 
TN and RFTN could be associated with the amount of power delivered or with 
insufficient time exposure of the tissue subjected to the RF (given the effects of 
mechanical force of the needle against the tissue). Anatomic variation of FO size and 
thickness may contribute to variation in the forces for FO puncturing and septal tearing. 
Using the TN as a baseline, we found that either the ETN or RFTN led to comparable or 
better results—evidence that all 3 devices perform similarly. A chronic study is required 
with several months of follow-up to examine the post-procedure recovery of the FO and 
to investigate the post-procedure healing of punctures performed by both mechanical and 
RF methods. 
 
Septal tearing  
We observed significant differences in septal tearing properties by sheath size; our results 
correspond with previous investigations [31]. It appears that a critical sheath diameter 
exists at which tearing forces dramatically increase (Figure 18). As new procedures 
continue the trend toward larger catheter sizes to reduce septal tearing, the initial 
puncture holes created are still of concern. Yet, the clinical implications of iatrogenic 
atrial septal defects remain to be clinically determined. It is important to note that some 
physicians are already using closure devices to treat these defects [40]. 
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Figure 18. Peak septal tearing forces by sheath size: 12-, 16-, 18-, or 23-Fr. The only significant 
difference occurred when using the 23-Fr sheath, as compared with the other 3 sizes. *P<0.001 
 
Regardless of the needle type (TN, RFTN, or ETN), we found no statistically significant 
differences in the tearing forces with the 12-, 16-, and 18-Fr systems. This finding 
suggests that, on an acute scale, no single technology has demonstrated a clear reduction 
in iatrogenic atrial septal defect size. Someday, technologies may facilitate tissue 
remodeling resulting in better closure. Future investigations are needed to determine 
whether or not transseptal punctures aided by RF will generate better natural closure in 
the long term.  
 
Additional work is needed to better understand the ETN and to account for variations in 
anatomic differences. Opportunities also abound to further investigate different iterations 
of the ETN that may perform better than the one used in this study. 
 
Study limitations 
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In our analyses of the septal tearing tests, we assumed that the surrounding anatomy of 
the FO had little impact on the observed forces. Depending on the pertinent anatomy 
targeted in the procedure, catheter torquing might be amplified, resulting in changes in 
tearing forces. An in vivo study or a biomechanical model examining this behavior would 
aid in identifying the importance of other factors relative to septal tearing.  
 
In addition, our study focused on transseptal elements at the time of puncture. Additional 
work is needed to study the residual hole that is formed, including a safety study to 
examine FO healing. Although our study found no statistically significant difference by 
needle type and FO thickness, additional work is needed to study the interactions between 
device size and anatomic variation in FO thickness and size. Finally, the ability to 
perform similar studies on fresh tissue isolated from human hearts would be ideal; such 
studies are ongoing in our laboratory, but it will take time to acquire the necessary 
specimens. 
 
Conclusion 
Using a range of devices and catheter sizes, we investigated the relative puncture and 
tearing forces required to perform transseptal punctures and FO tearing. Normalized 
mean puncture forces using the TN and RFTN were not significantly different.  
 
Additional studies aimed at reducing septal puncturing and tearing forces are needed, 
optimizing designs by refining not only the shapes and sizes of delivery systems but also 
the power utilized. Solutions must be found to improve the safety of transseptal 
punctures.  
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Section 2 Effects of Radiofrequency and Cryothermal Ablations 
on Cardiac Tissues 
This section of my thesis focuses on investigations related to complications that may 
primarily arise during the applications of radiofrequency or cryothermal ablations. 
Complication rates as high as 4-6% has been reported for such cardiac ablation 
procedures [41,42], and this leaves extensive opportunities for future improvements 
relative to the safeties and/or efficacies of such procedures. To focus even further our 
investigations concentrated on complications that are initiated on an acute time scale. For 
example, following the transseptal puncture necessary for radiofrequency ablation 
procedures to be performed on the left side of the heart, catheters often need to be 
maneuvered extensively to reach various target locations. Typically, the clinician must 
carefully position lesions and connect these focal lesions to ensure that aberrant electrical 
signals are isolated. Mapping catheters connected to electrical mapping systems and 
fluoroscopy aid electrophysiologists in guiding catheters to their desired locations. 
Unfortunately, these visualization techniques have a number of limitations when one 
hopes to minimize associated complications with such applied procedures: one cannot 
directly visualize the ongoing response of catheter manipulation of the septal anatomical 
structures. 
 
Furthermore, in an effort to ensure transmural lesion generation, clinicians will often 
attempt to increase contact forces to catalyze proper lesions. These applied forces may in 
turn add additional strain to the fossa ovalis, which is transeptally supporting the 
catheters and thus this may even increase the risks for eliciting cardiac tamponade due to 
subsequent cardiac perforations. Additionally, during procedures utilizing radiofrequency 
energy delivery, there are risks for the elicitation of steam pops; these explosive events 
are dependent on an array of not well-understood parameters, many of which correlate 
with the creation of transmural lesions. Interestingly to date, the cryothermal tolerances 
of cardiac tissues had lacked characterization: yet over-delivery of this energy may cause 
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phrenic nerve injury while its under-delivery hinders the development of transmural 
lesions. Nevertheless still today, identifying the optimal clinical dose delivery remains a 
challenge for both commonly employed ablation modalities. However, a better 
understanding of the biomechanical changes associated with these ablation modalities is 
essential knowledge needed in order to reduce the occurrence of complications. 
Delivering the appropriate ablative dose with minimal adverse effects is nontrivial, and in 
the following translational studies was performed to investigate a large number of 
associated factors and their roles in reducing the incidence of such complications. 
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Optimal Contact Forces to Minimize Cardiac Perforations Before, During 
and/or Following Radiofrequency or Cryothermal Ablations 
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Preface 
During cardiac ablation procedures, the atria may undergo forces that occasionally 
exceed their physical limits, and when these boundaries are surpassed perforation may 
occur and as a consequence life threatening cardiac tamponade may arise. While 
maneuvering catheters and applying required ablative energies there are risks for 
inducing perforations. This is especially important to consider during radiofrequency 
ablative procedures, where often higher contact forces are used to ensure the generation 
of transmural lesions. It has been reported that radiofrequency therapies require less 
contact force to perforate the atrial wall. This study provides invaluable data for both 
clinicians and device designers so to compare the contact forces required to perforate 
ablated swine and human atrial tissues.  Both radiofrequency and cryothermally ablative 
procedures were performed across a range of employed catheter sizes: the obtained date 
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helps to better define the boundaries of acceptable contact forces that may be applied 
clinically before complications occur. 
 
I was responsible for the study design, data and statistical analyses and the initial draft of 
the manuscript. Mike Van Heel aided in the collection of swine experimental data. The 
preliminary findings of this study were presented at the American College of Cardiology  
(ACC) in Washington, DC in March 2014. Ongoing research is being conducted in the 
Visible Heart Lab to further assess the contact forces required for perforations in human 
hearts that had been prior diagnosed to elicit atrial fibrillation. 
Summary 
Background: Catheter perforations remain a major clinical concern during ablation 
procedures for treating atrial arrhythmias, and may lead to life-threatening cardiac 
tamponade. Radiofrequency (RF) ablation alters the biomechanical properties of cardiac 
tissue, ultimately allowing for perforation to occur more readily. Studies on the effects 
cryoablation has on perforation force, as well as defining the perforation force of human 
tissue are limited.  
Objective: Investigate the required force to elicit perforation of cardiac atrial tissue 
following or during ablation procedures. 
Methods: Effects of RF and cryothermal ablation on catheter perforation forces for both 
swine (n=83 animals, 530 treatments) and human (n=8 specimens, 136 treatments) 
cardiac tissue were investigated.  
Results: Overall average forces resulting in perforation of healthy unablated tissue were 
406±170g for swine and 591±240g for humans. Post-RF ablation applications 
considerably reduced these forces to 246±118g for swine and 362±185g for humans 
(p<0.001); treatments with cryoablation did not significantly alter forces required to 
induce perforations. Decreasing catheter sizes resulted in a reduction in forces required to 
perforate the atrial wall (p<0.001). Catheter perforations occurred over an array of 
contact forces with a minimum of 38g being observed.  
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Conclusion: We consider that the swine model likely underestimates the required 
perforation forces relative to those of human tissues. We provided novel insights related 
to the comparative effects of RF and cryothermal ablations on the potential for inducing 
undesired punctures, with RF ablation reducing perforation force significantly. These 
data are insightful for physicians performing ablation procedures as well as medical 
device designers. 
 
Key Words: catheter ablation, cardiac tamponade, arrhythmia, cardiac perforation, RF 
ablation, cryoablation 
 
Glossary of Abbreviations: 
AF=atrial fibrillation 
RF=radiofrequency 
Introduction 
Today, atrial fibrillation (AF) affects over 5.1 million people in the United States and, as 
the population continues to age, the incidence is expected to increase at least 2.5 fold by 
2050 [43,44]. Recently, a complication rate of 4-6% was reported for catheter ablation 
procedures performed to treat AF [41,42]. These complications can be prompted by a 
number of factors, ranging from induced septal defects following transseptal punctures to 
perforation of the atria. More specifically, cardiac tamponade has been reported to occur 
in 1.3% of ablation procedures [41]. It is considered that complications may arise 
throughout these procedures due to a number of factors, such as transseptal punctures, 
adverse catheter maneuvers, or excessive contact forces during energy applications. 
 
Perforation of the atrial wall during ablation procedures, which may lead to pericardial 
effusions and/or life-threatening cardiac tamponade, has only recently gained attention. 
Cardiac perforation is most common in AF procedures and occurs less frequently in other 
cardiac procedures [45]. It is suggested that perforations may result from employing high 
power usages and/or contact forces to ensure the creation of transmural lesions via 
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radiofrequency (RF) energies. Unfortunately, there are no comprehensive studies 
reported in the literature investigating the causes of cardiac tamponade during ablation 
procedures. Yet, it is important to note that even procedures like transseptal punctures are 
associated with a complication rate as high as 0.79% and cardiac perforation with 
tamponade in 0.11% of cases [7]. Further, it is known that mechanical perforations with 
diagnostic catheters have also been associated with cardiac tamponade. Interestingly, the 
presentation of pericardial effusion in RF and cryothermal ablation procedures is not 
significantly different [46]. Furthermore, patients with AF have been reported to have 
thinner atrial walls; this likely elicits circumstances that allow for perforations to occur 
even more readily [47]. Other important factors to consider during these clinical 
procedures include movements of the heart throughout the cardiac cycle as well as those 
due to respiration, as these can alter the applications of desired contact forces and provide 
added challenges for clinicians [48]. 
 
Additionally, it is regarded that the biomechanical properties are altered during the 
heating and cooling of tissues. For example, loss of pulmonary vein compliance and the 
denaturation of collagen occurs at temperatures of 60-65°C, yet elastin remains 
unchanged until reaching temperatures of 80°C [49]. During cryoablation structural 
proteins remain intact, although realignments occur due to ice crystal formations [50]. 
Therefore, better understanding of the required contact forces for proper lesion formation, 
while minimizing ruptures, may lead to reduced occurrences of cardiac tamponade. The 
studies we present here provide novel insights related to the biomechanical effects of RF 
and cryothermal ablations relative to the potential to induce punctures of cardiac atrial 
tissues. These studies could be considered as translational since we compared results for 
both isolated viable swine and human atrial samples. 
Methods 
Sample Preparation 
Human heart specimens (n=8) were obtained from non-viable organ transplant donors 
through our local organ procurement organization LifeSource (St. Paul, MN, USA) 
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(Table 11): note these tissues were considered as viable, since these specimens were 
typically acquired and tested within 6-12 hours following explantation. It should also be 
noted that all non-AF heart had a non-dilated atrial pathology. Healthy 7 to 9-month-old 
Yorkshire Cross swine cardiac specimens (n=83; animal weight 75-110 kg; heart weight 
400-650g) were acquired from the University of Minnesota Meat Sciences Laboratory 
and the Visible Heart Lab (waste tissue from unrelated experiments) and stored in saline 
prior to testing. Fresh atrial samples from the free wall (atrial appendage and atrial roof) 
were carefully dissected out. 
 
Table 11.Human heart demographics 
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Cause of Death Cardiac History 
1 45 96 537 M 
Cerebral vascular 
accident 
Hypertension, 
Alcoholism 
2 34 86 422 M 
Cerebral vascular 
accident None 
3 62 73 456 F 
Cerebral vascular 
accident 
Hypothyroidism, 
Hyperlipidemia 
4 52 74 401 F 
Cerebral vascular 
accident None 
5 81 75 504 F N/A 
Atrial fibrillation, 
Mitral 
regurgitation 
6 67 82 330 M Bladder cancer None 
7 69 77 456 M 
Chronic obstructive 
pulmonary disease None 
8 67 59 496 F 
Chronic obstructive 
pulmonary disease None 
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Atrial samples (n=666) were randomized to the following study groups: 1) no treatment, 
2) RF ablation with a non-irrigated RF Marinr catheter (Medtronic, Minneapolis, MN) for 
1 minute at 30 W with a temperature limit of 65°C, 3) RF ablation using the same 
parameters as #2, with induced perforation during the last 5 seconds of applied ablation, 
or 4) focal cryoablation with a Freezer MAX catheter (Medtronic) for 2 minutes (Figure 
19). Cryoablated samples were permitted a sufficient amount of time for ice to thaw prior 
to the induced perforations. All samples were carefully anchored and submerged in saline 
before each ablative modality was applied. Each catheter was subsequently advanced at a 
rate of 500 mm/min with a mechanical force tester (Chatillon, Largo, FL, USA) until 
perforation occurred. An array of catheter sizes (5, 7, and 8 Fr) was also investigated in 
these experiments. 
 
Figure 19. Graphical depiction of the treatment groups in relation to the application of ablation and 
the induction of catheter perforation. Cryo=cryoablation treatment; RF=radiofrequency treatment. 
 
Data Analysis 
The maximum force readings corresponding to the perforation forces were analyzed with 
Minitab (State College, PA, USA). All force values were reported as mean ± standard 
deviation. Student’s t-test for one-to-one comparisons or analysis of variance (ANOVA) 
for the various study groups were used to compare normally distributed data. P-values 
≤0.05 were considered significant. 
  50 
Results 
Catheter perforation forces for the right and left atrium were significantly different for the 
prepared human and swine tissue samples for all ablation groups investigated (p<0.001). 
Importantly, the required perforation forces for the RF-ablated samples were almost 2 
fold less than those required for the cryoablated or untreated samples, as shown in Figure 
20 (p<0.001). In other words, the cryoablation procedures appeared to have little or no 
effect on perforation forces when compared to the control (no treatment) group (p=0.43). 
The effects of perforation during RF ablations were minimal and not statistically 
significant compared to the other RF ablation group (p=0.27).  
 
Figure 20. The perforation force for swine right and left atrium compared across different ablation 
modalities (*p<0.001). Perforation of the right atrium required substantially less force compared to 
the left atrium. Also, perforation following either radiofrequency (RF) ablation group entailed 
significantly less force than the cryoablated (Cryo) or the untreated (Normal) samples. Error bars 
represent STD. 
 
A noteworthy observation was that catheter size was highly correlated with the likelihood 
to perforate the myocardium following or during an ablation. Smaller catheters required 
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lower forces to induce ruptures than larger ones for all ablation modalities and tissue 
types (p<0.05, Table 12); ablation modality effects with RF reducing perforation forces 
were also confirmed within each catheter size. Additionally, human atrial perforation 
forces were significantly different than those for the swine tissues (Table 13). Here we 
observed that the minimum forces to perforate ablated and healthy human atrium were 38 
g and 57 g, respectively (Table 14). Similar minimum perforation forces of 63 g and 96 g 
for ablated and healthy swine atrium were also observed. It should be noted that the 
human atrial samples used in this experiment were from individuals without known 
histories of AF for all but one individual.  
 
Table 12. Comparison of perforation force sorted by catheter size, tissue type, and ablation modality 
 
Ablation 
Modality 
Perforation Force (g) 
P-value 5 Fr 7 Fr 8 Fr 
T
is
su
e 
T
y
p
e 
RA 
N 293±91 337±120 425±115 <0.001 
Cryo 318±124 333±106 412±141 0.033 
RF 214±76 209±79 294±134 <0.001 
LA 
 
N 345±115 421±120 691±148 <0.001 
Cryo 451±109 394±106 699±155 <0.001 
RF 246±76 237±78 426±172 <0.001 
RA=right atrium; LA=left atrium; N=no treatment; Cryo=cryoablation treatment; 
RF=radiofrequency ablation treatment 
 
Table 13.Comparison of perforation forces between swine and human tissue sorted by ablation 
modality and tissue type 
 
Ablation 
Modality 
Perforation Force (g) 
P-value Swine Human 
T
is
su
e 
T
y
p
e 
RA 
N 337±120 545±238 <0.001 
Cryo 333±106 595±183 <0.001 
RF 192±78 386±186 <0.001 
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LA 
 
N 421±137 692±218 <0.001 
Cryo 394±136 668±278 <0.001 
RF 237±79 445±235 <0.001 
RA=right atrium; LA=left atrium; N=no treatment; Cryo=cryoablation treatment; 
RF=radiofrequency ablation treatment 
 
Table 14. Minimum perforation forces of swine and human tissue sorted by ablation modality and 
tissue type 
 
Ablation 
Modality 
Perforation Force (g) 
Swine Human 
T
is
su
e 
T
y
p
e 
RA 
N 96 57 
Cryo 104 98 
RF 63 38 
LA 
 
N 187 149 
Cryo 131 258 
RF 67 62 
RA=right atrium; LA=left atrium; N=no treatment; Cryo=cryoablation treatment; 
RF=radiofrequency ablation treatment 
Discussion 
Here we describe novel results from an in situ experiment designed to investigate the 
required force to elicit perforation of cardiac atrial tissue following or during ablation 
procedures. We employed a translational approach in which we studied both viable swine 
and human specimens. Perforation forces following or during RF ablation and in the 
control/no treatment group were similar to those reported in the literature, with RF 
ablation reducing the forces required to elicit perforation significantly [51,52]. In these 
previous studies, an individual user manually advanced the catheter until perforation 
occurred, whereas in this present study we employed a uniaxial testing machine to 
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automate the advancement of the catheter at a constant speed. In other words, in our 
testing methodology, the goal was to remove variations due to the operator. Interestingly, 
we observed that the minimum perforation forces were 63 g for RF atrial ablated swine 
tissue versus 96 g for healthy non-ablated tissue, while Shah et al. reported values of 40 g 
and 131 g respectively for swine atrial tissue [51].  
 
To our knowledge, comparison studies relative to perforation forces following RF or 
cryothermal ablations have not yet been reported in the literature. Cryoablation did not 
alter perforation forces compared to untreated fresh tissue for both the swine and human 
tissue samples. It is important to note that we utilized fresh, viable tissue samples in these 
investigations. It was previously reported that frozen tissue samples typically are altered 
in the low stress state, with possible differences in other portions of the stress-strain curve 
[53]. Thus, any changes observed exist at the onset of force application and dissipate 
substantially as the applied force increases. It has been reported that freezing (the 
application of cryoablation) does not change the ultimate tensile strength or, if so, 
minimally [54,55]. This suggests that the forces required to perforate would be similar to 
those of native unablated tissue, which hold true for the results we present here.  
 
RF ablation is considered to cause the denaturation of collagen as well as cell membrane 
disruption. Specifically, at high temperatures (60-65°C) collagen breakdown occurs [56]. 
It is also suspected that while physicians attempt to create transmural atrial lesions, heat 
will build up in the myocardium. Typically, an ablation console will only provide data on 
the catheter tip temperatures, and these are not representative of tissue temperatures. One 
can consider that thermal energy builds up transmurally within the myocardium, since the 
endocardial surface and catheter tip will be convectively cooled by the flow of blood 
through the heart. While ablating tissue to a minimum of 50°C to ensure the creation of a 
myocardial scar for a successful isolation procedure, (reaching temperatures of 60°C) the 
transition zone for collagen breakdown is not unforeseeable. A breakdown of collagen in 
the ablated myocardium will weaken it, explaining the reduction in the perforation force 
following RF ablation. 
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Catheter size is not often considered during ablation procedures, yet it is an important 
factor influencing the incidence of cardiac perforation. We found that utilizing a larger 
size catheter significantly reduces the risk of perforation. Even enlarging the catheter size 
by a single French often increases the required force for perforation. It is important to 
note that given the aggressive ablation parameters used, transmural lesions were observed 
for all catheter sizes. Thus, lesion size likely had minimal effect on the observed 
perforation forces since it encompassed a much greater volume than the catheters. 
Therefore, with similar tissue damage a smaller catheter will perforate more easily. This 
finding is intuitive when considered from a mechanic’s perspective of the relationship 
between applied force, surface area, and resultant pressure. Implementing this knowledge 
regarding catheter size and punctures relatives to clinical procedures may reduce the 
occurrence of cardiac tamponade. Further research investigating the effects of catheter 
size on perforation force is needed to determine if these results can be extrapolated to 
larger than 8 Fr catheters. 
 
Physicians quite often apply contact forces that exceed the lower limit perforation forces 
we described here, which increases the likelihood of complications. For example, Kuck et 
al. observed that during AF procedures, contact forces of over 100 g were recorded in 
79% of patients with a high degree of inter- and intra-operator variability [57]. 
Importantly, high contact forces are not only detected during ablations but also 
throughout these cardiac procedures, such as with catheter manipulations and the relative 
movement of the heart associated with contractions and/or respiration. It should be noted 
that extensive catheter manipulation on the left side of the heart (via a transseptal 
puncture) also increases the risk for formation of iatrogenic atrial septal defects [58]. 
Additionally, transseptal punctures account for some portion of cardiac tamponade cases, 
so diagnostic and ablation catheters are not its only cause. Furthermore, high contact 
forces also increase the risk for either elicitation of steam pops and/or thrombus 
formation [59,60]. This underlies the need for force sensing catheter technologies, along 
with greater physician awareness of acceptable contact forces. It is important to note that 
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average contact forces below 10 g have been reported to result in higher incidences of AF 
recurrence, while contact forces above 20 g lowers the likelihood of such incidences [61]. 
This suggests that a lower bound for contact force of 20 g exists, thus facilitating 
successful ablation procedures. Defining the upper boundaries of applied ablative contact 
forces will be a step forward in reducing related complications like cardiac tamponade. 
Note again the minimum forces for perforation of human tissue (37 and 57 g for ablated 
and healthy atrium respectively) and the average forces to perforate (386 and 545 g for 
ablated and healthy atrium). Hence we suggest that contact forces below 50 g should 
greatly reduce the occurrence of cardiac perforations and/or tamponade. Perhaps a “sweet 
spot” of 20-50 g would be the ideal contact force range that physicians should aim to 
apply in order to achieve successful procedures that do not result in recurrences while 
ensuring minimal risk of cardiac perforations. 
 
Minimal human heart availability, the in vitro nature of experiment, and the inability to 
measure tissue temperatures were the major study limitations. Measurement of tissue 
temperatures in this experimental paradigm would have compromised the biomechanical 
properties of the cardiac tissue. However, transmural tissue temperatures would allow for 
a more accurate analysis of the interplay between ablations, temperatures, and 
biomechanical properties of the cardiac specimens. In addition, conducting an in vivo 
assessment of perforation forces would aid in the clinical applicability, but add in 
cofounding factors the authors desired to remove, such as variations due to the operator. 
The use of non-irrigated ablation catheters and inability to measure the compressive force 
during tissue anchoring are also important limitations to note. Furthermore, several of the 
human specimens were stored in saline for up to 24 hours as immediate testing was 
unfeasible. It is important to consider that these punctures were performed in non-beating 
tissue and not in intact hearts. Also, limited human heart availability for research was 
anticipated, so swine hearts were used instead to approximate the biomechanical 
properties of cardiac tissue. The available human tissue included only one individual with 
a history of AF, which restricts the ability to elucidate significant findings for AF 
patients. Unfortunately, the swine hearts lack thinner atrial walls like the typical AF 
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patient, so a direct translational comparison to the patient population of interest is 
restricted in nature. This highlights the need for further studies on human tissue with a 
history of AF. 
Conclusion 
Importantly, cryoablation did not result in statistically significant reductions in the 
contact forces required to perforate atrial tissues. In contrast, applied RF ablations elicited 
reductions in the forces required to perforate these tissues. This is the first study to 
investigate perforation forces during RF ablations and following RF or cryothermal 
ablation, as well as the impact of catheter size. We consider that the data presented here 
should be of substantial interest to clinicians, as it may help define an ideal contact force 
range for minimizing the occurrences of cardiac tamponade while still promoting 
transmural lesion generation. 
Clinical Perspective 
The aim of this study was to define the contact forces required to elicit perforations of the 
cardiac atrial walls during and following RF and cryothermal ablations. Subsequently, the 
authors propose that contact force ranging between 20-50 g be applied during ablations to 
minimize AF recurrences and limit the incidences of cardiac perforations. Furthermore, 
following RF ablations perforations were induced at lower contact forces when compared 
to non-ablated tissues. In contrast, the application of cryoablation did not reduce the 
required perforation forces. The selection of catheter size was also identified as a 
principal factor altering required contact forces to elicit perforations after transmural 
lesions were induced: interestingly smaller catheters increased the risks for perforations. 
Translational investigations of contact forces to induce perforation following RF or 
cryothermal ablation and the effect of catheter size are currently absent in the literature. 
Nevertheless during clinical procedures, physicians often exceed the minimum thresholds 
of contact force to cause perforations. It is considered here that increased awareness of 
these contact force boundaries and their implementations into clinical settings should 
greatly reduce the occurrences of cardiac perforations or tamponade associated with 
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ablation procedures. In other words, the knowledge herein and potentially the usage of 
force sensing catheter technologies have the potential to improve clinical outcomes 
during cardiac ablative procedures. 
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Preface 
During the delivery of radiofrequency energy to tissues, overheating may occur leading 
to the vaporization of fluid and/or the release of air/tissue emboli. These explosive steam 
pops events are believed to be associated with serious complications, such as cardiac 
tamponade, stroke, and/or myocardial infarction. The current literature acknowledges that 
this phenomenon occurs, but little has been done to understand the factors facilitating 
their elicitation. Oftentimes in an effort to encourage transmural lesion formation, power 
and temperature settings are pushed to undesirable or recommended limits. In this study 
we investigated a variety of parameters to identify how steam pops could be avoided in 
future clinical setting. Power, temperature, irrigation, catheter contact angle, and/or 
surface area contacts of employed catheters were associated with popping events. 
Ultimately the findings from this investigation could aid in improving patient outcomes 
and procedural safety: i.e., risky ablation parameters were classified and acceptable limits 
were defined.  
 
I was responsible for the design of experiments, data and statistical analyses, and 
composition of the draft of this manuscript. The preliminary results from this study were 
orally presented at the Design of Medical Device (DMD) Conference at the University of 
Minnesota, in April 2013. 
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Summary 
Background: It is known that during cardiac ablative procedures excess heating can lead 
to the generation of steam pops. This phenomenon causes the release of energy in the 
form of tissue and/or air emboli as well as can attribute to the elicitation of serious 
complications.  
Objective: Investigate the parameters thought to be associated with the elicitation of 
intracardiac steam pops and to visualize their relative impacts. 
Methods: Employing Visible Heart methodologies, we utilized 22 reanimated swine 
hearts to directly visualize the occurrences of steam pops.  The effects of various factors 
including applied power, temperature, usage of irrigation, location, repeat ablation sites, 
amongst others were investigated with regards to their manifestation (n=539 ablations). 
Results: The elicitations of steam pops were significantly increased with power 
application above 40 W for both non-irrigated and irrigated ablative applications 
(p<0.005). Catheter contact angles perpendicular to the tissue as well as greater surface 
area contacts of a given catheter both significantly increased the occurrences of steam 
pops (p<0.05). Minimum temperatures of 52°C for non-irrigated and 40°C for irrigated 
procedures were required for steam pop generation, and their incidences were typically 
observed 30±17 seconds into a given ablation application. Interestingly, the anatomical 
location within atria and if a site had been previously ablated did not effect steam pop 
elicitation. 
Conclusion: While performing radiofrequency ablations it is important to acknowledge 
the effects of power, temperature, irrigation, catheter contact angle, and surface area 
contact of the employed catheter on the potential to elicit steam pops. Accounting for 
these parameters improves the possibility to reduce steam pops and their associated 
complications. 
Introduction 
Radiofrequency (RF) ablations are routinely performed to treat patients with cardiac 
arrhythmias. Currently, atrial fibrillation (AF) make up the majority of those treated by 
ablations, as this disease affects over 5 million Americans [43]. The safeties and 
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efficacies of ablative procedures are comparable between RF and cryothermal ablations, 
yet complication rates as high as 4.5% were recently reported [41,62]. Noteworthy, 
cardiac tamponade, transient ischemic attack, and stroke have occurred in such patients at 
rates of 1.31%, 0.71%, and 0.23%, respectively [41]. Commonly during RF ablations, 
cardiac tissue must be heated to temperatures of at least 50°C to ensure transmural 
myocardial scar formations at the target sites [56]. Unfortunately when excessive heating 
occurs blood may be vaporized and steam pops can be generated. It is important to note 
that the catheter tip temperatures which are provided as feedback to clinicians typically 
vary from the actual endocardial tissue temperatures: i.e., because of convective blood 
flow and/or the usage of catheter irrigation. Furthermore, it has been reported that the use 
of irrigation allows for both the generation of larger lesions with fewer occurrences of 
steam pops [63]. Nevertheless, with all clinicians aiming to create transmural lesions with 
their radiofrequency ablation procedures and the relative disparities of resultant tissue 
temperatures, this will continue to create circumstances facilitating the elictitation of 
steam pops. 
 
The occurrences of steam pops associated with RF ablations may be quite damaging, 
potentially causing perforation of the atrial wall, release of tissue fragments, release of 
coagulum and/or air bubble generation [64,65]. The relative portions of complications 
associated with RF procedures that steam pops contribute to is currently unknown: yet 
such may induce cardiac tamponade, stroke, and transient ischemic attack. These 
phenomenon may occur extremely quick, within 10 ms, and are considered difficult to 
observe with fluoroscopy [66]. Previously, high contact forces have been correlated with 
significant increases in steam pop elicitation [59]. Additionally, it has been reported that 
lesion depth is associated with their occurrences, which suggests that factors increasing 
lesion depths facilitate their generation: e.g., temperature and applied power have been 
correlated with incidences [67,68]. To date, some of initiators for steam pop 
manifestation have been documented; yet, a comprehensive assessment is still lacking.   
The purpose of the present investigation was to further determine the parameters thought 
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to be associated with the elicitation of intracardiac steam pops as well as to visualize their 
relative impacts. 
Methods 
Hearts from 7 to 9-month-old Yorkshire Cross healthy swine (n=22; animal weights of 
84.5±9.8 kg) were excised and reanimated using Visible Heart® methodologies.[69] In 
each heart, 7 Fr RF catheters (Medtronic, Minneapolis, MN) were introduced to various 
locations within both the right and left atrium and ablations (n=297) were performed. 
Additionally, irrigated ablations were also performed (n=242), with flow rates of ~17 
ml/min. Contact angles of the catheters relative to the endocardial surfaces of the atria 
were visually determined (Figure 21), and if the catheter tip was surrounded by over 50% 
of the tissue this was also noted. Additionally, applied power, catheter electrode 
temperatures, and if a target site had previously been ablated were also recorded. This 
allowed for the investigations of a large number of parameters potentially associated with 
an increased incidence of steam pops. Their occurrences were verified both visually and 
audibly: i.e., one could see the release of gaseous and tissue emboli and occasionally hear 
such (Figure 22). 
 
 
 
Figure 21. Different catheter contact angles relative to the atria were examined: perpendicular (A), 
parallel/perpendicular (B), and parallel (C). 
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Figure 22. A 7 Fr RF catheter and 12 Fr FlexCath steerable sheath originating from the fossa ovalis 
are positioned near the left pulmonary vein ostia. The lesion before (A), during (B), and following (C) 
a steam pop may be observed as seen from an endoscope positioned within the left pulmonary vein. 
 
The associated rates of occurrences and the related parameters were analyzed using 
Minitab (State College, PA). All values were reported as mean ± standard deviation. 
Regression analyses were initially used to identify parameters associated with steam pops 
and following this analysis of variance (ANOVA) was used to compare the isolated 
factors. P-values ≤ 0.05 were considered statistically significant. 
Results 
Steam pop incidence was significantly associated with power (Table 15). Only at applied 
powers of 40 W or greater were steam pops observed for both the applied non-irrigated 
and irrigated ablations. Furthermore, embedding the catheter tips in the tissue 
(invaginations/pectinate muscles) and/or catheter contact perpendicular to the atria were 
also significantly associated with steam pop initiation for the non-irrigated ablations: 
there was a similar trend for irrigated ablations (Table 16). In contrast, the relative 
location of elicited lesions and if a target sites had previously been ablated were not 
correlated with steam pop occurrences.  
 
Table 15. Relationship of applied power with steam pop incidence for non-irrigated and irrigated 
ablations. 
  Non-irrigated 
Power (W) 
Average 
Temperature (C) Number of Ablations 
Steam Pop 
Incidence (%) P-Value 
10-29 46 50 0 
0.002 
30-39 50 40 0 
40-49 58 59 5 
50 64 74 24 
51+ 64 74 34 
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Irrigated 
10-29 44 46 0 
<0.001 
30-39 44 49 0 
40-49 46 51 16 
50 49 42 24 
51+ 50 54 37 
 
 
Table 16. Relationship of embedded catheter tip and contact angle of the catheter with steam pop 
incidence for non-irrigated and irrigated ablations. 
 
  Non-irrigated Irrigated 
Embedded Catheter 
Tip 
Number of 
Ablations 
Steam Pop 
Incidence 
(%) P-Value 
Number of 
Ablations 
Steam Pop 
Incidence 
(%) P-Value 
Yes 58 26 
0.041 
31 26 
0.099 
No 239 15 211 14 
   
  
   Contact Angle of the 
Catheter Relative to 
the Atria             
Parallel 56 7 
0.022 
94 3 
 <0.001 Parallel/Perpendicular 77 13 67 19 
Perpendicular 164 22 81 27 
 
Steam pops typically occurred 30±17 seconds following the initiation of the ablative 
energies, and there were no significant timing differences of popping onset between the 
groups investigated. Noteworthy, a catheter tip temperature of at least 52°C for non-
irrigated and 40°C for irrigated ablations were required to induce steam pops. Maximum 
average catheter tip temperatures were 77±14°C (non-irrigated) and 50±7°C (irrigated) 
during steam pop events and 60±15°C and 46±6°C respectively without them. In all 
cases, their occurrences were significantly correlated with temperature (p<0.001). 
Interestingly, the anatomic location of the catheter or if a site had previously been ablated 
had no impact on their relative formations. 
 
Discussion 
The results from this ex vivo experiment describe the parameters that may readily induce 
the formation of steam pops. We examined a large range of factors that may be associated 
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with the incidences of these events. It should be noted that a number of these initiators 
have been previously investigated: the influence of temperature, micro-bubble formation, 
impedance increases, and contact forces have been reported.[56,59,70] In general our 
data was consistent with these findings, however the aim of this study was to further 
examine a multitude of additional factors as they relate to steam pop formation.  
Catheter contact angles relative to the atria endocardium has been associated with steam 
pop formation and/or cardiac tamponade: e.g., Nakagawa et al. reported that catheters 
perpendicular to the atrium were most likely to induce pops leading to cardiac tamponade 
[71]. It has also been hypothesized that steam pops that occur near the epicardial surface 
will more likely induce tamponade while those more directly on the endocardium may 
lead to the release of air and tissue emboli, potentially causing stroke or myocardial 
infarction [67]. Noteworthy in the present study, perpendicularly oriented catheters were 
more than threefold likely to generate steam pops than those positioned parallel to the 
endocardial surface.  
Interestingly still today, the relative proportions of associated complications, such as 
stroke, myocardial infarction, and cardiac tamponade, that are considered in part due to 
steam pops remains uninvestigated. Yet, it has been reported that complications rates 
arising from transseptal punctures were as high as 0.79% with cardiac perforation in 
0.11% of cases [7]. Furthermore, mechanical perforations with diagnostic and ablation 
catheters also accounts for some portion of cardiac tamponade cases. It was reported that 
mechanical perforation caused tamponade in 20% of cases and popping was responsible 
for 80% [68]. The minimum contact force required to perforate the atria is routinely 
exceeded during procedures with RF requiring less force than cryothermal ablations 
[57,72]. Nevertheless, it has been previously discussed that there remains a need for 
further investigations to elucidate the types and relative degrees of complications related 
to steam pops.  
As anticipated in our study, power and temperature were significantly related to the 
elicitation of steam pops. Noteworthy, there appears to be a transition zone at power 
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levels above 40 W which significantly increased relative steam pop formations. 
Furthermore, Hsu et al observed that steam pop incidence was greater with higher power 
applications and only reported their occurrence at more than 48 W [68]. It should also be 
noted that high power usages have also been responsible for delayed complications like 
the formation of atrial-esophageal fistula [73,74]. Nevertheless, our results support the 
literature of a correlation between electrode temperature and steam pop incidence.[67] 
When considering this phenomenon from a heat transfer perspective, the effects of power 
and temperature produce expected reactions. As more energy is transferred to the system 
and as heat buildup reaches a threshold the fluid will be vaporized, and a steam pop will 
be elicited. Therefore, the ability to measure actual focal tissue temperatures would be of 
substantial benefit in reducing complications during ablation procedures while also 
improving efficacy. 
Importantly, the application of irrigated radiofrequency ablations relative to steam pop 
incidence was quite similar to non-irrigated procedures, as shown in Table 15. Yet, the 
cooling power from irrigation was anticipated to reduce steam pop occurrences, since 
heat buildup in the tissue will be reduced at least on the endocardial surface. The 
temperature profile will be shifted, so that the point of maximum temperature will be 
deeper in the myocardium. In other words, irrigation was not effective at reducing steam 
pop incidences given similar other parameters. Although irrigation was able to reduce the 
catheter tip temperatures, recall again that this is not an accurate indication of tissue 
temperatures. Hence, irrigation may be effective at reducing the temperatures at the 
electrode tissue interfaces, but this does not obstruct the accumulation of energy within 
the tissues that may potentially be released in the formation of a steam pops. This 
supports the need for a better means of measuring tissue temperatures so to help ensure 
the creation of transmural lesions while also minimizing the manifestation of 
complications, such as steam pops. Interestingly, there has been recent development 
using acoustic signals and microwave radiometry to predict popping events and even 
using intracardiac echocardiography to monitor their incidence clinically [75–78]. 
A number of the parameters investigated here had no effects on steam pop incidences, 
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which may also be explained through heat transfer mechanics. For example, the authors 
were unable to identify literature comparing the thermal properties of the various 
anatomical regions of the atria. Perhaps it can be considered that the tissue types of the 
right and left atria are similar in nature. Thus, one would not have expected a substantial 
difference in their thermal properties, which would correspond with the results herein. In 
addition, a greater tissue surface area contact with the catheter tip should produce more 
efficient heat transfer, ultimately facilitating steam pop formation. When preforming a 
repeat ablation at a target site, heat transfer to the tissue remains unchanged. This 
supports the supposition that repeat ablations had little or no influence on steam pop 
initiations. It should however also be noted that repeat ablation sites in this study were 
allowed sufficient time to cool. In other words, if a repeat ablation was preformed 
immediately after at the same location, this finding may not hold true since there will be 
residual energy at the lesion site. 
We consider here that it may be considered that the inability to use blood in our 
reanimated specimens and measure temperatures within the myocardium may be 
considered as study limitations. More specifically, modified Krebs-Henseleit buffer was 
used as a blood substitute to allow for visualizations, so direct comparisons to the clinical 
scenario may be somewhat reduced. However, heat transfer and fluid mechanics 
underlying this phenomenon remain consistent with a change of fluid. Unfortunately the 
use of blood would have obscured the detection of steam pops, since steam pop incidence 
in our study was validated with direct visualization. It should be reiterated that steam 
pops often create an audible pop, yet this is not always the case and may limit ones ability 
to detect such in other studies or in clinical situations. As noted above, measuring 
temperatures within the myocardium could further improve our understanding of the 
catheter-tissue temperature discrepancy as it relates to steam pop formation: we hope to 
do so in future studies, yet doing such may also modify native thermal properties. This 
highlights the need for clinical studies to investigate steam pops incidence and the 
complications that proceed them. 
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Conclusion 
Importantly, applied radiofrequency ablative power and temperatures statistically 
significantly correlated with cardiac steam pop formations. Noteworthy, perpendicularly 
orientated catheters relative to the atria as well as catheters with greater tissue surface 
area contact were more likely to initiate such events. Additionally, repeat ablations at a 
lesion site and anatomical locations of the applied therapies in the heart were not 
correlated to steam pop occurrences. The use of irrigated ablation catheters were not 
effective at reducing steam pop generations, compared to non-irrigated procedures. We 
consider here that the data presented are of interest to clinicians, as it should improve 
awareness of factors associated with steam pop elicitation and hence aid in reducing 
complications associated with cardiac RF procedures. 
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Preface 
The relative tolerances of tissues to radiofrequency ablation are well established, however 
the effects of cryothermal therapies on the induced injury to cardiac tissues lack defined 
boundaries. The clinical outcomes of cardiac cryoablation have been well characterized 
in numerous studies, but there exists a substantial knowledge gap in the therapeutic dose 
responses with respect to therapeutic times, cooling profiles, and/or real-time tissue 
temperatures. We hypothesized that quantifying the expected viabilities and physiological 
responses of tissues, especially if used in conjunction with subsequently modeling efforts, 
would ultimately lead to more efficacious future applications, with reduced associated 
complications. For instance, injury to the phrenic nerves during cryoablation is a common 
occurrence, and the reported incidence is as high as 4% to 24%, with greater incidences 
for utilizations of the second-generation cryoballoon [79–86]. Therefore, this is an area 
where great improvements may be made: it is considered here, that the findings from this 
study will allow for future optimizations of cryoablation therapies, thus limiting collateral 
injury.  
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In this study Ryan Goff and I developed and ran the ablation protocols together, while I 
was often responsible for the subsequent staining and imaging of the tissue specimens 
post ablation. I also aided with significant contributions to the manuscript. Robert 
Bueschler was essential in developing the MATLAB code to analyze the dose, 
temperature, and cooling response on tissue viability. Jeunghwan Choi augmented the 
results of this study by performing the cell culture work. This work was also orally 
presented at Cryobiology in Bethesda, Maryland in July 2013. Others and I are 
continuing this work in the laboratory examining the effects of single, double, and triple 
freeze thaw cycles. 
Summary 
Background: Despite widespread and growing clinical use of cryoablation, there remain 
questions regarding dosing and treatment times, which may affect efficacy and collateral 
injury. The major clinical complication is phrenic nerve palsy, at rates of 4-8%. 
Objective: To determine what cooling regimes lead to necrosis, injury, or recovery. 
Methods: Human and swine atrial, ventricular, and lung tissue samples were ablated 
using two cryoablation systems with concurrent infrared thermography. Post freeze-thaw 
samples were cultured, then stained with triphenyltetrazolium chloride to differentiate 
viable and non-viable tissue. Viability staining to freeze-thaw injury was correlated, to 
determine thermal injury thresholds. Specifically, HL-1 cardiomyocytes were cultured 
and subjected to controlled freeze-thaw cycles using a cryo microscopy stage. Post thaw 
viability was determined using Hoechst/Propidium Iodide dye exclusion assay. Tissue 
data were classified as live, injured, or dead based upon staining intensity at the lesion 
margin. 
Results: Thermal history at the transition was quantified, demonstrating that human and 
swine cardiac tissue injury begins at rates of ~10°C/min to 0°C with non-viable tissue, 
requiring cooling rates close to 100°C/min to ~-22°C for swine and significantly greater 
cooling to -26°C for human (p=0.041). At similar rates lung tissue injury began at 0°C, 
  70 
with human tissue requiring significantly less cooling to ~-15°C for complete necrosis 
and -26°C for swine (p=0.024).  
Conclusion: These experiments elucidate the myocardial tolerance of cryothermal 
treatments. Data presented here suggest that there are no significant differences between 
swine and human myocardial response, but there may be differences between swine and 
human lung cryothermal tolerance. 
 
Key Words: Cryoablation, phrenic nerve palsy, cryothermal tolerance, atrial fibrillation 
 
Introduction 
Cardiac balloon cryoablation for the treatment of atrial fibrillation has been gaining 
attention as an approach for isolation of the pulmonary veins (PV) since its first reported 
use in 2003 [87] and in the current clinical form in 2005 [88]. Focal cryoablation has 
been used surgically for many years [89], with transcatheter devices becoming available 
in more recent decades. One benefit of cryoballoon ablation is that it is a ‘single-shot’ 
approach, which is an advantage despite the sometimes slower nature of deeper freezing 
compared to radiofrequency (RF) energy (i.e., freezing is not point-by-point ablation like 
RF). In addition, the currently available ArcticFront cryoballoon (Medtronic, Inc., 
Minneapolis, MN, USA) has been shown to have comparable success rates to RF ablation 
with low adverse events [90,91]. The recent STOP-AF trial concluded similar findings to 
the more observational European studies, including an acceptable safety profile and 
positive response from patients who failed to respond to antiarrhythmic drugs [62].  
 
Despite widespread and growing clinical use, there are still questions regarding dosing 
and treatment times for cryoablation, which may affect both efficacy and collateral injury 
[92,93]. Parameters affecting RF ablation lesions are thoroughly characterized, and 
temperatures of 50°C or higher are required for the creation of myocardial scars.
8
 For 
instance, the effects of power, ablation duration, catheter orientation, catheter size, usage 
of irrigation, and contact forces on lesion size have been thoroughly studied for RF 
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ablation [94–97]. This is particularly relevant given the release of a second generation 
cryoablation device with a different cooling profile that may affect operation [98]. The 
highest regularly detected clinical complication is phrenic nerve palsy, at rates of 4-8% 
[62,91]. The esophagus may be incurring even higher rates of injury, but this is not 
normally detectable unless specifically investigated using endoscopy [99,100]. Given that 
the phrenic nerve and esophagus are in intimate contact with the right PVs and posterior 
wall of the left atrium (LA), respectively, one can see how adjusting dosing may lead to 
better outcomes. It is recommended by the manufacturer that two separate four-minute 
ablations are applied per PV.  
 
A survey of the literature was unable to uncover definitive data for hypothermic or 
cryoinjury to the myocardium and surrounding tissues impacted by ablation. This lack of 
data prompted the current study, which to the authors’ knowledge, is the first to report 
these limits for cryoablation. These data will be beneficial for future numerical modeling 
to help guide decisions such as balloon placement, treatment times, and other patient-
specific treatment planning scenarios. Such approaches could lead to optimization of 
treatment time and/or potentially shorter yet still effective treatments (i.e., transmural 
with minimal collateral injury). 
 
Conversely, in the hyperthermic treatment area (i.e., RF, laser, HIFU), there are data 
regarding injury to many tissues including the myocardium [101]. For instance, work by 
Pearce and colleagues [102,103] exploited cardiac tissue’s unique, native birefringence to 
detect protein denaturation after thermal ablation. Importantly, cellular protein 
denaturation is thought to be one of the main mechanisms leading to necrosis from 
hyperthermic treatments. In Pearce’s study, researchers measured collagen birefringence, 
an extracellular matrix protein, and correlated this to tissue destruction [102]. A similar 
imaging technique cannot be easily implemented during or after freezing because protein 
denaturation is not a major mechanism of cryoinjury and has not been correlated with 
cellular injury after cryo therapy. More specifically, the mechanism of cellular cryoinjury 
is related to water phase change (i.e., intracellular ice crystal formation and cellular 
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dehydration) during freezing [104,105] which has been studied in numerous cell types 
[106–108], although less in whole tissues [101,109]. Cooling below the actual freezing 
point of tissue is necessary for complete destruction, as shown in studies of the kidney 
[89,110] and liver [111] where cooling to -15°C or below was required. Furthermore, 
cellular injury is known to be both end temperature and cooling rate dependent, as 
described in reviews on cryosurgical injury in the literature [109,112]. 
 
It is therefore the goal of this work to determine what cooling regimes lead to necrosis, 
injury, or recovery (i.e., have no detectable effect on myocardium). Infrared (IR) 
thermography was selected, instead of a thermocouple, in order to measure temperature 
over a large area (i.e., every pixel produces a thermal profile). Additionally, IR is a 
noncontact measurement technique, which is particularly beneficial given the large 
thermal gradients produced during cryoablation (i.e., 100°C/cm), and has been used 
previously for cryothermic [113] and hyperthermic [114] studies in cancer [113,115]. The 
drawback of IR thermography is that accuracy suffers in comparison to other techniques 
(i.e., ± 2°C, or 2% of total range), and that the system used is limited to detection down to 
-30°C. This should be sufficient since tissue injury is expected below the phase change 
temperature of tissue (<-.5°C), down to a range of -15 or -20°C based on previous work 
in liver and kidney [110,116,117]. To measure the correlative injury in cardiac tissue post 
cryoablation, histological and enzymatic staining were used as previously described 
[110]. In addition, correlative measurements of cryoinjury in a cardiac muscle cell line 
were performed as a function of both end temperature and cooling rate. 
Methods 
To benchmark this approach, a small sample of swine kidney cortex (n=6, from two 
animals) was obtained and ablated per the protocol described below for comparison to the 
literature. Kidney cortex is homogenous with a smooth, flat surface allowing ease of 
ablation, IR monitoring, and post cryoablation TTC (triphenyltetrazolium chloride) 
staining. After reproducing results from the literature with kidney, the approach was then 
used on cardiac tissue including myocardium and a smaller set of lung samples. Finally, 
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HL-1 cardiac muscle cells were also obtained from culture [118], exposed to controlled 
cryoinjury, and evaluated for cellular level injury for comparison with tissue data. 
 
Sample preparation 
Female Yorkshire Cross swine hearts (n=15 animals), lungs (n=5, from 2 animals), and 
kidneys (n=6, from 2 animals) were chilled and stored in modified Krebs-Henseleit 
buffer within 30 minutes post-mortem from the University of Minnesota Meat Sciences 
Laboratory (Minneapolis, MN, USA). Swine hearts were then transported to our 
laboratory within an hour. Human heart (n=3) and lung (n=3) specimens were obtained 
from non-viable cardiac transplant organ donors through the regional organ procurement 
organization, LifeSource (St. Paul, MN, USA) within 6 hours of cross-clamp time. 
Human and swine samples were dissected from the atria and ventricles to a nominal 
thickness of 5mm. Locations were selected that were relatively ‘flat’ with a low degree of 
invaginations to provide a uniform surface for IR imaging, to avoid out-of-focus effects 
and non-symmetrical ablation lesions. Samples were placed in individual petri dishes 
with room temperature phosphate buffered saline. 
 
The prepared samples were then placed in the apparatus and imaged by an IR camera, as 
shown in Figure 23 (left panel). The apparatus consisted of a plastic petri dish with central 
ablation probe and 2mm of Sylgard (Dow Corning, Midland, MI, USA) polymer formed 
to the bottom. This apparatus was designed to accommodate two cryoablation probes 
with different cooling powers. The first was the Galil Medical SeedNet system (Arden 
Hills, MN, USA) designed for prostate cryoablation, using an argon refrigerant to achieve 
cooling rates and end temperatures of approximately 400°C/minute and -120°C at the 
probe surface in the absence of load. The second system was the Medtronic Cryocath 
system using the FreezorMAX catheter with cooling rate and end temperatures of 
approximately 300°C/minute and -84°C in the absence of load. The samples ablated 
using the Galil system were transected by the needle in the middle, whereas the samples 
ablated using the Medtronic system had a 2mm biopsy punch hole placed in the center of 
the sample through which the catheter was advanced. Using this technique approximates 
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a situation that is easy to model numerically, removes the variability of catheter contact 
pressure, and creates uniform axi-symmetric lesions (Figure 23, right panel). 
 
Figure 23: (Left) Infrared imaging apparatus and resultant isotherms. The samples are 
transected by the cryoprobe and imaged from the top down. (Right) Resultant infrared (IR) 
isotherm at the end of an ablation performed with the Galil system, with white indicating 
temperatures less than -20°C, blue -20°C to -10°C, green between -10°C to 0°C, and red 
greater than 0°C. 
 
Infrared imaging and viability assessment 
Prior to sample placement in the petri dish, ~5ml of ultrasound gel was distributed 
uniformly about the bottom of the dish. After placement of the sample, another volume of 
ultrasound gel was added to surround the sample. Ultrasound gel has been shown to have 
very similar thermal properties to myocardium [119]. By surrounding the sample with 
ultrasound gel, we thereby minimized variation in sample size and created a more 
reproducible ablation volume.  
 
After sample placement, the emissivity and appropriate environmental parameters were 
input to the infrared software (ThermaCAM Researcher Pro 2.9, FLIR Systems, Inc., 
Boston, MA, USA). Emissivity was determined by comparison of IR temperature to a 
0.040” T-type thermocouple temperature (5SRTC, Omega Engineering, Stamford, CT, 
USA) being read by a Fluke 51II thermometer (Everett, WA, USA). A T-type 
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thermocouple with data logging was affixed to the active cooling metal portion of the 
cryoprobe with Kapton (3M, St. Paul, MN, USA) tape for later computer modeling. 
Cryothermal applications (i.e., ablations) of desired durations were subsequently 
performed. 
 
After ablation, samples were washed with phosphate buffered saline, incubated with 
60ml of cell culture media (DMEM/F12, 10% fetal bovine serum, and 1% 
penicillin/streptomycin), and placed in a cell culture incubator. Myocardium samples 
were incubated for 22-24 hours to allow full cryoinjury to manifest. Incubation of only 4 
hours was sufficient for lung and kidney samples. The effect of shrinkage or swelling was 
examined on a subset of ten samples by measurement of the distance between two 
distinct points pre-incubation and post-incubation. The average change and standard 
deviation was found to be an increase of 0.2±1.1mm. 
 
Samples were then stained with 1% TTC in Trizma buffer (7.4 pH) at 37°C for 1 hour, 
similar to previous work [110]. TTC functions by reduction of the compound (i.e., 
electron donation from NADH oxidation from metabolism) and forms a red formazan 
derivative when in contact with viable tissue [120]. Non-viable tissue turns pale or white 
after incubation, as shown in Figure 24. This stain has been validated and widely used for 
identification of infarct regions in artery occlusion models [121,122]. The discrepancy in 
incubation time between tissues is believed to be due to the higher mitochondrial content 
(i.e., more metabolic enzymes remaining active for longer periods) of cardiac tissues. 
   
Figure 24: Examples of TTC stained myocardium (left), kidney (center), and lung (right) 
with central ablation lesions. Scale bar for all is 10mm. 
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The first six samples for this study had a .040” gauge T-type thermocouple placed in a 
1mm superficial slit on the surface of the sample just under the endocardium. The IR 
thermographic data and thermal profiles were compared to ensure environmental and 
sample parameters were being appropriately captured in the IR software. The measured 
difference between IR thermography and thermocouple data was within the manufacturer 
published specification (i.e., less than ±2°C or 2% of measurement).  
 
Data analysis 
After incubation, the samples were digitally photographed under reproducible lighting 
with a ruler for calibration. The photographs were then analyzed using MATLAB 
(MathWorks, Natick, MA, USA) to determine the radial distance from cryoprobe to 
where the lesion ended and a zone of injured and live tissue began by plotting the gray 
values from the cryoprobe edge outward radially and then normalizing these values to 
demarcate live and dead tissue areas. This yielded a sigmoid-like curve from 0 to 1 (i.e., 
dead to live tissue, Figure 25). A single operator then selected two critical points on the 
curve where the transition from dead, injured, and live tissue occurred, as determined by 
TTC intensity. Samples that did not yield clear sigmoid curves, indicating non-
axisymmetric lesions, were removed from analysis. This was necessary as the injury 
analysis algorithm relies on the symmetric nature of the lesion to obtain and compare all 
data at a given radius from the probe to obtain an average and standard deviation for a 
given temperature, T(r,t). This approach also maximized the amount of data available 
from a given lesion (i.e., multiple points per sample) to obtain the highest fidelity in 
reading injury for a given radius (and thus thermal history). 
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Figure 25: (Left) A plot of the normalized gray values of a TTC stained image plotted 
radially outward from the cryoprobe. (Right) Classification of data after selecting the two 
critical points (blue stars) on the sigmoid curve. 
 
The raw IR data were analyzed with a MATLAB program that extracted temperature at a 
particular radial distance. This was then compared to sigmoidal staining intensity curves 
at the same radial distance (Figure 25). Eventually a full database of thermal profiles and 
another database of staining profiles as a function of radius were obtained for a given 
tissue tested. Finally, by comparing these databases, it was possible to determine the 
thermal history (i.e., cooling rates and nadir temperatures) that resulted in dead tissue, 
injured tissue, and live tissue in the test. 
 
Cell culture and freeze–thaw 
HL-1s cell lines, murine cardiac muscle cell lines with differentiated cardiac 
morphological, biochemical, and electrophysiological properties, were cultured as 
described in Claycomb et al [118]. Briefly, the cells were allowed to proliferate in 75cm
2
 
tissue culture flasks coated with gelatin/fibronectin. The cells were grown in a 5% CO2, 
37°C incubator with Claycomb media further supplemented with 10% Fetal Bovine 
Serum, Noreprinephrine,L-Ascorbic Acid, and L-Glutamine (SAFC Biosciences, Lenexa, 
KS, USA). The cultured cells were trypsinized (0.05% trypsin, Life Technologies, NY, 
USA) and harvested as suspensions for freeze-thaw experiments.  
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5-10uL of cell suspensions were placed on a quartz crucible which, in turn, was placed on 
a cryostage (Linkam BCS196, Surrey, UK) for controlled freeze-thaw [108]. All samples 
were pre-nucleated at -2°C by bringing the outer edge in contact with a chilled needle. 
The partially frozen samples were allowed to melt almost completely by bringing the 
temperature back up to -0.6°C. Thus with a small number of ice crystals present at the 
onset of the process, the samples were cooled down at varied rates (0.5 to 130°C/min) to 
varied end temperatures (-5 to -60°C) and held for 0 to 3 minutes. The cells were then 
rapidly thawed at a rate of 130°C/min to room temperature, then incubated (5% CO2, 
37°C) for 15 minutes prior to the subsequent viability assay. Post thaw viability was 
determined using a Hoechst/Propidium Iodide (PI) assay[108] (Sigma-Aldrich, St. Louis, 
MO, USA) where a minimum of 100 cells were counted from multiple fields of view 
using a fluorescence inverted microscope (Olympus IX51, Center Valley, PA, USA). 
Results & Discussion 
The resultant categorical tissue response (i.e., live, injured or transition zone, dead) to the 
thermal ablation was plotted against the cooling rate and minimum temperature reached. 
The swine kidney results shown in Figure 26 were found to agree with previously 
published data on thermal injury. Comparing the right and left panels of Figure 27, one 
can see that similar patterns arise in both the atria and the ventricles. Furthermore, human 
myocardium responses are shown in Figure 28. The effect of cooling rate on post thaw 
survival of HL-1 cells is shown in Figure 29 (left panel), while the effect of the lowest end 
temperature reached during the cooling process is shown in Figure 29 (right panel). 
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Figure 26: Swine kidney tissue viability response to ablation with Galil Seednet probe (n=6). 
 
 
Figure 27: Swine atrium (Left; n=8) and swine ventricle (Right; n=14) tissue viability 
response to ablation with Medtronic FreezorMax. 
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Figure 28: Resultant viability curves for swine ventricular and atrial samples (Left;, n=39) 
and human myocardium (Right; n=6). 
 
 
Figure 29: (Left) Effect of cooling rate on HL-1 cell post freeze thaw viability as determined 
by Hoechst/Propidium Iodide dye exclusion assay. All samples were pre-nucleated then 
cooled at rates shown to an end temperature of -20ºC. Samples were held at -20ºC for 1 
minute prior to subsequent rapid thawing (n=6). (Right) Effect of end temperature on HL-1 cell 
post freeze thaw viability as determined by Hoechst/Propidium Iodide dye exclusion assay. All 
samples were pre-nucleated then cooled at 5
o
C/min to end temperatures shown. Legend indicates 
time duration held at end temperatures prior to subsequent rapid thawing (n=6). 
 
This study reports on cardiac tissue cryothermic tolerance. This approach can be adapted 
to other tissue types, as shown here and in previous literature on heat and cryo lesions in 
human and animal tissues [110,123]. This methodology may also be used to study the 
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effects of multiple freeze-thaw cycles or complex cooling regimes. Pooling human and 
swine myocardial data suggests that it needs to be cooled to at least -22±3°C for the atria 
and -22±4°C for ventricular tissue to obtain complete necrosis at rates of -105±33°C/min 
and -112±39°C/min, respectively. The cooling regime contains variable cooling (and 
thawing) rates and hold times in addition to end temperature, which can all affect 
viability. Thus the authors suggest cautious and conservative use of these numbers. 
 
Data presented here suggest that kidney tissue needs to be cooled to -19±4°C at cooling 
rates of -82°C/min to obtain complete necrosis (Table 17). These data agree with 
previously published data on kidney cryothermal tolerance [110,116,117]. Benchmarking 
the system against previous research data on kidney tissue demonstrates the ability of the 
system to determine injury thresholds accurately.  
 
Table 17. Necrotic thermal injury thresholds summarized by tissue type and probe 
treatment  
Tissue 
 
Cryoprobe 
 
Injured to Dead Transition (average) 
End Temperature 
[C] 
Cooling Rate 
[C/min] 
Human myocardium Pooled (n=6) -26±4 † -102±23 
Human lung Pooled -15±8 ‡ -78±23 
Swine atrium 
FreezorMAX (n=8) -24±3 † -134±26 
Galil (n=8) 
 
-21±4 † -80±8 
Swine ventricle 
FreezorMAX 
(n=14) 
-23±3 † -136±35 
Galil (n=9) 
 
-20±4 † -81±13 
Swine lung Pooled (n=5) -26±5 ‡ -104±20 
Swine kidney Galil (n=6) -19±4 -78±12 
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*Statistical differences were detected by use of a T-test between end temperatures and 
cooling rates. † Human myocardium compared to pooled swine myocardium (p=0.041); ‡ 
Human lung compared to swine lung (p=0.041). 
 
Interestingly, the lung data suggest that there may be significant differences between 
swine and human cryothermal tolerance. The human data indicate that cooling to -
15±8°C at cooling rates of -78°C/min may be required for complete lesions (Table 17). 
The temperature necessary to destroy healthy swine lung tissue is lower than for human 
tissue. Specifically, temperatures of -26±5°C at -104°C/min (Table 17) were required for 
complete lung lesions which are approaching the limit of the current infrared camera (i.e., 
-30°C). The discrepancy may be due to age, disease state, species variation, and/or pre-
procurement sample treatment (e.g., human samples were transported at near 0º 
temperatures for up to several hours before experiments). Nevertheless, these rare human 
specimens provide unique and translational insight to cryothermic injury thresholds of the 
lung. 
 
This work is not without limitations, as is the case with any in vitro animal tissue-based 
model. The effect of the tissue being perfused is not fully understood. However, work by 
other groups on the kidney [110,116,117] have found similar temperatures are necessary 
for complete necrosis in experimental groups that were perfused or non-perfused. The 
TTC stain is an indicator of metabolic activity and therefore not truly a direct indicator of 
live versus dead tissue. It was considered in this experiment as an acceptable surrogate 
for viability based upon the wealth of previously published literature using cardiac tissues 
(e.g., left anterior descending artery occlusion models). 
 
The results with HL-1 cells allow us to gain further insight into some of the possible 
mechanisms that affect tissue-level destruction. The left panel of Figure 7 shows that 
while a significant subpopulation (>30%) of cells will survive at an end temperature of -
20°C if cooled at a rate of 5°C/min, complete destruction can be attained at the same end 
temperature if cooling rates greater than 50°C/min are employed. Likewise, the right 
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panel of Figure 7 suggests that even with a cooling rate of 5°C/min (an apparent optimal 
rate for cell survival), complete destruction can be achieved at an end temperature 
somewhere between -20 and -40°C. These results with HL-1 cells are similar to results 
for myocardium, in which complete lesions are observed in regions where the minimum 
temperature reached was around -22°C and where the maximum cooling rate was greater 
than 60°C/min.  
Conclusions 
Here we report tissue-level experiments to elucidate the myocardial tolerance of 
cryothermic treatments. The data suggest minimal differences between swine and human 
myocardial response, although there may be a difference between swine and human lung 
cryothermal tolerance. This thermal injury assessment approach may be used in future 
experiments on multiple tissue types to study the viability response to simple or complex 
cooling regimes. 
Clinical Perspective 
This work further elucidates the degree of cooling required to create cryothermal lesions 
in both human and swine cardiac tissues. It also demonstrates that human lung tissues 
may be more sensitive to cryothermal energy, and therefore care should be taken when 
cryoablation procedures are applied near lung tissues. Furthermore, these data fill a void 
in knowledge relative to the transmural temperatures cardiac cryoablation should be 
targeting, to achieve therapeutic doses. Such data could also be employed to develop 
computer simulations as a means to further refine dosing protocols. This work supports 
the supposition that swine myocardium behaves similarly to human tissues after exposure 
to cryothermal energy, and thus swine may be used as an appropriate animal model for 
testing of these therapeutic conditions as well as for new devices and procedures. In the 
future, as advanced temperature monitoring capabilities become available in routine 
clinical practice (e.g., magnetic resonance themography), our data may be applied to 
determine practice limits for optimizing lesion formations. 
  84 
Tensile Properties of Cardiac Tissues Relative to the Application of 
Radiofrequency or Cryothermal Ablative Therapies 
 
Submitted to  IEEE Journal of Translational Engineering in Health & 
Medicine ,  in review. 
 
 Stephen G. Quallich, BS
1,2
; Kevin, K. Kriege, BS
3
;  Paul A. Iaizzo, PhD
1-3
 
 
1 
Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN 
2
 Department of Surgery, University of Minnesota, Minneapolis, MN 
3
 Department of Physiology, University of Minnesota, Minneapolis, MN 
 
Preface 
In general, the temperature thresholds and mechanisms of injury of radiofrequency and 
cryothermal ablations have been previously studies; although, the specific cardiac tissue 
responses to these therapies remains largely uninvestigated. Importantly, associated 
changes of the cardiac tissue properties may alter the heat transfer as well as facilitate the 
development of complications, such as pulmonary vein stenosis, atrial-esophageal fistula, 
and/or cardiac tamponade. For example, in one of our previous studies we have shown 
that ablation modalities may lower the contact force required to perforate the atria [72]. A 
more comprehensive understanding of the impacts ablation may have on cardiac tissues 
could also be beneficial in the generation of accurate computational models of such 
ablative therapies. In an effort to better elucidate the cardiac tissue responses to ablation 
modalities, this study investigated the effects of both radiofrequency and cryothermal 
ablations on specific cardiac biomechanical properties. It was observed that 
radiofrequency ablations altered the cardiac tensile strengths, Young’s moduli, and 
strains at failure, while cryothermal treatments produce minimal biomechanical 
transformations. It is considered here that these results utilized in conjunction with 
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computational models may aid in alleviating complications associated with cardiac 
ablative procedures and thus improve clinical awareness of the secondary consequences 
of such applications. 
 
I was primarily responsible for the study design, data and statistical analyses and the 
initial draft of the manuscript. Kevin Kreige was an essential contributor, aiding in the 
dissection of specimens and data collection of the uniaxial tissue responses. The 
preliminary results from this study were presented at the Biomedical Engineering Society 
in San Antonio, TX in October 2014. On going research is also being conducted in the 
laboratory. 
Summary 
Changes in cardiac biomechanical tissue properties following the applications of various 
ablation modalities may lead to the development of an array of associated complications. 
The applications of either radiofrequency (RF) or cryothermal ablations will alter the 
biomechanical properties of various cardiac tissues in a differential manor: in some case 
this may be attributable to increased incidences of cardiac tamponade, pulmonary vein 
stenoses, and/or atrial-esophageal fistula. Thus, a greater understanding of the underlying 
changes in tissue properties induced by ablative therapies will ultimately promote safer 
and more efficacious procedures. The effects of either applied RF or cryothermal 
energies on the biomechanical properties of pulmonary vein, left atrial or right atrial 
samples (n=367) were examined from fresh excised porcine (n=35) and donated human 
tissue (n=11). Radiofrequency ablations were found to reduce the tensile strengths of the 
porcine cardiac specimens (p<0.05), and a similar trend was noted for human samples. 
Cryoablations did not have a significant impact on the tissue properties compared to the 
untreated tissue specimens. Locational and species differences were also observed in this 
experimental paradigm (p<0.001). Incorporating these findings into cardiac device design 
and computational modeling should aid to reduce the risks of complications associated 
with tissue property changes resulting from cardiac ablative procedures. 
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Introduction 
Atrial fibrillation (AF) continues to affect millions of individuals in the United States 
alone, and the incidence of this disease is expected to grow rapidly, 2.5 fold, by 2050 
[44]. In general, individuals over the age of 80 elicit incidences above 10% [44,124]. 
Unfortunately, complications associated with catheter ablation procedures for AF occur 
at approximate rates of 4-6% [41,42]. A number of these complications are the secondary 
result of the applications of either RF or cryothermal ablative energies, such as cardiac 
tamponade, pulmonary vein (PV) stenosis, and/or atrial-esophageal fistula. While it is 
generally considered that the heating or cooling of tissues will alter their biomechanical 
properties, the exact therapeutic thresholds have not been identified in controlled 
experiments. Additionally during such RF clinical procedures, surpassing the minimum 
target temperature of 50°C for myocardial scar formation, is quite plausible, especially 
when aiming to create transmural lesions [56]. It is considered that RF energies build up 
within the associated tissues during RF ablations [125]. Exceeding ablations temperatures 
of 60-65°C has been reported to result in the denaturation of collagen, temperatures 
higher than 80°C causes elastin denaturation, and both of these contribute to a loss of 
total tissue compliance [49]. In contrast, it is considered that ice formation during 
cryoablations induces altered alignments of structural proteins without compromising 
their integrities, although there were noted modifications to their elastic moduli [50]. In 
other words, the applications of ablation energies, changes the biomechanical as well as 
the tissue properties that may play roles in the manifestations of the aforementioned 
complications. Thus, a greater understanding of how and why these transformations 
occur could ultimately reduce their elicitations relative to these cardiac treatments.  
 
Interest in thermal tolerance tissue properties has also increased in order to improve 
ablation procedures. For example, characterizing the cryothermal tolerances of cardiac 
and adjacent tissues is essential for predicting and minimizing phrenic nerve injury, 
amongst other complications as well. Phrenic nerve injury has been reported to occur at 
rates of 2-11% and was also considered to be a more prominent in the early uses of 
second-generation cryoballoon [62,79,126]. Also, during freezing it was reported that 
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thermal conductivities increase while specific heats decrease [127]. Perhaps such 
knowledge may explain why phrenic nerve injury occurs more readily with cryoablation 
compared to RF ablation. In addition, resultant protein denaturation and water 
vaporization reduces the thermal conductivities and specific heats of cardiac tissues, 
changing the thermal profile during heating and their responses to secondary energy 
applications [128]. Furthermore, accounting for all such tissue alterations is essential if 
one hopes to generation accurate computational models of ablative therapies; e.g., in 
order to attenuate the incidences of phrenic nerve injuries, amongst other complications. 
 
The biomechanical characterizations of various myocardial structures within the heart as 
a whole are currently underway. For instance, the biomechanical properties of the fossa 
ovalis have been investigated in an effort to reduce iatrogenic atrial septal defect 
formations [58]. Additionally, our laboratory has studied the relative contact forces 
required to cause perforations and the associated relationships with various ablation 
modalities [72]. Furthermore, interest in engineered heart tissues as well as rapid 
utilizations of transcatheter valves has led to the study of both valves and chordae 
tendineae properties so to better mimic their native behavior [129,130]. Therefore, a 
detailed understanding of the biomechanical as well as biothermal tissue properties 
associated with ablative therapies remains an intense area of interest.  Further, as 
cardiovascular technologies continue to advance, computational modeling’s role in both 
device development and personalized medicine will likely become readily available and 
increasingly important [131]. 
Methods 
Human heart specimens (n=11) were acquired from non-viable organ transplant donors 
through LifeSource (St. Paul, MN) as well as the University of Minnesota Bequest 
Program (Table 18). Also, Yorkshire cross swine (n=35) cardiac tissue was also obtained 
from both the University of Minnesota Meat Sciences Lab and our laboratory. Fresh atrial 
and ostial PV’s (n=367) were carefully dissected into dog-bone shape tissue bundles and 
2-0 silk sutures (Surgical Specialties Corp., Reading, PA) were tied to both ends (Figure 
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30). This dog-bone orientation allows for repeatable failures of these tissues near their 
midpoint: evulsions occurred at the tissue regions with the smallest cross sectional area. 
All tissue samples dimensions were measured with calipers to allow for subsequent data 
normalizations. All swine samples were tested within 24 hours post-explantion; some 
human specimens were tested beyond this timeframe, but within 48 hours. Samples were 
stored in saline at 4°C prior to uniaxial testing. The prepared samples were randomized to 
the following study groups: 1) no treatment (NT), 2) RF ablation for 1 minute at 30 W, 
with a 65°C temperature limit, or 3) focal cryoablation for 2 minutes. Specimens were 
then pulled uniaxially until failure at a rate of 100 mm/min with a mechanical force tester 
(Chatillon, Largo, FL).  
 
Table 18. Human heart demographics. 
Heart 
# 
Age 
(Yr) 
Weight 
(kg) 
Gender 
 
COD 
 
Cardiac History 
 
1 45 96 M CVA Hypertension, Alcoholism 
2 34 86 M CVA None 
3 62 73 F CVA 
Hypothyroidism, 
Hyperlipidemia 
4 52 74 F CVA None 
5 81 75 F Natural AF, Mitral regurgitation 
6 67 82 M Bladder cancer None 
7 69 77 M COPD None 
8 68 137 M CVA 
Hypertension, 
Hyperlipidemia, CABG 
9 58 93 F Head Trauma Hypertension 
10 52 94 M Drug overdose None 
11 57 106 M CVA None 
*Cerebrovascular accident 
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Figure 30. A typical example of a prepared dog-bone shaped specimen, which was then mounted in 
the mechanical force tester using sutures. The scale bar depicts 1 cm. 
 
Data Analyses 
Ultimate tensile strengths, strains at failure, and Young’s moduli were calculated and 
analyzed with Matlab (MathWorks, Natick, MA) and Minitab (State College, PA). All 
determined values are presented as means ± standard deviations. Analysis of variance 
(ANOVA) for groups of 3 or more were used to compare normally distributed data. P-
values ≤0.05 were considered as significant. 
Results 
The relative tensile strengths, strains at failure, and derived Young’s moduli for a given 
tissue studied, were found to be significantly different: i.e, between the right/left atrial 
and PV specimens as shown in Table 19 (p<0.001).  Furthermore, there were significant 
differences between species, with human hearts having greater ultimate tensile strengths 
and Young’s moduli, but lower strains at failure: as provided in Table 20 (p<0.001).   
 
Table 19. Comparisons of porcine biomechanical properties sorted by tissue type. 
  Location 
P-value 
  RA LA PV 
Ultimate Tensile Strength (MPa) 0.69±0.35 1.04±0.76 1.64±0.95 <0.001 
Strain at Failure (%) 87±33 117±39 153±68 <0.001 
  90 
Young's Modulus (kPa) 15±8 19±10 31±23 <0.001 
Number 33 23 39   
 
 
Table 20. Comparisons of pulmonary vein biomechanical properties sorted by species: human versus 
swine. 
 
Species 
P-Value 
 
Human Swine 
Ultimate Tensile Strength (MPa) 5.90±5.22 1.64±0.95 <0.001 
Strain at Failure (%) 58±28 153±68 <0.001 
Young's Modulus (kPa) 224±219 31±23 <0.001 
Number 29 39 
 
 
 
The applied ablation modality and therapeutic application site within these hearts were 
both shown to be factors influencing the resultant biomechanical properties. Following 
therapeutic applications, the relative tensile strengths for both the porcine pulmonary 
veins and left atrial tissue specimens were significantly different; as shown in Table 21 
(p<0.05). Note, that post-treatment responses of the porcine right atrial and human PV 
samples followed the same trends, but these effects did not achieve significance (Table 
22). Further, the applications of RF energies reduced the tensile strengths of all 
investigated tissues; typically this resulted in reduced evulsion forces by approximately 
one third following RF ablations. In contrast, cryoablative therapies elicited no statistical 
impacts on the ultimate tensile strengths regardless of the tissue tested. 
 
Table 21. Comparisons of the biomechanical properties of porcine pulmonary veins, right atrium, 
and left atrium in each treatment group: controls (NT), radiofrequency (RF) therapy or cryothermal 
therapy (Cryo). 
  Ablation Modality 
P-value 
Pulmonary Vein NT RF Cryo 
Ultimate Tensile Strength (MPa) 1.64±0.95 1.09±0.59 1.41±0.49 0.012 
Strain at Failure (%) 153±68 128±62 147±72 ns 
Young's Modulus (kPa) 31±23 21±13 27±18 ns 
Number 39 27 32   
          
Left Atrium 
Ultimate Tensile Strength (MPa) 1.04±0.76 0.64±0.30 0.83±0.49 0.044 
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Strain at Failure (%) 117±39 90±33 85±21 0.001 
Young's Modulus (kPa) 19±10 15±10 21±12 ns 
Number 23 25 29   
          
Right Atrium 
Ultimate Tensile Strength (MPa) 0.69±0.35 0.54±0.40 0.63±0.30 ns 
Strain at Failure (%) 87±33 69±36 84±32 ns  
Young's Modulus (kPa) 15±8 14±8 15±9 ns 
Number 33 37 40   
 
Table 22. Comparisons of human pulmonary vein biomechanical properties associated with 
treatment group: controls (NT), radiofrequency (RF) therapy or cryothermal therapy (Cryo). 
  Ablation Modality 
P-value 
  NT RF Cryo 
Ultimate Tensile Strength (MPa) 5.90±5.22 3.85±2.62 6.69±5.91 ns  
Strain at Failure (%) 58±28 55±21 64±25 ns 
Young's Modulus (kPa) 224±219 144±108 219±225 ns 
Number 29 30 25   
 
Discussion 
The observed biomechanical properties of cardiac tissues studied here were identified to 
be similar to those reported in the literature. For instance, studies examining the 
biomechanical properties of porcine peripheral and coronary arteries observed ultimate 
tensile strengths and Young’s modulus in agreement with this study [53,132]. It should 
be noted, that there were to be expected differences between arteries and the 
venous/cardiac tissues used in this experiment. Also, Venkatasubramanian et al reported 
a shift in Young’s modulus of the physiological region of the frozen samples so that they 
acted stiffer [53]. Similar behavior was observed in this study during cryoablation with a 
shift of Young’s modulus (data not shown). Furthermore, it was reported that RF energy 
applications caused a loss of pulmonary vein compliances, which were exacerbated with 
temperature increases beyond 60-65°C [49]. Note that a temperature limit of 65°C was 
utilized in our experiments, and although there was a reduction in compliance, inversely 
related to Young's moduli, no significant changes were observed. In other words, in the 
current study approach, since this temperature threshold was only approached without 
being exceeded for relatively short periods of time, this transformation may be masked by 
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the large variability in biological specimens. Additionally, similar effects of ablations 
were exhibited for the esophagus with RF significantly reducing the ultimate tensile 
strength, and cryoablation having no noticeable impact [133]. In general, the effects of 
RF and cryothermal ablation seen in this study are in agreement with those manifested in 
a variety of other tissue types including veins and esophagus. 
 
The biophysical disruption of the structural integrity of tissues in relation to heating has 
been characterized numerous times [49,134–137]. As temperatures exceed 65°C collagen 
denaturation occurs and at temperatures above 80°C elastin denaturation is incited [49]. 
In this experimental paradigm a temperature limit of 65°C was used, which allowed for 
collagen breakdown in these tissues following the application of RF therapeutic ablations. 
Therefore, reduced structural integrities were expected and were found to be agreement 
with our presented results.  In contrast, cryoablative therapy is considered to have 
minimal affects on the integrities of structural proteins, so reductions in ultimate tensile 
strengths would not be anticipated and were not observed in this study. Yet, the relative 
induced changes that RF and cryothermal ablative energies had on the structural proteins 
were associated with the tissue and species specific biomechanical responses. 
 
Although we identified significant difference between the swine and human 
biomechanical properties, there are a number of other factors one needs to consider. The 
tissue samples studied here were from 6-9 month old swine, while samples from human 
donors ranged between the ages of 34-81 years. Aging processes will alter biomechanical 
properties: e.g., studies examining the chordae tendineae reported that with age the 
collagen orientations becomes more disorganized along with alterations in the collagen 
wave structure [138]. More specifically, the large ranges in both the sample ages and 
their associated disease state of the donor human specimens studied here, may have 
contributed to the observed variabilities and the differences when compared to the swine 
samples. Note that some of the donors had cardiac conditions, which may have altered 
their anatomy and biomechanical properties of the tissue. Also, given the relatively small 
sample size for human tissue, additional testing would aid in validating these findings. 
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Nevertheless, swine hearts were used as a translational model to approximate tissue 
biomechanics following ablation 
 
The biomechanical properties assessed in our investigations of both the human and swine 
tissues should be of interest to scientist, engineers, as well as electrophysiologists 
utilizing these therapies to treat patients. We consider here that this is one of the first 
studies to examine the effects of ablative energies on the biomechanical properties of 
various cardiac tissues. Greater awareness of the resultant differences RF and 
cryothermal ablation applications have on tissues, may influence future iterations of such 
delivery devices and/or be used to fine tune clinical procedures, so to minimize 
circumstances leading to the development of associated complications. For instance, the 
knowledge that RF weakens the ultimate tensile strength of various tissues could be 
advantageous in particular applications. For example, the Baylis RF transseptal needle 
takes advantage of these induce effect and uses the aid of RF energy to more readily cross 
the septum: i.e., as a alternative to solely applying mechanical force. Additionally, the 
results presented herein may have numerous implementations for device design in 
numerous clinical scenarios that again may aid to improve the safety and efficacy of all 
types of ablation procedures. 
 
This study had some inherent limitations that need noting, which may include:  1) tissue 
temperatures during applied therapies were not monitored; 2) only uniaxial force 
responses were studied; and 3) the relative viability of the human tissues was not always 
optimal. Monitoring of the contact tissue temperatures would have allowed for a more 
accurate examination of the influence temperature has on biomechanical properties. 
However, we employed clinical systems for therapeutic delivery and this type of 
monitoring would in turn be invasive and in itself may have compromised the measured 
tissue properties of interest. Furthermore, samples were typically near or less than 1 mm
2
 
in cross sectional area, so catheter tip temperatures were expected to be quite close to 
maximum tissue temperature. Noted above, biomechanical properties were only 
examined uniaxially and these tissues likely have directional differences, since they are 
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not homogeneous in nature. Furthermore, some of the human tissue used was not tested 
within 24 hours post-explantation. Although, we did not observe significant differences 
between the relative properties of our obtained human samples: this may have been 
masked by the small sample size. Therefore, further experiments need to be conducted to 
investigate these potential aforementioned study limitations.  
Conclusion 
The effects RF and cryothermal ablations have on the biomechanical properties of cardiac 
tissues were investigated using a translational approach. Applied RF energies induced 
significant denaturation of structural proteins, ultimately leading to decreases in tensile 
strengths, but without associated changes in strains at failures and/or derived Young's 
modulus. Cryoablations did not elicit significant effects on any tissue properties 
compared to untreated specimens. There are tissue specific and species variations that 
need to be accounted for in applications interested in the biomechanical properties of 
cardiac tissues. Thus, special consideration should be taken when using animal models as 
substitutes for human tissues in device design efforts. This research highlights the need 
for further studies to investigate the tissue property transitions that occur during and 
following the application of ablation modalities, especially with respect to clinical 
complications. 
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Preface 
Augmenting our investigations on the effects ablative therapies have on cardiac tissues, 
this study specifically targeted the relative responses of the pulmonary veins. 
Unfortunately, pulmonary vein stenosis is a complication that occurs at rates as high as 
phrenic nerve injury, up to 15.6% [139], but its development can be further masked by 
time. As such, it is often developed months following the ablative procedure and not 
impeding until the progressive effects become substantially enough; severe induced 
stenosis may be life threatening. To date, there have been few investigations performed 
relative to identifying the initiators that spur the development of such stenosis. Hence in 
this experimental paradigm, we investigated the development of pulmonary vein stenosis 
on an acute time scale as a means to better understand how such biomechanical changes 
may play a role. Radiofrequency and cryothermal treatments caused shrinkage of the 
pulmonary veins compared to untreated controls, suggesting that increased stress states 
may lead to a greater likelihood of stenosis development. 
 
I was responsible for the design of experiments, data and statistical analyses, and the 
initial draft of this manuscript. The preliminary results of this study were presented orally 
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at the European Cardiac Arrhythmia Society (ECAS) in Munich, Germany in March 
2014. 
Introduction 
Over 5 million Americans are currently affected by atrial fibrillation, and as the 
population continues to age the incidence is expected to rise 2.5 fold by 2050 [44]. 
Radiofrequency (RF) and cryoablation are routinely used to treat atrial fibrillation to 
hopefully be a curative treatment. Yet, development of pulmonary vein (PV) stenosis is 
facilitated following cardiac ablation procedures. Although it is frequently asymptomatic, 
it may become a potentially life threatening condition: as the degree of stenosis escalates 
typically the severities of symptoms increases as well. 
Noteworthy in one study, 15.6% (3.4% severe, 4.4% moderate, 7.7% mild PV 
stenosis) of patients were reported to develop PV narrowing 3.5 months after RF ablation 
procedures; it was considered that PV stenosis progression subsides 3 months following 
ablation procedures [139]. However, it has also been reported that 2 years following RF 
ablation, up to 28% of patients are affected by PV stenosis and/or occlusion. 
Furthermore, it is important to acknowledge that distal ablations inside the PV’s 
compared to ostial ones were associated with over a 5 fold increase in the development of 
stenosis [140]. In cryoablation procedures PV stenosis incidence rates were 3.1%, and it 
has been suggested that cryoablation is less likely to elicit stenosis compared to RF 
ablation [62]. Clearly, a concerning portion of AF treated patients develops PV stenoses. 
There have been several chronic studies examining this phenomenon. However this study 
aims to investigate the development of stenosis in the distal and ostial PVs on an acute 
time scale using translational approaches to understand and reduce its occurrence. 
Methods 
Fresh pulmonary vein samples from Yorkshire Cross swine (n=25) were carefully 
dissected into 1 cm
2
 squares and the orientation relative to the PV anatomy was noted. 
Human tissue (n=3) acquired from non-viable organ transplant donors through our local 
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organ procurement organization LifeSource (St. Paul, MN) were also used. PV specimens 
were sorted into ostia and 1 cm distal to the ostia groups.  
 
Four sutures were attached to each side of the pulmonary vein samples, and they were 
subsequently mounted in a biaxial testing machine (Figure 31). Each specimen was used 
as its own control in this experimental paradigm. Samples were subjected to five 
preconditioning cycles of 10% strain initially, stretched to 20% strain, thus mimicking 
changes associated with normal physiological function, and then a randomized ablation 
modality of RF or cryoablation was applied tangentially (Figure 32). RF ablation was 
applied employing a 7 Fr Marinr® catheter (Medtronic, Minneapolis, MN) using 25 W 
with a 65°C temperature limit for 1 minute. Cryoablation was applied with a Freezer Max 
catheter (Medtronic, Minneapolis, MN) for 2 minutes. The resulting stresses in the axial 
and circumferential directions were measured for 6 and a third minutes following the 
ablation. 
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Figure 31. The pulmonary vein specimens were mounted on a biaxial testing machine using sutures 
in alignment with the axial and circumferential directions of a given vessel. 
 
Figure 32. Graphical representation of strain imposed on the pulmonary vein sample throughout the 
experiment. The ablation was started at the 60-second time point. 
Results 
Normalized resultant circumferential stresses following the ablations were 
significantly different in the distal RF ablation group compared to the non-treatment 
controls for the porcine PV tissues as shown in Figure 33 (p<0.05). Cryoablation was 
significantly different immediately following the ablation, but this effect subsided 
following ice thaw. Of note, there was a trend in reduced circumferential stresses 
between the human RF ostia and swine RF ostia groups following ablation as shown in 
Figure 34 (p=0.07). However, significance was not achieved likely due to the limited 
available human samples utilized in this study. Importantly, this trend was not observed 
with the swine tissue. There were no noteworthy findings in the axial domain. 
Interestingly, a number of the results discussed herein support clinical observations and 
fall in agreement with similar in-vitro investigations. 
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Figure 33. Normalized circumferential stresses following distal RF ablation (n=9) were significantly 
different compared to the non-treatment controls, while cryoablation (n=8) was only significantly 
different during thaw. (*p<0.05 for RF ablation, **p<0.05 for cryoablation) 
 
Figure 34. Performing RF ablations produced a reduction in observed circumferential stresses for 
only the human ostia (n=3) when compared to the swine ostia (n=8). No differences were observed 
between the distal human (n=3) and distal swine (n=9) groups. 
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Interpretation 
In the circumferential direction cryo energies initially significantly increased the stresses 
associated with the presence of ice, but following thaw the stresses remained only 
somewhat elevated. It is considered that cryoablation causes the realignment of fibers, 
dehydration of tissues, yet leaves the extra cellular matrix intact. Also, it shifts the stress-
strain relationship resulting in higher stresses in physiological ranges [53]. Our study 
used a strain of 20% and then we observed similar stress behaviors following 
cryoablation. In contrast, RF ablations induced significant increases in stresses that were 
sustained. RF ablation therapy is considered to: 1) denature structural proteins, 2) cause a 
loss of compliance, and 3) induce shifts of stress strain curve [49]. These described 
phenomena with RF ablation were observed in our studies for both the porcine and 
human tissue samples investigated. 
 It is suggested that such increases in induced tissue stresses and loss of PV 
compliances that occurs following ablations, likely initiates the development of PV 
stenosis in patients. Importantly, cryoablation is less likely to facilitate the development 
of stenoses compared to RF ablation [62,139]. We observed here, that although both 
ablation modalities increased circumferential stresses following treatment, only RF was 
significantly different compared to the non-treatment controls. These data may support 
the supposition that following an ablation procedure the increased stress state leads to a 
greater likelihood of PV stenosis development.  
 Here we also noted that the ostia and more distal ablations of the PV also 
provoked interesting insights. Minimal circumferential stress changes were induced for 
the swine ostia versus more distal PV tissue, however there were differences for the 
human tissue. In the swine model there is a distinct transition from muscular atrial to PV 
tissue, whereas in the human anatomy this transition lacks a clear demarcation and 
muscular tissue typically extended partially into the PV. In this experimental paradigm, 
swine tissue appeared uniform in both location groups while human tissue was not. 
Further studies are needed to investigate the discrepancy of the swine model as it relates 
to the human patient populations of interest: a translational approach is essential for 
investigations of underlying mechanisms. This data is particularly valuable since it 
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addresses anatomical differences between species and circumferential stress changes as it 
relates to clinical ablation complications. RF and cryoablations cause an increase in 
circumferential stresses that may potentially spark the developments of PV stenoses. 
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Section 3 Visualization of Tissue Responses to Cardiac Ablation 
Procedures  
The ability to directly visualize the device tissue interface during cardiac ablation 
procedures is invaluable. The utilization of Visible Heart® methodologies has allowed 
for investigations of cardiac ablative procedures, specifically this procedural application 
and associated complications that may arise within the various cardiac chambers. For 
instance, the explosive steam pop phenomenon was visualized inside the atrium to 
demonstrate the intense release of energy and potentially damaging particulates. 
Furthermore, additional infrared imaging investigations on the epicardial tissue 
temperatures were conducted to further improve our understanding of the temperatures, 
which the nearby phrenic nerve may experience during a performed clinical procedure. 
Additionally, a typical cryoballoon ablation procedure was visualized from the 
transseptal puncture to the difficulty clinicians face when positioning balloon. The 
information gained from these investigations may provide important insights to both 
clinicians performing such procedures as well to device designers. 
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Preface 
Although this study does not directly examine cardiac ablation procedures, it provides the 
background required to generate a heart-lung bloc model that has numerous benefits for 
such studies. The addition of the lung(s) provides native pulmonary vein ostium that can 
then be invaluable for studying the device/tissue interface. This study describes the 
reanimation of both swine and human heart-lung blocs; the development of this 
methodology also allowed for the following two studies to be conducted. For example, 
epicardial infrared imaging to observe surface temperatures during pulmonary vein 
isolation would not be representative of the clinical scenario. The addition of the lungs to 
our reanimation procedure fabricated a more robust model that accurately represents the 
native anatomy and physiology, especially when performing cryoballoon ablation 
procedures. 
 
I was responsible for data and statistical analysis of swine and human heart specimens. In 
addition, all of the contributors aided with the reanimation of these cardiac specimens. 
The lab is still using these techniques today, especially when representative pulmonary 
vein anatomy is required. 
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Summary 
Background: In vitro isolated heart preparations are an invaluable tool for the study of 
cardiac anatomy, physiology, and device testing. Such preparations afford investigators a 
high level of control, independent of host or systemic interactions, and high throughput if 
desired. Here we present that isolated human and swine preparations with the lung(s) 
attached are particularly valuable for the study of device-tissue interaction and anatomy. 
Additionally we detail our laboratory’s experience with developing these methodologies 
for heart/lung bloc studies 
 
Methods and Results: Four human and 18 swine heart-lung preparations were procured 
using techniques analogous to those of cardiac transplant. Specimens were then 
rewarmed and reperfused using modifications of a previously developed apparatus and 
methodologies by our laboratory. Positive pressure mechanical ventilation was also 
employed, and epicardial defibrillation was applied to elicit native sinus rhythm after 
rewarming. Videoscopy, fluoroscopy, ultrasound, and infrared imaging were performed 
for anatomical and experimental study. Systolic and diastolic pressures observed for 
human and swine specimens, respectively, were 68/2±11/7 and 74/3±17/5 mmHg, with 
heart rates of 80±7 and 96±16 bpm. High resolution imaging within functioning human 
pulmonary vasculature was obtained among other anatomies of interest. One specimen 
elicited poor cardiac performance post-defibillation. 
Conclusion: We report the first dynamic images of the pulmonary vasculature during 
cardiopulmonary function in isolated reanimated heart-lung blocs. This experimental 
approach provides unique in vitro opportunities for the study of medical therapeutics 
applied to both human and large mammalian heart-lung specimens. 
 
Key Words: heart-lung bloc; device-tissue interaction; pulmonary vasculature; isolated 
heart 
  105 
Introduction 
In vitro isolated heart preparations have been a cornerstone of cardiac research since 
Langendorff’s original methodology was described in the 1890s [141]. The benefits of 
isolated heart research are numerous and can be remarkable depending on the 
investigator’s goal. Isolated hearts offer a high degree of control over the system 
including, but not limited to: perfusate selection, flow control, and pre- and after-load 
variability. For a thorough historic summary of these experimental models the reader is 
referred to a review by Hill et al [142]. Furthermore, numerous pharmacological studies 
using such approaches can help elucidate the direct action of agents on the isolated 
cardiac tissues, i.e., while avoiding systemic interactions of other agents or breakdown 
products (e.g., cardiac-nervous system, hepatic metabolism) [143]. 
 
Additionally, high-throughput cardiac perfusion systems can be designed, or now even 
purchased off the shelf, in which multiple small mammalian hearts can be experimented 
on simultaneously. Isolated heart preparations have garnered notable insights to 
mechanisms of arrhythmias
 
[144] and have been reviewed elsewhere
 
[145]. Depending 
upon the system configuration, a wide range of equipment and modalities are available to 
the investigator including: electrophysiologic monitoring and stimulus, ultrasonography, 
ultrasonic stimulation, fluoroscopy, infrared thermography, direct visualization via 
videoscopes, and anatomical mapping systems. Furthermore, the utilization of large 
mammalian isolated hearts allows for critical pre-clinical testing of device-tissue 
interactions in an environment highly similar to actual human anatomy and physiology, if 
the proper animal model is selected for investigation
 
[146]. Comparative imaging of 
normal versus pathologic conditions, or interspecies comparisons, to determine optimal 
approaches, models, and designs are critical to development of novel therapeutics
 
[147]. 
To the medical device designer, engineer, or clinician, these insights have proven to be of 
high educational value
 
[148,149]. 
 
Despite isolated heart preparations being a valuable tool, proper anatomical relationships 
can be compromised when the lungs are removed. In particular, the pulmonary veins and 
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their native ostia are of interest in the context of pulmonary vein isolation ablation 
treatments for atrial fibrillation. Heart-lung preparations have been utilized previously to 
elucidate the release of atrial natriuretic peptide
10
 and expand the pool of lung transplants 
to non-beating donors [150]; they have also been used in numerous pharmacologic 
studies. Interestingly, the first heart-lung preparations are often attributed to Knowlton 
and Starling [151], however their work acknowledges  the methods of Martin [152] 
which were presented in lecture at Johns Hopkins in 1883. The first publication by 
Martin of his heart-lung bloc preparation was released in 1881 [153], therefore predating 
Langendorff’s work by fourteen years. In short, this preparation cannulates in situ the 
superior vena cava and one of the branches coming off the aortic arch. A closed loop is 
created by which pressure can be monitored, a compliance chamber is incorporated, and 
pre- and afterloads are varied. 
 
It is also possible for human hearts from non-viable organ donors to be successfully 
reanimated using an isolated experimental apparatus [142]. The Visible Heart® 
methodologies have been previously described by our laboratory [154], but more recently 
we have expanded these experimental approaches to incorporate whole large mammal 
heart-lung blocs, including both human and swine studies. To the authors’ knowledge, 
this is the first description of large mammalian heart-lung blocks being used to achieve 
dynamic imaging in the pulmonary vasculature. The goal of the current study is to 
determine feasibility and characterize viability of large mammalian heart-lung 
preparations. 
Methods 
The technique developed by our laboratory has been used successfully to reanimate 
human and swine hearts with right, left, or both lungs attached and functioning. Swine 
studies were approved by the Internal Animal Care and Use Committee at the University 
of Minnesota. Human hearts were approved for study by the Human Subject Committee 
Institutional Review Board. Consent for use of the hearts for research purposes was 
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received from the donors’ family members before explantation via LifeSource (St. Paul, 
MN, USA).  
 
The detailed procurement procedure has been described previously [142,154]. Briefly, a 
median sternotomy was performed and an aortic root cannula implanted for delivery of 
cardioplegia. The inferior vena cava (IVC) was ligated and, just prior to cardioplegia 
delivery, the IVC for human preparations was removed with the liver if it was being 
recovered for transplant, and the superior vena cava (SVC) and aorta were cross-clamped. 
Cardioplegia was then delivered under pressure to rapidly cool and arrest the heart. The 
heart and lungs were then dissected and the heart-lung bloc removed by transection of the 
major vessels, trachea, and esophagus. The human specimens were then transported on 
ice to the laboratory within 6 hours of cross-clamp depending upon logistics of 
transportation of viable organs to recipients. The human heart-lung specimens were non-
viable cardiac donors (e.g., unknown cardiac arrest period, cardiac disease). An 
analogous procedure was performed on swine hearts in our laboratory (mean animal 
weights of 84±14kg; n=18) using two liters of 4°C St. Thomas’s cardioplegia for 
induction of cardiac arrest. We have typically performed these studies with just one lung 
attached, but the method has been utilized to include both lungs. Preparations with only 
one lung allow cannulation of the non-utilized pulmonary vein, which may be used to 
access the left atrium for imaging or device introduction.  
 
Upon arrival of human (or after explantation of swine) specimens, hearts were placed in 
an ice slurry of modified Krebs-Henseleit buffer while cannulation of the great vessels 
was performed (i.e., IVC, SVC, and aorta). If a one-lung preparation was desired, the 
left/right pulmonary veins and artery were dissected from the left/right lung, and the lung 
was removed. These vessels were cannulated as well, and a hemostasis valve was fitted 
for access. If both lungs were desired in the preparation, the pulmonary trunk was 
cannulated to allow control of the buffer flow, either directing all flow through the lungs 
or allowing some flow to the reservoir (i.e., a parallel path through the lungs and to the 
reservoir). An intubation tube was placed in the trachea and connected to a ventilator to 
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control flow through the airway. Preparations were ventilated at a respiration rate of 11-
15 per minute and a volume of 150-250 milliliters per lung.  
 
The heart-lung blocs were then connected to the apparatus described in detail previously 
[154] that was adapted for such use. A schematic of this system can be found in Figure 
35. The system was altered to vary the aforementioned parameters of other isolated heart 
research systems and functioned in either partial or four-chamber working mode. Partial 
working mode is similar to a Langendorff apparatus function, but fluid flow continues 
through an isolated lung (i.e., the right heart continues to function). The system utilized a 
cardiovascular bypass oxygenator and heated water jacketed fluid reservoirs to maintain 
the proper physiologic environment. The preparations were cradled on custom sized soft 
foam cushions to support the tissue. Seven to eight liters of modified Krebs-Henseleit 
buffer were contained in the system and buffer changes of approximately four liters were 
performed regularly to wash out metabolites and maintain visualization as desired.  
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Figure 35. (Top right) External view of human heart 277 in systole and attached to the system. 
(Center) Flow diagram for a functional heart and lung reanimation consisting of: (1) a respirator 
connected to the cannulated trachea and thus attached to the lung(s), (2) a pre-load chamber for the 
right side of the heart, (3) an aortic after-load chamber which mimics the resistance that the left 
ventricle works against, (4) a left pre-load chamber employed when only one lung is present, (5) an 
oxygenator reservoir for pooling fluid expelled by any cannulated branch of the pulmonary artery, (6 
& 7) fluid pumps to maintain the pre-load pressures, (8) hemostasis valves that allow access for 
delivery of cameras, instruments, and assorted devices, (9) valves that may also be used to redirect 
flow as physiologically appropriate, while (10) cannulation of the pulmonary vein(s) are shown here 
for a right lung preparation, but are absent or translated when either both lungs or the left alone 
respectively are used. 
 
Once the specimen was re-warmed to 37°C, dobutamine was added to the system and the 
heart was defibrillated with 34 joules of energy supplied by a programmer-analyzer unit 
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(#88345 Medtronic, Inc., Minneapolis, MN, USA) via a pair of external patches (#6721, 
Medtronic, Inc.) placed epicardially above and below the ventricles. These hearts 
generally began beating in native sinus rhythm after a single defibrillation. It should be 
noted that one human heart developed heart block at two hours post-reanimation, and was 
then paced by a temporary pacing lead at 60 beats per minute; all specimens could be 
paced as desired. Hemodynamics of the left and right ventricle were recorded by Utah 
Medical pressure transducers (Model DPT-200, lot#1101991, Midvale, UT, USA) via 
water columns from venogram balloon tipped catheters (Attain 6215, Medtronic, Inc.).  
 
High-resolution Olympus commercial endoscopes (Model 1V8200T, Model 1V8420, 
Center Valley, PA, USA) were then placed within these heart and/or lungs to capture 
functional anatomy. To our knowledge, these are the first images of the pulmonary veins 
and arteries within the lung of functioning human heart-lung blocs.  
Results & Discussion 
Using this experimental approach, eighteen swine and five human heart-lung blocs were 
successfully reanimated. Hemodynamic functioning of these in vitro reanimated 
specimens was augmented by the delivery of inotropic agents (1.5 mg doubutamine) 
and/or by increased dosing with extracellular calcium (3.5 mg calcium chloride). Prior to 
heart recovery, the mean heart rate and blood pressure for the swine were: 91±13 beats 
per minute and 105/56±13/9 mmHg, respectively. Table 23 provides partial cardiac 
medical histories for the organ donors from which the human hearts were recovered. 
Table 24 provides the relative hemodynamic performance data for these reanimated 
heart-lung preparations. These data points are calculated as 5 minute averages at the 1 
hour time point post defibrillation. 
 
Table 23. Summary of donor information and hemodynamic status prior to organ recovery 
Human Specimens 
Specimen Gender 
Age 
(yrs) 
Weight 
(kg) Cause of Death 
HR 
(bpm) 
BP 
(mmHg) 
CVP 
(mmHg) 
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HH 277 M 60 113.4 Head trauma 71 105/61 15 
HH 284 F 78 54.4 CVA 103 118/70 11 
HH 291 F 58 114.7 CVA 92 100/50 12 
HH 295 M 34 68.0 Cardiac arrest 92 130/75 - 
HH 308 F 36 53.0 
CVA, 
previously 
transplanted 87 97/71 10 
Average   53.2 80.7   89.0  110/65 12 
Standard 
Dev.   18.4 31   11.6  14/10 2.2 
BP=blood pressure; HR=heart rate; CVA= cerebrovascular accident; CVP=central 
venous pressure 
 
Table 24. Hemodynamic performance of each reanimated heart/lung bloc specimen  
Swine Specimens 
Specimen 
HR 
(bpm) 
LVSP 
(mm 
Hg) 
LVEDP 
(mm 
Hg) 
+dLVP/dt 
(mm 
Hg/s) 
-dLVP/dt 
(mm Hg/s) Tau Lung 
1 95.8 91.2 12.4 982.8 -903.0 31.2 Right 
2 91.0 25.0 -2.0 430.8 -343.8 36.2 Right 
3 100.0 77.0 -4.0 961.0 -462.0 30.0 Right 
4 81.7 73.5 2.3 772.3 -354.5 37.7 Right 
5 91.8 85.7 1.3 927.0 -509.8 33.2 Right 
6 99.5 62.8 11.3 574.0 -435.0 30.2 Right 
7 55.8 82.0 5.7 600.2 -358.2 63.0 Right 
8 90.3 79.3 -4.3 842.5 -618.0 33.5 Left 
9 92.7 75.7 12.0 623.3 -771.7 32.5 Left 
10 102.5 67.5 1.2 637.8 -513.2 29.7 Right 
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11 76.7 101.7 10.7 786.5 -501.5 39.7 Right 
12 123.3 76.3 1.3 729.0 -624.5 26.0 Right 
13 124.8 58.7 2.7 762.5 -532.7 24.0 Right 
14 84.5 87.2 0.7 888.8 -646.0 54.0 Right 
15 114.0 91.7 -2.7 922.3 -808.0 27.5 Right 
16 105.0 70.8 0.0 607.7 -446.3 28.8 Right 
17 101.3 56.5 3.8 529.8 -317.7 29.8 Right 
18 91.2 75.7 7.0 618.3 -810.2 33.0 Right 
Average 95.7 74.3 3.3 733.2 -553.1 34.4   
Standard 
Dev. 16.3 17 5.4 163.6 177.6 9.7   
 
Human Specimens 
HH 277 85.8 65.7 -7.3 624.5 -475.5 37.2 Right 
HH 284 81.2 79.5 1.7 848.2 -377.7 37.5 Right 
HH 291 70.3 53.3 8.0 341.3 -273.7 45.3 Both 
HH 295 81.3 72.5 4.2 415.7 -343.0 37.7 Right 
HH 308 57.2 73.0 0.0 963.0 -469.8 56.2 Right 
Average 75.2 68.8 1.3 638.5 -387.9 42.8   
Standard 
Dev. 11.6 9.9 5.7 268.1 86 8.2   
HR=heart rate; LVSP=left ventricular systolic pressure; LVEDP=left ventricular end-
diastolic pressure; +dLVP/dt= maximal positive derivative of left ventricular pressure 
with respect to time; -dLVP/dt= maximal negative derivative of left ventricular pressure 
with respect to time 
 
It should be noted that one of the early reanimated swine heart-lung specimens (#2) 
elicited poor hemodynamic performance from the beginning of reanimation. We suspect 
that injury occurred during isolation and/or that emboli caused poor coronary perfusion. 
Additionally, recorded data from several hearts elicited negative values for end-diastolic 
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pressures; we suspect that this is due to a vacuum or syphoning effect, potentially 
occurring in the current system modification to incorporate the lungs.  
 
Interestingly, compared to our long-term experience with lone heart reanimation using 
endoscopes, a large degree of remaining particulate and blood within the lung 
complicated our initial imaging during certain studies. Therefore, more frequent buffer 
changes were required to obtain clear, high-fidelity images and video. 
 
The main benefit of this model is the maintenance of proper pulmonary ostia and vessel 
anatomies. A selected anatomical image series of a videoscope being retracted from 
either the pulmonary arteries or veins is shown in Figure 36; a corresponding video can 
be accessed via supplemental materials (Supplemental Video) or online at 
http://www.vhlab.umn.edu/atlas. The study of cryoballoon ablation procedures motivated 
much of the development of this model, and a series of cryoballoon procedures have been 
performed, as viewed from within the vein as displayed in Figure 37, panel C. The 
Supplemental Video of the functioning pulmonary arteries and veins gives the reader an 
appreciation of the truly dynamic nature of these vessels, which are usually thought to be 
relatively passive structures. To the authors’ knowledge, this report has provided first 
time dynamic images of the pulmonary vasculature during normal cardiac function in 
both reanimated human and swine heart-lung blocs. This model provides a unique in vitro 
approach for the study of medical therapeutics from both human and large mammalian 
heart-lung specimens.  
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Figure 36. Image series obtained from reanimated human heart-lung bloc 284 (A,B) and 277 (C,D). 
Series shows the path through the distal pulmonary arteries and veins, respectively. The 
corresponding fluoroscopic images (B,D) in each case show the relative locations of the videoscopes 
(A,C). A video of the journey through the vasculature can be viewed as well (see online 
Supplementary Video). 
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Figure 37. Time series of images from human heart 277. Series shows tricuspid valve closure from 
the right ventricle (A) and right atria (B). Images are displayed 1/15th per second apart in time. 
Panel C displays ice formation on the distal portion of a cryoballoon ablation catheter (Artic Front, 
Medtronic, Inc., Minneapolis, MN) as seen from within the pulmonary vein. The images are spaced 
post-ablation 30 seconds, 1, 2, and 3 minutes apart. 
 
In a similar embodiment (i.e., without the lungs), this reanimated heart model has been 
utilized in numerous cardiac studies. In the electrophysiologic area, these studies have 
included the use of endocardial noncontact mapping, pacemakers, defibrillators, leads, 
and catheters [155]. The Visible Heart® model has also been employed to study the 
dynamic nature of valves and transcatheter valve deployment [156]. Importantly these 
methodological approaches also allow for use of echocardiography and fluoroscopy to 
guide procedures, such as for comparative imaging [157]. Most recently, this approach 
has proven to be quite valuable for the study of novel cardiac treatments, such as leadless 
pacing devices [158]. Nevertheless, the addition of a lung(s) to this paradigm still allows 
for any of the prior studies to be conducted, but may in turn reduce the number of 
hemostasis valve access points that were previously available.  
 
Our continued use and enhancement of Visible Heart® methodology has also facilitated 
the creation of an open-access educational website, The Atlas of Human Cardiac 
Anatomy (http://www.vhlab.umn.edu/atlas) [159]. The anatomical images and videos on 
this website are free to download and use for presentations and teaching, however we 
request that proper citations be used. In other words, the images and/or comparative 
imaging of functional cardiac anatomies are of high value in teaching the nuances of 
cardiac anatomy, especially of active, complex structures such as valves. It should be 
noted that this website also provides instructional tutorials on cardiac anatomy and 
physiology, as well as full cadaveric thoracic cavity dissections. Finally, a cardiac device 
tutorial is also available, which has been well noted as being beneficial in explaining 
therapies to patients.  
 
The model described here is not without limitations, as is true with all in vitro systems. 
Despite supersaturating the buffer with oxygen, there remains a significant difference in 
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the oxygen content of the buffer compared to blood. For this reason, the function of the 
heart slowly declines over time from the initial reanimation. Yet reasonable physiologic 
function to perform the aforementioned investigations is generally elicited for up to 4 to 8 
hours, based on our previous experiences. It is possible that the addition of the lungs may 
extend the functionality, which we tend to believe at this point, but need more data to 
substantiate. Most recently, we are employing a full anesthesia suite ventilator to more 
closely control the ventilation parameters (e.g., provide positive end expiratory pressure, 
PEEP). In such experimentation, one also needs to consider that although it is also known 
that hypothermal transport of organs is protective, global ischemic injury still occurs to 
some degree. Further, our current system is designed to replicate physiologic pre- and 
after-loads, but there potentially are important physiological effects that are not 
completely replicated, such as vessel compliance. Likewise, in our studies the heart-lung 
blocs are cradled on soft foam sponges which may focally alter perfusion compared to the 
natural state. Finally, due to the nature of acquiring non-viable donor human heart-lung 
specimens, there are numerous differences between inherent status of the hearts that 
cannot be controlled. Such differences in status include, but are not limited to: method of 
cardiac arrest, transport time before arriving in the laboratory, inotropic support, potential 
air or other emboli in the coronary vasculature (potentially generated during 
explantation), and prior pathologies. Despite being unable to control for these parameters, 
the described system produced comparable pressures to other isolated human heart alone 
preparations [142,160]. As reviewed in Table 2, despite these variances the hemodynamic 
data are fairly comparable from specimen to specimen. It should be specifically noted 
that we are extremely grateful and privileged to obtain these donated human heart-lung 
preparations as gifts for research. 
Conclusions 
To conclude, this extension of Visible Heart® methodologies has enabled functional 
anatomical heart-lung anatomical visualization. Further, unique abilities to image the 
device-tissue interactions using this approach are unparalleled. Therefore, we consider 
that these obtained images are of high value to the medical device designer, educators, 
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and clinicians for both training and educational purposes. The lab will continue to 
reanimate hearts and heart-lung blocs using these methodologies and thereby enable the 
study of dynamic anatomies, insights into the device-tissue interface, and creation of new 
materials for the free-access Atlas of Human Cardiac Anatomy website.  
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Preface 
Steam pops may be associated with serious complications such as cardiac tamponade, 
stroke, and/or myocardial infarction. In this experiment we aimed to visualize the 
formation of a steam pops, as a means to observe the release of energies associated with 
these events. Commonly, clinicians may or may not hear pops in a surgical suite and 
believe it to be a mild event because of their inability to perceive them. However, a 
number of clinicians after seeing this publication and associated video were surprised at 
the damage inflicted and amount of tissue and air debris discharged from the lesion site. 
 
I was responsible for the experimental design, data collection, and drafting of the 
manuscript. Ryan Goff assisted with the experimental design and data collection. 
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Introduction 
Importantly, during clinical ablation procedures, the elicitation of elevated tissue 
temperatures may induce audible steam pops. Rapidly induced high endocardial tissue 
temperatures are considered to generate these events as a result of blood/tissue 
vaporizations. In addition, discrepancies between monitored catheter tip temperature and 
actual endocardial tissue temperature may be related to the unanticipated elicitation of 
steam pops. Ultimately, these induced tissue disruptions can have important clinical 
consequences. They even may result in perforations of the atrial wall and/or the release of 
tissue or air emboli from the affected tissues [65]. 
Case Report 
A heart (427.3 g) isolated from a Yorkshire-Cross swine (87.2 kg) was reanimated using 
previously described Visible Heart methodologies [69]. The tricuspid valve annulus was 
aggressively ablated using a 7 Fr Marinr ablation catheter (Medtronic Inc, Minneapolis, 
MN). The occurrence of a steam pop was recorded using an intracardiac endoscope 
(IplexFX, Olympus Corp, Tokyo, Japan) and a high-speed camera (MotionXtra N4, 
Olympus Corp) equipped with a borescope (88370AX, Karl Storz, Tuttlingen, Germany) 
(Figure 38). Of note, formation of focal microbubbles at the ablation site was observed 
before steam pop initiation. The application of progressive ablative energies generated 
and further released large quantities of explosive bubbles/tissue disruptions, which 
actually caused the catheter to fly away from the application site. The duration of the 
recorded steam pop was less than 10 ms, although submillimeter air emboli and tissue 
fractions were released for seconds after the initial burst. In this case, the endocardial 
damage caused by this induced “explosion” was a void 7 mm in diameter and 4 mm in 
depth. 
Discussion 
It is important to consider that the use of fluoroscopy alone as an imaging modality 
during such clinical procedures, limits an operator’s abilities to detect relative incidences 
of steam pops and other associated tissue damage. In other words, the only indication in 
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such cases may be a visual displacement of the catheter tip and/or a rapid change in the 
electrode temperatures. Interestingly, an unintended catheter repositioning, causing a loss 
of wall contact, results in these same observations.  During our unique visualization 
studies of applied RF ablations, we also noted that with early application of energies, we 
could observe the formation of focal micro-bubbles preceding the steam pop, which if 
one could detect them they may act as an early indicator for more undesired events. 
Additionally, trying to determine one’s catheter tip-tissue orientation may help ensure 
proper lesion formations, while importantly minimizing the potential for inducing steam 
pops. Furthermore, it should be noted that in our setting, these observed tissue explosions 
were not always audible, suggesting that recognizing their occurrence may be even more 
clinically challenging [67]. In summary, the unique utilization of a high-speed 
visualization system and Visible Heart® methodologies allowed for investigation of this 
phenomenon at a visually perceptible rate. 
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Figure 38. The explosive energy can be observed in frames 1.5 ms apart immediately prior to (Top) 
and during the steam pop (Bottom). 
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Key Teaching Points 
 Cardiac ablation–induced steam pops release air/ tissue emboli that may cause 
myocardial infarctions or strokes. The resulting endocardial damage, if excessive, 
may result in perforations and/or the development of cardiac tamponade. 
 Microbubbles often are released before the elicitation of steam pops. If these 
microbubbles could be detected, then the immediate reduction of power or halting 
of an ablation may reduce the occurrences of undesired steam pops. 
 Identifying steam pop incidences via fluoroscopy alone may be quite challenging. 
Movement of the catheter during such an event, especially when there is no 
associated audible indicator (ie, a pop), may be misconstrued as a simple loss of 
wall contact.  
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Preface 
This experiment utilized the methods developed in our lab for reanimating heart-lung 
blocs. We demonstrate the typically performed clinical cryoballoon ablation procedure: 
i.e., with direct visualization. It cannot be stressed enough that representative pulmonary 
vein ostia are essential for mimicking the challenges and issues clinicians must 
overcome. This study visualizes the native pulmonary vein isolation from the transseptal 
puncture to ablation energy application. Some of the current procedural challenges were 
highlighted, such as the difficulties in proper balloon placements so to ensure there are no 
leaks: incomplete occlusions may lead to ineffective cryothermal lesions. This study also 
identified some of the predicaments incurred due to anatomical limitations. 
 
Ryan Goff and I were responsible for the study design and image collection. Lars 
Mattison and I processed the acquired images and video. I was also responsible for the 
initial draft of the manuscript. 
Case Report 
It is considered that cryoballoon and radiofrequency ablation have comparable efficacy 
[161]. Optimal positioning of catheters is essential, albeit challenging due to anatomical 
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and morphological variations. Furthermore, respiratory and cardiac movements can cause 
difficulties for catheter placements [48]. Our objective was to directly visualize 
cryoballoon ablations to highlight procedural challenges. Human hearts deemed not 
viable for transplantation (n=11) were reanimated using Visible Heart® methodologies 
[69]. Videoscopes were placed inside the atria to visualize cryoballoon ablations with 
either ArticFront or ArticFront Advanced catheters (Medtronic, MN, USA). 
Hemodynamic monitoring and simultaneous fluoroscopy were obtained. Figure 1 
illustrates the direct visualization of cryoballoon placements in four different reanimated 
human hearts. Videoscope views from the left atrium detected ice formation as well as 
the presence of ostial leaks near the pulmonary vein antrum; i.e., green dye was injected 
distally within the pulmonary veins. There was incomplete occlusion of the right inferior 
pulmonary vein in two hearts (verified using contrast fluoroscopy). These visualizations 
provide valuable insights into the potential challenges faced while performing 
cryoablation procedures of the pulmonary ostia. These images are especially valuable to 
clinicians, engineers, and device designers, as they accentuate anatomical and 
morphological differences. 
 
A supplemental video displaying a functioning heart during the transseptal puncture, 
including maneuvering of the catheter to the pulmonary veins and the application of 
ablation in the right and left superior pulmonary veins, is also available. 
 
Funding Source: Research contract with Medtronic, Inc. (no role in study design, data 
collection/analysis/interpretation, or report writing) 
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Preface 
This study also relied on the unique methodologies described in our reanimated heart-
lung bloc manuscript: here we investigated thermal ablation applications, specifically 
comparing the use of the ArticFront and ArticFront Advance catheters. In conjunction 
with our in vitro infrared cryothermal tolerances assessment, this study assessed the 
behavior of pulmonary vein isolation ablation systems in a setting that closely simulated 
such clinical situations. Identifying epicardial tissue temperatures throughout the 
application of cryothermal ablations should aid in better understanding the high 
incidences of phrenic nerve injury associated with such procedures. It was determined 
that the Artic Front Advances catheter appeared to be more effect in cooling larger areas 
of atrial tissues than the previous iteration catheter. The results from this study should 
also help aid in determining appropriate cryothermal dosing, as well as how to limit 
collateral injury to surrounding tissues such as the phrenic nerves. 
 
Ryan Goff and I were responsible for experimental design, data collection, and statistical 
analyses. I also contributed to the writing of the manuscript. This work is currently 
ongoing in the Visible Heart® laboratory. 
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Introduction 
Cardiac balloon cryoablation for the treatment of atrial fibrillation has been gaining 
attention as an approach for isolation of the pulmonary veins (PV): i.e., since its first 
reported use in 2003 [87] and in the current clinical form in 2005 [88]. Yet, it should be 
noted that focal cryoablation has been used surgically for many more years [89] with 
transcatheter devices becoming available in more recent decades. An advantage of 
cryoballoon ablation of a pulmonary vein ostium, is that it is a ‘single-shot’ approach, 
which aids in accelerating the slow nature of freezing compared to RF energy (i.e., not 
point-by-point ablation). Further, the currently available ArticFront (Medtronic, 
Minneapolis, MN) cryoballoon has been shown to have comparable success rates to 
radiofrequency (RF) ablation with lower adverse events [90,91]. The recent STOP-AF 
trial concluded similar findings to the observational European studies: that being an 
acceptable safety profile and superiority to antiarrhythmic drugs in those who have failed 
to respond to them [62].  
 
Despite widespread and growing clinical use there are still questions regarding dosing 
and treatment times for optimal cryoablation therapy, which in turn may affect both 
efficacy and collateral tissue injury [92,93].  Conversely, parameters affecting RF 
ablation lesions have been investigated in numerous preclinical and clinical studies, and 
temperatures of 50°C or higher are required for the creation of necessary myocardial 
scars [56]. Additionally, although many open scientific questions remain, the effects of 
power, ablation durations, catheter orientations, catheter sizes, usage of irrigation, and 
contact forces on lesion size have been investigated for RF [94–97]. Furthermore, the 
release of a second generation cryoablation device with a different cooling profile merits 
additional research to compare to both the previous versions of theses devices and also to 
ablation using RF energy [98]. It should be noted, to date, the highest regularly detected 
clinical complication for ablation with the cryoballoon is phrenic nerve palsy with rates 
of 4-8% [62,91]. Yet, it remains unknown, the impact on esophageal cooling may also 
differ for the second generation balloon: importantly, esophageal injury is not normally 
detectable unless specifically searched for using endoscopy [99,100]. Reports of 
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hemoptysis are also reported in patient series of cryoballoon ablation, indicating the lung 
may be injured during these treatments as well [79,162,163]. It is currently recommended 
by the manufacturer that two separate four minute ablations are applied per PV: yet, 
several clinicians have recently suggested that only one may be adequate.  In other words, 
given that the phrenic nerve and esophagus are in intimate contact with the right PVs and 
posterior wall of the LA, respectively, optimization of dosing is important to both ensure 
permanent isolation of the pulmonary vein tissue while minimizing the impact to these 
structures. 
 
It is well accepted that in order for cardiac ablation lesions to be effective long-term, it is 
necessary that they are transmural. In the present study through the use of infrared (IR) 
imaging, the epicardial surface temperatures were monitored as well as the relative times 
to reach those temperatures. Due to the anatomical relation of the aforementioned 
collateral tissues that might be impacted during treatment, these epicardial thermal 
profiles should be in the range of those experienced collaterally. That is to say that since 
the tissues injured collaterally are in intimate contact with the epicardial surfaces, that the 
epicardial temperature profiles measured here are in the range of the most extreme 
temperatures the collateral tissues may encounter. This infrared imaging data, with 
additional information regarding the thermal thresholds of injury, may help guide 
decisions on dosing. 
Methods 
Isolated Heart-Lung Preparation 
Swine studies were approved by the Internal Animal Care and Use Committee at the 
University of Minnesota. The use of human specimens for research were approved for 
study by Human Subjects Institutional Review Board:  consent for use of the hearts for 
research purposes was received from the donor’s closest relative(s) via LifeSource (St. 
Paul, MN). Note, the detailed procurement procedures have been described previously 
[142].  The human specimens were then transported on ice to the laboratory within 8 
hours of cardiac arrest. 
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For isolation of the swine specimens, a median sternotomy was performed and an aortic 
root cannula implanted for delivery of cardioplegia. The inferior vena cava (IVC) was 
ligated and just prior to cardiolpegia delivery the IVC was removed with the liver and the 
superior vena cava (SVC) and aorta were cross-clamped. Cardioplegia was then delivered 
under pressure to cool and arrest the heart/lung blocs. The heart and one or both lungs 
were then dissected and the bloc then removed by transection of the major vessels, 
trachea, and esophagus. Note, we most commonly have performed these studies with just 
one lung attached, but the method has been easily adapted to have both lungs attached.   
 
The heart-lung blocs were then connected an apparatus described in detail previously 
[154] that has been modified to accommodate the lung. The system can vary standard 
parameters of other isolated heart research systems (i.e., pre-load, after-load, perfusates, 
see Hill et al. [142]) and functions in either partial or four-chamber working mode. Partial 
working right-side mode allows fluid flow to continue through the isolated lung(s), but 
without added flow directed into the left atrium. Four-chamber working mode is 
analogous to the native function of the heart and was used during all ablation procedures 
and throughout the thawing phase. Hemodynamic performance of these hearts is 
summarized in Table 1. Note, that as best as possible, the reanimated lung(s) were 
ventilated at a respiration rate of 11-15 per minute and a volume of 150-250 milliliters 
per lung. To do so, the remaining airway (the distal main trachea) was intubated by 
placement of an endotracheal tube (if only one lung was isolated the other primary branch 
bronchus was tied off) and subsequently attached to the ventilator. Video endoscopes 
(IPLEX FX series, Olympus Corp., Tokyo, Japan) were employed so to observe the 
proper placements of the cryoballoons within the pulmonary vein.  A supplemental video 
provided here, shows an anterior view of on specimen and then the simultaneous 
multimodal imaging performed during the experiments.  
 
Infrared Imaging and Data Analysis 
A FLIR SC620 (FLIR Systems, Inc., Boston, MA) infrared (IR) camera was used to 
capture thermographic data at a minimum rate of one hertz. The emissivity and 
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appropriate environmental parameters were input to the infrared software (ThermaCAM 
Researcher Pro 2.9, FLIR Systems, Inc., Boston, MA). Emissivity was determined by 
comparison of IR temperatures to a 0.040” T-type thermocouple (Omega Engineering) 
being read by a digital thermometer (Fluke 51II, Everett, WA). It should be noted that 
this IR system is only capable of measuring temperatures as low as -30 Celsius, below 
this level the accuracy of the measurements are reduced.  
 
Measured parameters using FLIR software include: lowest epicardial temperature 
reached, epicardial area cooled to 10, 5, 0, and -5 °C, and time from start of an ablation 
until epicardial temperatures of 10, 5, 0, -5, and -10 °C were achieved. If required, the 
heart was held in a more lateral position to best view with the IR camera, the area being 
treated/cooled.  
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Figure 39. Shown above (A) the heart-lung bloc, with overlaid thermograph, attached to the Visible 
Heart ® apparatus with heart held laterally to best image area of therapy. Panel B shows a close up 
view of the resultant thermograph with the temperature scale ranging from -18 to 37 °C in this 
example. 
 
Ablation Procedure 
A steerable outer catheter (FlexCath, Medtronic, Inc.) was placed into the left atria (LA) 
by either a transseptal puncture via the inferior vena cava or directly via the contralateral 
PV cannulated with a fixture containing a hemostasis valve. Using direct endoscopic 
  132 
visualization and a 0.035” guidewire (PV tracker, Medtronic, Inc.) the ablation catheter 
was then inserted over the wire into the LA. Once the preparation and catheter delivery 
sheath were in place the IR camera was setup and not moved throughout that given 
experimental procedure. The cryo-catheters investigated here were 28 mm ArticFront and 
ArticFront Advance (Medtronic, Inc.). The catheters were marked along the length of the 
balloon with colored fiducial markers, so to ensure that the clocking of the catheters in 
between exchanges or ablations were consistent (see Figure 40 and supplemental video). 
 
 
  
Figure 40: ArticFront 28 mm balloon cryoablation catheter with colored markings for optimizing the 
alignments of catheter position between ablations. The blue band corresponds to the top of the 
catheter handle and the red band corresponds to the left side of the handle (i.e., the operator’s 
perspective).  
 
Data are presented as the means ± standard deviations. These results were compared on a 
day by day basis using a paired T-test (=0.05) to determine if there were statistical 
differences between the various parameters of interest and between the catheters 
employed. 
Results 
Swine data 
Using these methods a total of 8 heart-lung blocs were reanimated and studied. In most 
cases, two or three ablations per catheter (ArticFront and ArticFront Advance) were 
performed per day; note in one instance only one ablation was performed due to technical 
difficulties.  The daily results of the cooling measurements were averaged by catheter 
type.  This approach was chosen to compare the differences between catheters without 
the influence of daily variabilities such as: camera position, atmospheric conditions, 
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cardiac outputs, and differing anatomies. The relative hemodynamic performances of 
these specimens during these applied thermal therapied were provided below in Table 25. 
 
Table 25. Hemodynamic performance of reanimated swine heart-lung blocs. 
Specimen 
HR 
(bpm) 
LVSP 
(mm Hg) 
LVEDP 
(mm 
Hg) 
+dLVP/dt 
(mm Hg/s) 
-dLVP/dt 
(mm Hg/s) Tau Lung 
1 94.0 77.8 -2.3 857.5 -553.5 32.0 Right 
2 106.5 85.5 1.8 838.2 -664.2 28.3 Right 
3 76.8 89.3 -1.0 893.3 -640.7 40.0 Left 
4 105.2 70.7 12.0 715.8 -682.2 30.2 Left 
5 108.0 79.2 1.5 683.3 -564.0 28.5 Right 
6 119.7 74.0 9.0 716.5 -622.3 25.0 Right 
7 90.8 96.3 5.0 853.8 -681.0 37.7 Right 
8 105.0 82.0 -3.5 809.2 -662.2 31.3 Right 
Average 100.8 81.9 2.8 796.0 -633.8 31.6   
Standard 
Dev. 13.1 8.4 5.5 79.3 50.4 5.0   
Human Specimens 
HH 277 63.7 71.8 -3.0 485.3 -428.2 50.7 Right 
HH 284 104.5 83.0 0.8 836.0 -641.0 28.8 Right 
 
The temperature area measurements were made using the time point at which the most 
extreme cooling had occurred. A total of 24 and 26 ablations for ArticFront and the 
ArticFront Advance were measured, respectively. When all the data were examined, 
including cases in which the ablation had not reached the indicated temperatures (i.e., an 
area value of zero), Figure 41 demonstrates that ArticFront Advance cooled greater areas 
and in most cases achieved lower temperatures. However, when the subset of data in 
which only ablations which reached the measured temperature were plotted in Figure 42, 
one can see that the differences were less pronounced. 
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Figure 41. Relative area cooled by employing ArticFront (blue)  and ArticFront Advance (red) 
catheters were compared. Above each bar is the number of ablations in which the indicated level of 
cooling was achieved. For each the ArticFront and ArticFront Advance catheters, 24 and 25 
ablations were analyzed, respectively. Ablations which did not achieve cooling to the measured 
temperature were averaged with the other ablations performed that day as zero area cooled.  (*= 
p<.05) 
 
 
Figure 42. Relative area cooled during therapy application by ArticFront (blue)  and ArticFront 
Advance (red) catheters excluding cases in which the measured temperature was not achieved (e.g., if 
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-5°C was not achieved, that ablation was not analyzed in the-5°C group). The number of ablations 
measured is displayed above the error bars. (*= p<.05)   
 
The cooling time to epicardial temperatures of 10, 5, 0, -5, and -10°C were measured in 
16 ablations delivered using ArticFront and 20 ablations for ArticFront Advance 
catheters. Note, that these Ns differ from the area measurements, due to subsequent 
technical problems during which the digital video recording system was damaged, thus 
making the syncing of multiple timed systems not possible (e.g., IR computer and 
CryoConsole).  
 
Figure 43. Time to reach indicated epicardial temperatures from beginning of ablation. Note that 
differences between treatments delivered with ArticFront (blue, n=16) versus ArticFront Advance 
(red, n=20) catheters were not found to be significant.  
 
The lowest temperature achieved during these series of ablations were measured for each 
application. Again, it should be noted that the limitations of IR imaging somewhat 
complicated this analysis, because of the considered reduced accuracy of this specific 
camera for temperatures less than -30°C: therefore ablations that demonstrated very low 
temperatures (i.e., reading less than -40°C) were considered to be not lower than -40°C 
for the results shown in Figure 44 to take a conservative measurement approach. This 
occurred once for an ArticFront ablation and four times during ArticFront Advance 
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treatments, suggesting that the ArticFront Advance catheters allow for greater cooling 
potential. The histogram shown in Figure 45 displays the distribution of nadir 
temperatures: temperatures less than -30°C are denoted by an * to indicate that they may 
not be reliable. 
 
Figure 44. Minimum temperature achieved by treatment applications with ArticFront (blue) and 
ArticFront Advance (red) catheters (p=0.036). 
 
 
* 
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Figure 45. Distribution of nadir temperatures achieved following treatments with either catheter 
system: ArticFront (blue)  and ArticFront Advance (red). Note, accuracy of temperatures less than -
30°C may be decreased as denoted by an *. No temperatures fell within the 50°C bin and therefore it 
was omitted. 
 
 
Human data 
Data was collected from two human hearts. In each specimen two ablations with the 
ArticFront Advanced 23 mm catheter were performed. To compare the results of the 23 
mm catheter in human versus swine, one swine experiment with six ablations using the 
23 mm catheter was performed. The data is included due to the unique opportunity to 
study human versus swine specimens, thus making these studies of high translational 
value.  
 
Since it is not feasible to compare different human samples or human to swine samples 
on the same day, with the same setup and anatomy, a ruler was included in the recording 
to scale the images. However, the ruler was not held perfectly planar to the lens by an 
apparatus, but was approximated. The results suggest that a smaller area is cooled in 
human samples as indicated by Figure 46. However, as can be seen there are very large 
standard deviations. Data on cooling speeds could not be calculated due to syncing 
technical difficulties mentioned previously. Comparing the data on the lowest 
temperature achieved the differences minimal, with swine achieving -17.9±18.9°C and 
human samples reaching 14.2±16.6°C. 
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Figure 46. Area cooled by ArticFront 23 mm catheter in human (blue) and swine (red). The number 
of ablations measured is displayed above the error bars. (*= p<.05)   
 
Discussion 
Here we present a technically challenging study utilizing external infrared imaging data 
obtained during cryoablation treatments applied employing ArticFront (blue) and 
ArticFront Advance (red) catheters.  We uniquely performed these studies employing 
both reanimated human and swine heart/lung blocs and believe this to be the first report 
of thermal ablation studies using such a method.  Yet, one must also consider that the 
translational experimental methodology presented here, may be considered as a possible 
worst case scenarios or extreme cases, in the sense that the measured temperatures are 
expected to be colder than what would be measured in-vivo. This is due to the fact that 
the reanimated heart and lung(s) were surrounded by air.  Note that this experimental 
design was required so to be able to obtain these real-time infrared measurements of the 
resultant tissue temperatures. Therefore, the metabolic heat generated by surrounding 
organs is not being transferred to the isolated block. Additionally, air is a superior 
insulator compared to tissues by orders of magnitude and will in effect keep the cooling 
within in the tissue, having very little warming effects from the air. It should be noted, 
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attempts by our laboratory to utilize IR imaging in-situ open chest models proved 
difficult to obtain direct visualization of the zone of ablation. The use of isolated hearts is 
already well established in cardiac research [142,154] and this methodology incorporates 
native sinus rhythm with physiologically relevant hemodynamics. 
 
The results of the cooling area measurements suggest that AFA will cool a larger area 
and more frequently to colder temperatures. However, there may be other influencing 
parameters that will dictate how large an area is cooled, such as, anatomical variance and 
catheter pressure. This is suggested by the differences between Figure 41 and Figure 42. 
The time to cool the epicardium to a particular temperature did not vary much between 
catheters. This is expected because rate of heat transfer transmurally is most likely 
governed by the thermal conductivity of tissue, which should remain relatively constant 
between samples. The fact that it varies little between catheters may speak to the 
robustness of this methodology. The depth of cooling appears to be greater for AFA than 
AF based upon the distribution of nadir temperatures. This technique is not limited to the 
use of cryoablation catheters. Any thermally based ablation targeting the pulmonary 
veins, or even other structures, may be studied using these approaches. The authors 
believe that this one of the most translational methodologies available for study, 
especially when human heart specimens are available.   
 
The data presented here suggests that differences exist between human and swine 
cryoballoon ablation cooling profiles. The differences may be due to tissue thickness, 
age, disease state, fibrosis, and relative mass. It should be noted that we have observed 
that the pulmonary veins in aged human samples that our laboratory has received are 
thicker than the relatively young swine. The lungs of the human samples were also larger 
than those of the swine. The fact that only some of the area measurements were 
statistically different, and the end temperatures not significantly different, suggests that 
the translational aspect of the swine data is valid. The human data translates to the 
clinical case, but as mentioned previously the temperatures are most likely colder, and/or 
the rate of cooling faster, than those experienced in-vivo.  
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Reviews of cryosurgical injury are readily available in the literature [109], and it is 
accepted that differing tissues and cells have varying thermal tolerance. Unfortunately, 
the thermal tolerance of myocardium, esophagus, and lung is not fully understood. In our 
lab efforts are underway to further characterize some of these tissues. However, it is 
accepted in the cancer field that if the vascular supply is damaged a lesion will eventually 
result. The vascular susceptibility to cooling also differs by tissue, but has been generally 
reported to be in the range of -20 to -30°C [109]. Whether or not this applies to tissues 
that are in contact with blood (i.e., myocardium and PV) is unclear, but may guide the 
community until better data is published. However, taking this into account with the 
aforementioned data suggests that shorter treatments may be necessary to avoid collateral 
injury. As a precaution, shorter treatment times are already being proposed in the 
literature [164]. 
 
Work done on the swine phrenic nerve is our lab suggests that cooling to mild subzero 
temperatures will acutely, irreversibly cease conduction [86] in most cases. This data is in 
agreement with previous studies [165,166]. Taken into account with the findings 
presented here, an operator should be particularly careful to avoid placing a cryoballoon 
deep within the pulmonary veins and phrenic nerve monitoring should be used, as is 
standard now. However, certain patients may possess atypical phrenic anatomy that is 
less compatible with cryoballoon and/or RF ablation of the pulmonary veins, such as: 
close right superior PV and superior vena cava relationship [167] or the right upper PV 
ostium to the right pericardiophrenic artery [168].   
 
To the author’s knowledge this is the first publication of such an experimental 
methodology to investigate the effects of cardiac thermal ablation. The data from these 
experiments may aid in the guidance of dosing. Future experiments using these 
methodologies could be performed to determine the characteristics of novel ablation 
devices and how they may impact the myocardium and surrounding tissues. 
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Thesis Summary 
The complication rates during transcatheter cardiac ablation procedures remain 
concerning. The transseptal puncture procedure, the relative navigation of catheters to 
difficult anatomies, and the application of ablation modalities to ensure transmural 
lesions are all primary areas where therapeutic complications may arise. In my thesis 
projects, our work targeted these three areas while also specifically considering a means 
to reduce such complications. Specifically, iatrogenic atrial septal defect formation was 
investigated by assessing the biomechanical changes of the atrial septum that may occur 
during transseptal punctures and the further injury the septum may incur during 
subsequent catheter manipulations. Furthermore, the contact forces required to perforate 
the atria were characterized in order to determine the boundary force conditions 
associated with both catheter navigation and ablation energy application. In addition, the 
biophysical changes manifested during and following the application of ablation 
modalities, as well as, the parameters that facilitate the development of explosive steam 
pops were investigated. Finally, the cryothermal tolerances of cardiac tissues were 
identified to aid in reducing collateral injury and to optimize dose delivery. The insights 
gained from these translational studies will help define various parameters and boundary 
conditions that should improve both the safeties and efficacies of clinical cardiac ablation 
procedures. In addition to characterizing these factors, the direct visualization of such 
complications provides invaluable insights to engineers as well as clinicians. 
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Changes in Cardiac Tissue Properties Relative to the Applications of 
Radiofrequency or Cryo Ablative Therapies 
 
Selected for poster presentation at Biomedical Engineering Society 2015, 
San Antonio, TX.  
 
 Stephen G. Quallich; Kevin K. Kriege; Paul A. Iaizzo 
 
Introduction: The biomechanical characterization of the myocardial structures within 
the heart is currently underway. For instance, interest in tissue engineered heart valves 
has led to the study of valve properties to better mimic their inherent 
properties/behaviors. Yet, there remains a lack of research investigating the 
biomechanical changes associated with cardiac ablations. Further, an array of associated 
complications including cardiac tamponade, pulmonary vein stenosis, and atrial-
esophageal fistula may result from induced changes in tissue properties during such 
procedures. Thus, a greater understanding of how and why these transformations occur 
should ultimately lead to reductions in complications relative to these cardiac treatments. 
Materials and Methods: Fresh atrial and pulmonary vein tissue samples were obtained 
from Yorkshire Cross swine (n=43) were carefully dissected. Additionally, one human 
tissue specimen was also acquired with donor consent. These biopsies were subsequently 
prepared into a dog-bone shape samples (n=285), sutures were tied to each end, and then 
a therapy applied. Prior to uniaxial pulling until failure, samples were randomized to the 
following study groups: 1) no treatment, 2) radiofrequency (RF) ablation for 1 minute at 
30 W, or 3) focal cryoablation for 2 minutes. 
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Results and Discussion: The ultimate tensile strengths were significantly different 
between applied locations and/or study groups (p<0.01). RF ablations decreased 
subsequent tensile strengths and strains at failure, while cryoablation had minimal or no 
effects compared to the control (Table 1). Determined Young’s moduli were also reduced 
by RF ablation; however it was noted that this effect was not statistically significant 
(p=0.15). Additionally, RF ablation caused specimens to failure at lower strains 
compared to the no treatment group. Furthermore, the ultimate tensile strengths, strain at 
failures, and Young’s moduli were significantly different depending on the tissue type 
(p<0.01). In addition, similar trends in biomechanical properties were observed with the 
human tissue regarding ablative therapies. 
 
 
Treatment 
Ultimate Tensile 
Strength (g/mm
2
) 
Strain at 
Failure (%) 
Young's 
Modulus (kPa) 
Left 
Atrium 
None 106±16 117±8 18±2 
RF 65±6 90±7 15±2 
Cryo 85±9 85±4 21±2 
Right 
Atrium 
None 70±6 87±6 15±1 
RF 55±7 69±6 14±1 
Cryo 64±5 84±5 15±1 
Pulmonary 
Vein 
(Axial) 
None 167±16 153±11 31±4 
RF 111±12 128±12 21±3 
Cryo 144±9 147±13 27±3 
 
Table 1. The ultimate tensile strength, strain at failure, and Young’s modulus are listed 
by ablation and tissue type. Values are presented as mean±standard error. 
 
Conclusions: This is one of the first studies that we are aware of that was performed to 
examine the effects of ablation modalities on the biomechanical properties of cardiac 
tissue. Noteworthy, cryoablations elicited negligible effects on the biomechanical 
properties of cardiac tissues, whereas RF ablations caused reduced ultimate tensile 
strengths, strains at failure, and Young’s moduli. Biomechanical property alterations 
following cardiac ablation were not previously well documented; this data will likely be 
particularly useful to scientists, engineers, and physicians in minimizing the related 
complications incurred during ablation procedures. 
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Assessing Iatrogenic Atrial Septal Defect Formation with Novel Transseptal 
Puncture Device 
 
Selected for poster presentation at American College of  Cardiology 2015, 
Washington, DC.  
 
Stephen G. Quallich; Mark A. Benscoter; Megan M. Schmidt; 
Lars M. Mattison; Salah J. El Haddi; Paul A. Iaizzo 
 
Introduction: As ablation and transseptal procedures become more common due to the 
aging population, transseptal puncture complications become a larger concern. Iatrogenic 
atrial septal defects (IASDs) are typically considered to close within a year with 7% 
remaining at 12 months following a puncture with a 12 Fr catheter. IASDs are also 
attracting attention because cryoablation and MitraClip® procedures that use larger 
sheaths are common. The purpose of this experimental paradigm was to characterize the 
biomechanical properties of the fossa ovalis in an animal model commonly used for 
testing these procedures. 
 
Methods: The atrial septa from Yorkshire Cross swine (n=86) were excised for 
experimentation. The inferior edge of the fossa ovalis was cut off for catheter tear testing. 
Samples were randomized to 3 groups, and the transseptal puncture was performed with 
a: 1) standard Brockenbrough needle, 2) Baylis RF needle, or 3) custom RF 5 Fr needle, 
which is unique to this study. Catheter tear testing allowed the investigation of the effects 
varying catheter sizes and different transseptal approaches have on inducing trauma.  
 
Results: The type of needle used for the transseptal puncture had no statistically 
significant effect on tear force (p>0.05).  This suggests that on an acute time scale how a 
clinician crosses the septum is one of personal preference, since no technology 
demonstrated an increase in tear force and thus a reduction in IASD formation. 
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Additionally, there were significant differences in tearing the septum between different 
size sheaths (p<0.05). Noteworthy, the forces required to initiate tearing in this study 
were within the range of the forces able to be generated by clinically used catheter and 
sheaths.  
 
Conclusions: Tissue properties and their role in the formation of IASDs were not 
previously well studied. This suggests a need to improve the understanding in how septa 
tearing arise and a means to minimize damage created during procedures. This is the first 
study to investigate a novel transseptal approach in an effort to minimize IASD 
formation. 
High-speed Visualization of Steam Pops During Radiofrequency Ablation 
 
Selected for oral and poster presentation at Design of Medical Devices 
2014, Minneapolis, MN.  
 
 Stephen G. Quallich; Ryan P. Goff; Paul A. Iaizzo 
 
Background: Atrial fibrillation (AF) affects up to 5 million people in the United States, 
and as the population continues to age, the incidence is expected to further increase. The 
overall cost associated with treatment for AF was estimated to be in excess of $6.5 billion 
dollars annually [1]. Currently, radiofrequency (RF) ablation is routinely used for the 
treatment of cardiac arrhythmias. In RF ablation alternating current is applied to heat the 
myocardial tissues, inducing temperatures of 50°C or higher that lead to the creation of a 
myocardial scar which is hopefully therapeutic [2]. 
However, when excessive and/or rapid tissue heating occurs, at temperatures of greater 
than 50°C, cellular content may be vaporized and in some cases an audible steam pop 
heard. Although temperatures measured at the electrode tip may be considerably less than 
50°C, steam pop generation can result from high endocardial tissue temperatures. 
Importantly, it should be considered that temperatures recorded from the catheter tip may 
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not be indicative of the tissue temperatures because convective flow of blood or irrigation 
cools the electrode tip. Nevertheless, these induced steam pops can be quite damaging; 
potentially causing perforations of the atrial wall, clot formations on the catheter which 
could dislodge and form emboli, and/or air bubble generation [3]. 
Methods: To visualize the generation of steam pops, porcine Yorkshire Cross animals 
(n=14) with weights of 84.5±9.8 kg were reanimated using Visible Heart® 
methodologies previously described by Chinchoy and colleagues [4]. The tricuspid annuli 
of these reanimated hearts was aggressively ablated using a 7 Fr Marinr® catheter 
(Medtronic, Inc., MN) introduced through the superior vena cava and guided via 
fluoroscopic imaging. The incidences of steam pops were then recorded using a high-
speed camera (666 frames/second) and videoscopes from within these hearts. 
Results: The occurrence of a steam pop causes the ablation catheter to jump away from 
the lesion site: i.e. due to the explosive generation of gas bubbles (Fig. 1). Interestingly, 
the typical duration of the pops was less than 10 milliseconds, although in the case shown 
in Fig. 1, air bubbles were observed to linger for a longer period of time around the lesion 
site. In this case, the catheter tip temperature reached 76°C before the explosion, and 
dropped significantly after because of the lack of wall contact: the void created during the 
explosion was approximately 0.7 cm in diameter and 0.4 cm deep (Fig. 2). 
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Figure 1. Frames every 1.5 ms of generated steam pop recorded with a high-speed 
camera as seen from within the right atrium. The explosive force produced during this 
event can be observed. 
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Figure 2. Photograph of post-study endocardial damage from steam pop (left) and cross-
sectional view of myocardial damage (right). 
In this series of studies, the relative occurrences of steam pops was 5% at energies of 40-
50 W (n=59), 25% at energies of 50-60 W (n=73), and 26% at energies of 60-100 W 
(n=69) with average catheter tip temperatures of 52°C, 64°C, and 65°C respectively. 
Additionally, steam pops happened 63% of the time when power rapidly increased, at a 
rate of 3 W per second, from 40 W to 100 W (n=38). Applied power significantly 
affected steam pop generation (p<0.01). Steam pops occurred 33.3±17.2 seconds after the 
start of the ablation without any significant differences between power settings (p>0.05). 
Interpretation:  
AF is a serious health concern that affects a large number of individuals. The decrease in 
quality of life and cost associated with the disease are also a significant issue. One of the 
treatment options, RF ablation, can be accompanied by a relative risk of steam pop 
occurrences that can in turn cause severe damages to the myocardium. Noteworthy, there 
is the possibility for complete atrial rupture, which would then lead to cardiac tamponade. 
Additionally, released gas bubbles and tissue emboli created during the elicitation of such 
an event may critically lead to myocardial infarction and/or stroke if this occurs on the 
left side of the heart or pulmonary emboli on the right side. High-speed video was used to 
visualize the steam pop explosion at a visually perceptible rate. 
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It is important to note, that using fluoroscopy alone as an imaging modality, it is likely 
difficult for operators to detect the occurrences of steam pops. In other words, the only 
indications of these events being perhaps the visual displacement of the catheter if 
fluoroscopy is running at the time of the pop and/or a detected rapid reduction in tip 
temperatures (Fig. 3). Interestingly, the explosions are not always audible suggesting that 
operators may have difficulty recognizing the incidence of steam pops while using 
fluoroscopy alone [5]. We have shown here one example of high-speed footage of a 
steam pop and the resulting myocardial damage created: i.e., visualized in vitro using 
Visible Heart® methodologies. This is the first documented instance to the authors’ 
knowledge, of visualization within a beating heart using a videoscope or high-speed 
camera. 
We consider here, that this study highlights the difficulty physicians may encounter in 
recognizing steam pop incidences. In other words, these events may be occurring 
unnoticed: until the related complications arise. For this reason, developing a database of 
parameters effecting steam pop formation and a system for steam pop detection requires 
investigation and is underway by our laboratory. With the increasing prevalence of AF, 
understanding how to reduce the occurrences of steam pops may have important clinical 
insights. 
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Figure 3. Frames every 17 ms of a generated steam pop from videoscope within the right 
atrium (top left), ablation console (top right), and fluoroscopy (bottom left). The 
movement artifact of the catheter is visible on fluoroscopy in this particular steam pop. 
References: 
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Value Health, vol. 9, no. 5, pp. 348–56, 2006. 
[2] D. E. Haines, “The biophysics of radiofrequency catheter ablation in the heart: the 
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Analyzing the Perforation Force of Swine and Human Atria Before, During and 
Following Cardiac Ablation 
 
Selected for poster presentation at American Col lege of Cardiology 2014, 
Washington, DC.  
 
 Stephen G. Quallich; Paul A. Iaizzo 
 
Introduction: Clinical perforation of the atrial wall may lead to pericardial effusions 
and/or life-threatening cardiac tamponade. It is suggested that such may result from high 
contact forces to ensure the creation of transmural lesions. It has been reported that 
cardiac tamponade occurs in 1.3% of ablation procedures. It should be noted that patients 
with atrial fibrillation (AF) have thinner atrial walls; this likely creates circumstances for 
perforation to happen more readily. Therefore, better understanding the required contact 
forces for proper lesion formation while minimizing rupture may lead to the reduced 
occurrences of cardiac tamponade.  
 
Methods: Fresh atrial samples from Yorkshire Cross swine (n=72) and humans (n=4) 
were carefully dissected out. Atrial samples (n=448) were randomized to the following 
study groups: 1) no treatment, 2) Radiofrequency (RF) ablation for 1 min at 30 W with a 
temperature limit of 65°C, 3) RF ablation perforating during the last 5 seconds of 
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ablation, or 4) focal cryoablation for 2 minutes. All samples were carefully anchored, 
then therapy applied, and an ablation catheter was advanced at a rate of 500 mm/min until 
perforation occurred.  
 
Results: Catheter perforation forces for the left atrium (344±86 g) and right atrium 
(275±95 g) were significantly different for all groups (p<0.01). There was a significant 
difference in perforation force between species (p<0.01). Importantly, the RF ablation 
groups required significantly lower forces to induce perforations than the control group 
(p<0.01). Catheter size had a significant affect on perforation force (p<0.05).  
 
Conclusions: Understanding the factors that may lead to atrial perforations is essential, 
since cardiac tamponade remains a potential complication of ablation procedures. This is 
the first translational study to specifically investigate relative atrial perforation forces 
with a variety of catheter sizes during and after the application of RF. This acquired data 
should be particularly useful for clinicians, engineers, and scientists to reduce the 
occurrence of cardiac tamponade during AF ablations, while yet ensuring the elicitation 
of transmural lesions. 
Acute Pulmonary Vein Stenosis During and Following Ablations 
 
Selected for oral presentation at European Cardiac Arrhythmia Society 
2014, Munich, Germany.  
 
 Stephen G. Quallich; Paul A. Iaizzo 
 
Background: Atrial fibrillation affects over 5 million Americans, and the incidence of 
this disease is expected to increase further as the population ages. Pulmonary vein (PV) 
stenosis following cardiac ablation procedures is a potentially life threatening condition. 
Up to 28% of patients are affected by severe PV stenosis and/or occlusion 2 years after 
radiofrequency (RF) ablation. It has been suggested that cryoablation is less likely to 
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cause pulmonary vein stenosis when compared to RF ablation. Numerous studies have 
examined stenosis in chronic settings, but the development of stenosis on an acute time 
scale lacks investigation.  
 
Methods: Fresh pulmonary vein samples from Yorkshire Cross swine (n=22), animal 
weight 75-110 kg, were carefully dissected out. A human tissue specimen (n=2) was also 
acquired with donor consent. 4 sutures were attached to each side of the pulmonary vein 
sample, and they were mounted in a biaxial testing machine. Each specimen was run as 
its own control prior to treatment. Samples were preconditioned, stretched to 20% strain, 
a randomized ablation modality (RF, cryo, or no treatment) was applied, and the resulting 
stress was examined for up to 12 minutes.  
 
Results: The forces in the axial and circumferential direction were significantly different 
between the treatment groups (p<0.05). Additionally, there were force differences 
between ostial PV tissue and PV tissue 1 cm distal to the ostia. The RF and cryoablation 
axial and circumferential forces compared to the no treatment group were significantly 
higher following ablations. This suggests that on an acute time scale these ablation 
modalities caused shrinkage or contraction of the tissue as seen by the increased force 
measurements.  
 
Conclusion: Optimization of ablation parameters can minimize detrimental 
biomechanical changes, which may lead to PV stenosis. This is the first study to the 
authors’ knowledge to report real-time force measurements during PV ablation, identify 
location dependent biomechanical differences, and investigate the developmental factors 
of PV stenosis on an acute time scale. Preliminary results suggest that RF and 
cryoablation are related to PV shrinkage acutely. 
Assessing the Biomechanical Properties of the Porcine Fossa Ovalis 
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Selected for poster presentation at European Cardiac Arrhythmia Society 
2014, Munich, Germany.  
 
Stephen G. Quallich; Bryce C. Holmgren; 
Stephen A. Howard; Paul A. Iaizzo 
 
Introduction: As ablation and transseptal procedures become more common due to the 
aging population, transseptal puncture complications become a larger concern. Iatrogenic 
atrial septal defects (IASDs) are typically considered to close within a year with 7% 
remaining at 12 months following a puncture with a 12 Fr catheter. IASDs are also 
attracting attention because cryoablation and MitraClip® procedures that use larger 
sheaths are common. The purpose of this study was to characterize the biomechanical 
properties of the fossa ovalis (FO) in an animal model commonly used for testing these 
procedures. 
 
Methods: The atrial septa from Yorkshire Cross swine (n=86) were excised for 
experimentation. Each fossa ovalis (FO) was dissected into several dog-bone shape tissue 
bundles for uniaxial testing (n=41), or the posterior or inferior edge of the FO was cut off 
for tear testing (n=70). Uniaxial testing was performed to assess the directional 
biomechanical properties of the FO samples. Tear testing allowed us to examine the 
effects of directionality and/or catheter sizes on inducing trauma.  
 
Results: It was observed that the biomechanical properties of swine FO were dependent 
on directionality; stress, strain, and tearing force were significantly affected by 
orientation (p<0.05) requiring higher forces in the anterior - posterior orientations 
compared to that of superior - inferior. Catheter size also significantly correlated with the 
average and peak tearing forces of these FOs (p<0.05); larger catheters required greater 
forces to tear the FO. The measured forces required to create IASDs in this experimental 
paradigm were similar to the forces previously noted to generate such by catheter and 
sheaths employed clinically. 
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Conclusion: The tissue properties of the porcine FO were not previously well 
documented; improving the overall understanding of biomechanical properties and 
tearing forces is essential for expanding scientists, engineers, and physicians’ view of the 
elicitation of IASDs. The biomechanical properties of the porcine FO exhibit a 
dependence on orientation. Provided here are our laboratories initial finding as to the 
characterization of the tissue properties of the swine FO: additional studies are ongoing. 
 
External Infrared Visualization of an Endocardial Cryoablation: Performed on a 
Reanimated Swine Heart 
 
Selected for oral presentation at the 2013 International Mechanical 
Engineering Conference and Expo, Houston, TX.  
 
 Ryan P. Goff; Stephen G. Quallich; Paul A. Iaizzo 
 
Today, clinical electrophysiologists still considered cryoablation a relatively new 
treatment modality for cardiac arrhythmias. Interestingly, the bioheat transfer in this 
environment has been largely unstudied. Furthermore, during the clinical applications of 
cyrotherapy, adjacent tissues may become injured from the induced cooling. These facts, 
along with the desire to validate models of cryotherapy, to potentially increase efficacy 
and safety, warrants the study in reanimated large mammalian hearts where visualization 
of heat transfer is feasible. Specifically, cryoballoon catheters (ArticFront, Medtronic 
Inc.) were positioned in the superior vena cava and the clinically recommended ablation 
duration of four minutes was applied. Similarly, focal cryo-catheters (FreezorMax, 
Medtronic Inc.) were placed in the right atrial appendages and spot ablations were 
performed for four minutes. We believe that this novel model allows for both high spatial 
and temporal resolutions for the study of these treatments. More specifically, multi-modal 
imaging can be performed, with: intracardiac videoscopes, externally with IR and video 
cameras, with fluoroscopy and/or echocardiography and all while hemodynamic 
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monitoring of the heart (Fig. 1). Time from beginning of ablation is displayed in the top 
left corner and temperature scale to the right. 
 
Figure 1: Quad-split of simultaneous video.            Cryoballoon ablation 
 
                                          Cryoballoon ablation                                                              Focal ablation 
 
Focal ablation 
In-Vitro Characterization of Myocardial Cryothermal Injury 
 
Selected for oral presentation a Cryobiology 2013, Washington, DC.  
 
Ryan P. Goff; Stephen G. Quallich; Robert A. Buechler; 
Jeunghwan Choi; John C. Bischof; Paul A. Iaizzo 
 
Background: Cardiac balloon and catheter cryoablations for the treatment of atrial 
fibrillation have been gaining attention as approaches for treating arrhythmias, in 
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particular for isolation of the pulmonary veins (PV).  Despite widespread clinical use of 
cardiac cryoablation, there are still questions regarding dosing and treatment time, which 
may affect both efficacy and collateral injury. To date injury thresholds for therapy of 
cardiac tissues are largely unreported in the literature.  
 
Methods: Slices of ventricular myocardium (n=11) and left atrial tissue (n=6) from 
female Yorkshire Cross swine hearts were dissected including the native endocardial 
surface. Samples were placed in an infrared imaging apparatus consisting of a plastic 
petri dish with central ablation probe (1.5 mm IceSeed, Galil Medical, Arden Hills, MN) 
and 2 millimeters of Sylgard polymer formed to the bottom. The tissue slices were 
impaled on the central cryoprobe and infrared thermography was captured using a Flir 
A20 looking from the top down.  Subsequently, samples were cultured for 24 hours in a 
cell culture incubator (myocardium) at 37°C or 4 hours at room temperature (PV) for 
optimal lesion identification with 1% TTC in Trizma buffer for 1 hour at 37°C.  
Photographs of the resultant TTC staining of each sample were captured and a custom 
Matlab program was used to normalize staining intensity and correlate the average 
staining intensity with the average thermal profile at any radial distance from the 
cryoprobe. The relationship between the staining intensity and end temperature was fit 
with a sigmoidal curve. Samples with a fit of greater than R
2
 > 0.99 were analyzed. The 
transition from dead to injured tissue was defined as the point on the curve fit where the 
staining ratio was 10% of the range between the lower and upper asymptotes of the 
sigmoid (i.e., 10% of the grayscale value change at the lesion margin closest to the 
lesion).  The maximum cooling rate correlated to this ratio and end temperature was then 
calculated from the thermal profiles. Eight thermal profiles at different radii were 
averaged to obtain a characteristic thermal profile for each sample. This approach has led 
to the creation of a database of thermal profiles that results in either completely or 
partially injured tissues. 
 
Results: Initial results suggest that cooling rates of -103±49 and -72±9 °C/min and end 
temperatures of approximately -21±6 and -17.2±3.2 °C are necessary for complete 
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necrosis of ventricular and left atrial tissue, respectively. Using a two-tailed t-test 
assuming equal variance the difference in end temperature and cooling rate between 
ventricular and left atrial tissue were non-significant (p=0.21, p=0.20 respectively). 
 
Conclusions: Experiments are ongoing to determine cryothermal injury thresholds of 
tissues associated with cardiac ablation, such as: lung and esophagus. The TTC staining 
protocol is in the process of being validated by comparison to H&E stain. Cellular 
viability assays are being performed to compare to these findings. 
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